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ABSTRACT
This project sought to establish how lanthanide metals (Ln) bind to cell membranes, 
whether they are transported into cells and how they are distributed in vivo.
Europium (Eu), chosen as a representative of the Ln series, as the chloride salt, 
formed stable aggregates (microprecipitates) in solution at neutral pH, even in phosphate- and 
bicarbonate-free conditions. The uptake of EuClg by intestinal brush-border membrane 
vesicles (BBMV) was difficult to determine because the aggregates interfered with the 
BBMV uptake assay and the concentration of available Eu^"  ^was not known.
When tested as Eu-citrate, Eu-nitrilotriacetate and other complexes (ratio of 
Euiligand, 1:2) of intermediate stability constants (log Kg of about 7 - 12) Eu was available 
for uptake by BBMV in phosphate- and bicarbonate-free conditions. Complexes with lower 
log Kg did not keep Eu in solution whilst those of higher stability did not donate it to BBMV. 
The relationship, expressed as a reverse-sigmoidal curve, between log Kg and uptake of Eu 
by BBMV was consistent for most complexes with the exception of Eu-catechol complex.
Eu bound to BBMV at two sites, as judged by displacement with the powerful ligand 
diethylenetriaminepentaacetic acid (DTP A). Binding to the DTP A-sensitive (membrane 
exterior) site predominated at 20°C. Uptake by the DTPA-resistant site was markedly 
enhanced at 37®C, suggesting a strong association with the membrane. Only small amounts 
(< 10 %) of bound Eu were released into the vesicle interior, confirming the poor membrane 
penetration of Ln ions. Thus Ln binding may be responsible for cytoprotective effects and 
changes in BBMV shape which were observed with Ln.
Eu precipitation from most complexes was promoted in solutions containing 
phosphate and bicarbonate. However, the Eu-DTPA complex was stable in physiological 
solutions. Pre-formed Eu-albumin, despite a relatively low log Kg (6.4), was more stable in 
physiological solutions than complexes of log Kg of 7 - 12. Eu precipitation in physiological 
solutions could also be prevented by increasing ligandiEu ratio.
When injected intravenously into rats, EuClg was sequestered by the liver and spleen.
Eu in the liver was present in parenchymal and non-parenchymal cells. Eu injected as the Eu- 
albumin and Eu-DTPA complexes was rapidly excreted in the urine; a small but significant 
amount of Eu was retained in the kidney.
EuClg did not effect Ca^ "*" uptake by BBMV and HoClg increased the calcium content 
of isolated hepatocytes, suggesting that Ln might not inhibitors of Ca^"^ transport in all 
biological systems. These results question the validity of ubiquitously using Ln as analogues 
of calcium.
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CHAPTER 1
INTRODUCTION
1.1 Background
Metals have many important roles, which can be summarized as signalling, catalytic,
da Silva
redox and structural, in human biology (Harrison & Hoare, 1980; Frausto^ Williams, 1991). 
These functions are carried out by four major metals (Ca, K, Mg, Na) which are required in 
bulk and six metals required in smaller amounts (Co, Cu, Fe, Mn, Mo, Zn). Obviously, of 
vital importance is an adequate uptake of these metals, as demonstrated by the disorders 
arising from deficiencies. These metals must also be distributed and maintained in a very 
specific, heterogeneous manner, for example low concentrations of sodium inside cells but 
high concentrations outside, in order that they fulfil their biological role. Mechanisms of 
uptake, buffering, storage and excretion, ensure that each metal is handled properly.
For non-essential metals, in which are included the lanthanide metals, there is no 
requirement for absorption into the body and uptake by cells but these processes do occur. 
Such "exogenous" metals may also become localized in cells, bind to cellular molecules, and 
may exhibit a wide range of activities e.g. cytotoxicity or therapeutic activity.
Understanding of mechanisms of cellular uptake is thus important in investigating a) 
deficiencies of essential metals, b) the biological activity of essential elements c) intake of 
non-essential metals d) biological activity of non-essential metals. Prior to introducing the 
lanthanides, which are the main topic of this project, it is of interest to look at general 
principles involved in the cellular uptake of metals.
1.2 Cellular Uptake of Metals
Gastrointestinal absorption is a reasonable index of the capacity for cells to absorb or 
take up metals from the diet (the absorption of some essential metals as a percentage of 
dietary intake is shown in Fig. 1.1). The bioavailability of these metals mainly reflects the 
ability of intestinal absorptive cells to take up metals but may not necessarily reflect the 
mechanisms of metal uptake in other tissue types, for example muscle, blood. The 
mechanisms available for metal uptake by cells are however examined in the context of all 
cells.
Table 1.1 The Bioavailability of Some Essential Metals
Metal Absorption (% of metal in diet)
Calcium 30-80
Copper 50-60
Iron 2-15
Manganese 3 - 12
Zinc 58-77
The bioavailabilities are estimated for humans in conditions of sufficiency. 
Ganong (1981), Friberg et a l (1986).
There appear to be three considerations that determine the uptake of metals by cells. 
1) "Form" of metal, i.e. free ion, valency, ligand-bound metal, 2) cellular mechanisms of 
metal uptake, 3) competition between ions.
Phospholipid membranes are relatively impermeable to all but small and lipophilic 
molecules. Thus metal ions cannot readily diffuse across without the aid of cellular
mechanisms. Lipophilic metal compounds, for example methyl mercury and Zn-diodoquin 
(Foulkes, 1984; Delves et al., 1975) however, readily move across and are well absorbed by 
all cell types.
The transport of ions across membranes is aided by specific ion channels, a number of 
types of ion transporters (carriers) and by energy-requiring enzymes. The molecular 
mechanisms involved in these are well characterized for the bulk metals but much less so for 
essential trace metals and non-essential heavy metals.
Ion channels are pores in the membrane through which metals can selectively diffuse; 
they are important in the entry of bulk metals into excitable cells (Hille, 1989). Whilst 
normally these may be highly specific for one element, in some cases these channels may 
exhibit a broad specificity for other ions e.g. Zn^ **" and Mn^ "*" enter hepatocytes via Ca^"^ 
inflow systems (Crofts & Barritt, 1990) and cadmium can enter pituitary cells via voltage- 
sensitive Ca^ "*" channels (Hinkle et al., 1987). The effect of some cations is to block transport 
of essential metal across these channels e.g. lanthanide ion inhibition of Ca^ "*" entry (Weiss, 
1974; this process is addressed in Section 6 of this chapter).
The transport of metals across membranes can also be facilitated by membrane ion 
transporters or carriers. The simplest carriers help diffusion of a single metal down a 
concentration gradient; these carriers, and channels which appear to be indistinguishable from 
carriers when measuring metal transport, have been proposed to be involved in the 
absorption of metals e.g. Ca^"  ^(Bronner, 1987) across the luminal membrane of the intestinal 
absorptive cell. The transport of the bulk ion, sodium, is often linked to that of other metals 
or other substrates via transporters; the Na in/out concentration gradient drives the movement 
of the substrate e.g. Na‘*'-Ca^‘^  exchangers which move Na**" in and Ca^*  ^out (Carafoli, 
1987), Na'*‘-glucose and Na'^-amino-acid co-transporters facilitate reabsorption of glucose 
and amino-acids across intestinal and renal bmsh-border membranes (Murer & Kinne, 1980; 
Hopfer, 1987). Energy-dependent carriers for cations e.g. plasma membrane Na'^/K’** pump 
(ATPase) and Ca^ "*" pump (ATPase) help maintain ion gradients across cell membranes 
(Armstrong, 1987; Carafoli, 1987).
Metals are also internalized by cell endocytosis of ligand bound metal. This is 
exemplified by the cellular uptake of F^bound to the plasma protein transferrin in tissues 
containing transferrin receptors (Huebers, 1987) and the absorption of cobalt as cobalamin 
(Donaldson, 1987). Transferrin also binds and thus delivers significant amounts of 
exogenous metals such as Al, Ga and possibly Ln. In addition to specific mechanisms of 
endocytosis, metals can also enter cells by non-specific phagocytosis of precipitates or 
microaggregates e.g. after i.v. injection of large doses of metals.
This project sets out to study some features of the cellular uptake, transport and 
distribution of the lanthanide (Ln) metals with the aim of providing information on the uptake 
and biological activity of these metals. Amongst a number of interesting activities (Weiss, 
1974; Arvela, 1979; Evans, 1990), lanthanides are similar to calcium and thus present an 
opportunity to compare the cellular uptake of non-essential metals with a related essential 
element.
1.3 An Introduction to the Lanthanides
The lanthanides (Ln) are the group of m etals ranging in the periodic table 
(Appendices 1 & 2) from lanthanum (La; atomic No. 57) to lutetium (Lu; atomic No. 71). 
They were discovered in the 19^  ^century (reviewed in Ihde, 1964); their similar chemical 
nature made separation of the individual elements difficult. Traditional uses of the impure 
metal mixtures e.g. the grinding of lenses, purifying steel, in arc lamps, are still important 
(Spedding, 1987). Applications for the pure metals, which have become available in 
appreciable quantities in the 20^ Century, include as fluors in TV screens, as a contrast agent 
in a whole body imaging technique (magnetic resonance imaging, MRI) and in many research 
applications (see below); a possible future use is as components of superconducting alloys.
Biologists have become interested in them even though they are not essential for life 
nor pose, at present, an environmental or occupational health hazard. Their principle
94-application has been as research tools. The lanthanides can substitute for Ca and have been 
employed in vitro to investigate the biochemical and physiological significance of calcium 
(for reviews see dos Remedies, 1981; Evans, 1983; Evans, 1990; Martin & Richardson, 
1979). In addition the useful physicochemical properties that some members of the group 
possess allows them to probe metal binding sites (for reviews see Biinzli & Choppin, 1989; 
Evans, 1990). It is the paramagnetic properties of gadolinium, that make the stable 
compound, Gd-DTPA, a suitable contrast agent in the whole body imaging technique of MRI 
(magnetic resonance imaging). In electron microscopy, lanthanides have been employed to 
specifically stain cell membranes because of their electron density and apparent membrane 
impermeability. Some workers have investigated the pharmacological and toxicological 
properties of these elements (for reviews see Arvela, 1979; Evans, 1990). The uptake and 
metabolism of cerium has been carefully studied to try to predict the consequences of 
environmental contamination with radioactive ^^^Ce, ^^^Ce and ^^^Ce which are products 
of fallout and waste in nuclear power plants (reviewed in NCRP 60, 1978). In the same 
context, the lanthanides have also been used as analogues for radioactive actinides in 
environmental studies.
Explaining the chemistry of the lanthanides at an early stage is useful in order to 
understand the motivation, design and results of experiments with these metals in biological 
systems.
1.4 Chemistry of the Lanthanides Relevant to their Biological Properties
The lanthanide metals are also called the rare earth metals. The term "rare earth" was 
coined at the beginning of the 19^^ century because the lanthanides possessed similar 
chemical properties to the alkaline earth metals and were thought to be scarce (Evans, 1990). 
The description rare earth was unfortunate because the word "Earth" describes the oxide of a 
metal, rather than the metal itself, and the lanthanides are not particularly scarce (Section 5.1
of this chapter). Yttrium, which is directly above lanthanum in the periodic table, is often 
included with them because of its similar properties. They are sometimes subclassified into 
light (La to Sm), middle or transitional (Eu to Tb) and heavy lanthanides (Dy to Lu). The 
chemical properties of yttrium, however, group it with the heavy lanthanides.
Ln are not stable in the elemental state and are rapidly and sometimes explosively 
oxidized to form trivalent cations. Unlike transition metals where many oxidation states may 
be available for each element, the lanthanides only have this one predominant stable state; 
Eu^"^ and Ce^'^ are the only other species formed that are stable over a period of days in 
aqueous solutions (Choppin, 1989).
The chemistry of the members of the series shows a difference in degree rather than 
kind. The tripositive charge of all the ions accounts for the similarity in kind of chemical 
properties. The decrease in ionic radius along the series, a phenomenon known as the 
"Lanthanide contraction" (Fig. 1.1), confers a gradual change in the degree of their chemistry, 
with a higher charge density with increasing atomic number. The actual size of metal ion 
is dependent upon co-ordination to neighbouring atoms and surrounding water
molecules.
The ability of lanthanides to replace calcium at binding sites is due to the similarity in 
size of their ions. In calcium’s usual co-ordination Nos. of 6,7  or 8, ionic radii of 1.00,1.06 
and 1.12 A respectively overlap with the size of Ln ions (Fig.1.1).
The flexibility in the co-ordination numbers probably explains the ability of all Ln to 
some extent to substitute for calcium (for a detailed review of the chemistry of lanthanide ion 
binding see Williams, 1982 and for a more general discussion Evans, 1990). Ln have also 
been found to be able to replace sodium in some biological systems (Birnir et al., 1987; 
Stevens & Kneer, 1988); again a similarity in size, the ionic radius of sodium is 1.02 A, may 
be the basis of this replacement.
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Fig. 1.1 Effective ionic radii of the lanthanides and calcium.
Data from Shannon (1976).
CN = co-ordination number.
Due to their relatively high charge density ("Hard-acid" character), Ln^'*' interact 
preferentially with anions of a high negative charge density ("Hard-base" character) such as 
O or F, rather than N, S or P. Their bonding is strongly ionic. Much of the behaviour of 
lanthanides in solution resembles that of other ions with a high charge density e.g. Fe (III) 
and Al (III). They interact strongly with OH"; for example at pH 7, about half of the lantha­
nide Eu will be present as Eu^ "*" and half as Eu(OH)^*^ (Choppin, 1989). Further hydrolysis 
can occur to give Ln(OH)g which is very insoluble (Table 1.2). The addition of Ln salts to a 
unbuffered solution makes the solution more acid because of the reduction in [OH"].
The formation of hydrolyzed Eu species creates technical problems as they sorb to the sur­
faces of containers or to suspended materials in solution; to reduce losses they are best stored 
at acidic pH in millimolar concentrations in containers made from Pyrex rather than soda 
glass (Ellis & Morrison, 1975).
Studies with lanthanides are also hampered by the need to use phosphate and
bicarbonate-free solutions because Ln form very insoluble lanthanide salts with these anions 
(Table 1.2). Other buffers, e.g. citrate, glycine and TRIS form lanthanide complexes which 
reduce lanthanide availability in solution, though unwittingly, by preventing Ln hydrolysis, 
this may have been advantageous in some experiments. HEPES and PIPES buffers interact 
only minimally with lanthanides and so appear more suitable for biological studies (cited in 
dos Remedios, 1981). Lanthanides readily bind to and form complexes with molecules con­
taining charged oxygen groups, e.g. carboxylic acids. Multidentate ligands e.g. EDTA and 
DTPA form very stable Ln complexes (see Chapter 4.1).
Table 1.2 Solubility of Some Ln Salts
Anion Salt Solubility Remarks
Chloride LnClg Soluble
Nitrate Ln(NOg)g Soluble
Sulphate Hydrate Ln2(SO^)g Soluble 90g /L
Hydroxides Ln(OH)g Insoluble log Kgp = -21.3
Carbonates Ln2(COg)g Insoluble log Kgp = -32.2
Phosphates LnPO^ Insoluble log Kgp = -22.3
Fluorides LnFg Insoluble
The solubility products quoted are for Gd.
References: Smith & Martell (1976), Evans (1990).
1.5 The Uptake and Handling of Lanthanides by Animals
1.5.1 Natural Occurrence of the Lanthanides
Even though they are also known as the rare earths, these metals are not particularly 
scarce. Cerium is the most abundant element of the series at about 45 ppm in the earths crust 
and the 26^^ most abundant element,on earth (cited in Choppin, 1989). Any of them are more 
common than iodine or any of the platinum group metals (cited in Choppin, 1989 and 
Spedding, 1987). Soil concentrations of lanthanides are about 100 ppm (cited in Evans,
1990) but can be higher in areas of lanthanide deposits. Entry into the environment appears 
to be limited by the small amounts, about 0.3 |Xg/l, that are dissolved by groundwater 
(Eisenbud et aU 1984). The weathering of deposits releases lanthanide particulates into the 
atmosphere.
Crops do not seem to accumulate Ln, with concentrations from one thousandth to one 
hundred thousandth of soil concentrations. However some studies have suggested that certain 
trees, mosses and ferns discriminate for or against Ln (cited in Evans, 1990).
The amount of these metals detected in organs of mammals has varied from a few ppb 
to a few ppm (cited in Evans, 1990), and no detailed study of human tissue content has been 
carried out. Concentrations reported in body fluids are small but inconsistent. Allain et al. 
(1990) measured concentration of less than 0.3 |xg/l of several lanthanides in plasma 
compared with 10 to 30 fold higher levels found by Cutolo et al. (1989) in normal subjects; 
Minoia et al. (1990) measured less than 1 pg/ml of La in serum but 1.42 |ig/l in blood. The 
eyes contain larger amounts than other tissues and this may be due to exposure to 
atmospheric lanthanides. The accumulation by the eyes is age-related with levels in the lens 
epithelium increasing from less than 9 ppm in a 0 to 5 yr age group to greater than 400 ppm 
in people aged between 50 and 60 (Swanson & Truesdale, 1971). High levels of Ln have 
been measured in the lungs of occupationally exposed subjects; it has been proposed that the 
retention of Ln in the lung may cause pneumoconiosis (Sabbioni et al.y 1982; Sulotto et al..
1986).
1.5.2 Absorption of the Lanthanides
Lanthanides, as their soluble salts or weak complexes, are very poorly absorbed after 
a single oral administration in all adult species tested, with 0.1% or less uptake of cerium 
chloride into rats (cited in NCRP 60, 1978), less than 0.001% uptake of promethium chloride 
into humans (Thompson, 1973) and less than 0.1% absorption of ^^C e, 152,154g^^ l^^Tb 
and ^^^Tm citrates by rats (Durbin et al., 1955). Only small amounts of La (less than 
0.011% dose/g was found in soft tissues and bone uptake slowly increased from 0.005 after 1 
day to 0.01 % dose/g after 3 days) were taken up from La-containing drinking water by rats 
(Rabinowitz et al. 1988). After feeding monkeys a combination of 7 lanthanides for 63 days 
only trace amounts (less than 0.1 ppm) of metals were detected in tissues (Hutcheson et al., 
1975).
This compares with the more complete absorption of essential metals (Table 1.1) The 
main reason for the very low absorption of Ln is probably the formation of insoluble 
phosphates, hydroxides and carbonates in the intestine and also to effective adsorption (up to 
90%) on to undigested food particles (Ellis & Huston, 1968). It is interesting to note that 
aluminium absorption is also very low because of the same factors (Fulton et al., 1989). 
Metal-metal antagonism e.g. Pb and Ca, Zn and Cd, is common in intestinal absorption 
(Foulkes, 1984) but it is not known if Ln interfere with the absorption of essential elements. 
Because of their poor gastrointestinal absorption lanthanides, as the.sparingly soluble oxides, 
have been used as non-absorbable markers for digestion studies in mature sheep, goats and 
cattle (cited in NCRP 60, 1978) and lanthanide oxides have been orally administered to 
improve contrast in computed tomography scanning of the gastrointestinal tract (cited in 
Evans, 1990).
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In neonatal animals up to 20 days old, lanthanides are much better absorbed from the 
gastrointestinal tract, with up to 50% absorption of cerium chloride in newborn mice (cited in 
NCRP 60) 20% in 5 day old rats and 4% in 13 day old rats (Shiraishi and Ichikawa, 1972; 
similar findings in the neonatal mouse, rat and pig are presented by Eisele et al., 1980). 
Increased absorption in neonatal animals compared to adults is not limited to these metals but 
is also seen for other macromolecules and particulate matter. Pinocytosis, leakage between - 
cells and anaerobic gut flora in newborn animals may account for this phenomenon.
Ln complexes are slightly more bioavailable in adult animals but they are probably 
also rapidly excreted (see section 1.7). When EDTA was orally co-administered with Ce to 
calves, urinary excretion increased from less than 0.1 % to about 1 %, suggesting absorption 
and excretion of the EDTA complex (Miller & Byrne, 1970). Other stable metal-EDTA 
complex (Cr-EDTA) are absorbed and excreted to a similar extent in rats; the uptake is 
mostly by paracellular mechanisms rather than enhanced cellular uptake of metal (Bjamasson 
et al., 1985). Gd-DTPA is being tested as an orally administered contrast agent for MRI 
imaging of the gastrointestinal tract.
Soluble lanthanides are slowly but more readily mobilized following parenteral 
administration e.g. following intramuscular injection less than 6.5% of '^ '^^Ce, 152,154g^^ 
and ^ ^ ^ m  citrates are retained at the injection site after 4 days (Durbin et al., 1955). 
LnClg, after intraperitoneal injection, coated the surfaces of surrounding organs e.g. pancreas, 
intestines and only about 25% of Ln was recovered from sample tissues (Shinohara & Chiba,
1991). Insoluble Ln fluorides, phosphates and colloidal preparations of oxides and 
hydroxides are retained at the site of injection (cited in Venugopal and Luckey, 1978). 
Following inhalation, the more soluble promethium chloride and perchlorate are better 
absorbed than promethium oxide (Thompson, 1973).
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1.5.3 Tissue Distribution of Lanthanides
1.5.3.I The Form of Lanthanides in the Blood
A glance at the composition of blood reveals many different components that could 
interact with lanthanides leading to the formation of precipitates, soluble salts and soluble 
complexes (Table 1.3). Phosphate, bicarbonate, and the pH will promote the precipitation of 
Ln^“*" (section 1.3) but other constituents form Ln-complexes and thus keep Ln in solution 
e.g. citrate, amino acids, albumin, transferrin etc (see below). To some extent the form of 
lanthanide in the blood depends on the form in which it is introduced into the blood. 
Lanthanides injected at or above physiological pH as hydroxy colloids remain in this form in 
blood and are rapidly sequestered by phagocytic cells (Aeberhardt et al., 1962). However, 
the spéciation of "Free" Ln^"  ^in the blood is of interest because Ln^"  ^could become available 
by dissociation from injected Ln complexes or on release from phagocytic cells.
Despite the presence of relatively high concentrations of phosphate and bicarbonate in 
blood, there is evidence that, at low concentrations, Ln^"  ^do not form precipitates in blood. 
At low concentration (2 ^iM), and initially present as the citrate complex (100:1 ratio of cit- 
rate:Eu) lanthanides form complexes in vitro with albumin (Schomacker et al., 1988) in 
human serum; only 5% of the lanthanide, Yb, was bound to other proteins. The stability 
constants of pure mixtures of Ln-albumin complex agreed with stability constants of Ln- 
human serum albumin mixtures giving additional weight to the hypothesis that albumin was 
the main chelator of lanthanides in serum (Schomacker et al., 1988). Heavier lanthanides 
form very much stronger complexes with albumin than lighter lanthanides (Table 1.4). 
Kanapilly (1980) too, found albumin (2.8%) to be able to complex Ce (0.3 p.M) in a solution 
containing physiological amounts of phosphate and bicarbonate but it was much less 
effective at just half this concentration.
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Table 1.4 Stability Constants of Ln-Serum and Ln-Human Serum Albumin Complexes.
Ln Atomic No. logK
(serum)
LogK
(Human Albumin)
Ce 58 4.73 + 0.04 4.90 ±0.03
Nd 60 5.65 ±0.04 5.39 ±0.03
Eu 63 6.25 ±0.10 6.41 ±0.02
Dy 66 7.37 ±0.14 7.40 ±0.002
Ho 67 7.51 ±0.10 7.62 ±0.003
Er 68 8.85 ±0.04 8.85.±0.01
Tm 69 8.94 ±0.01 8.93 ±0.03
Yb 70 9.55 ±0.02 9.54 ±0.01
From Schomacker et ah (1988).
Other plasma proteins can also bind Ln, as the following list demonstrates. The anti­
coagulant properties of lanthanides suggest that they interact with factors involved in blood 
clotting (cited in Evans, 1990). a-Globulin (1%) or a mixture of beta and gamma-globulins
(1%) complexed 92% and 79% respectively of Ce in SUF (Kanapilly, 1980). In contrast to
a g ,
the findings of Schomacker, Durbin et al., (1956^ suggested that Ln^^ bound preferentially to 
globulins and/or fibrinogen rather than albumin in heparinized plasma. In studies of metal 
binding sites in vitro, Gd bound to transferrin at ambient pC02  and pH 7.4 (Ig Kg = 6.83; Zak 
& Aisen, 1988) and also to IgG (Ig Kg of highest affinity sites = -5.2; Dower et at., 1975). 
Jackson et al. (1990) have attempted to calculate what species Gd would form in the blood 
from the stability constants of the Ln complexes. It was computed that at concentrations upto
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100 |iM, the metal would have almost entirely formed transferrin complexes. A drawback of 
this model is that precipitation as the carbonates, phosphates or hydroxides is not included; in 
addition the authors use a derived log Kg of 13 for the Gd-transferrin complex, much higher 
than the experimentally determined value of other workers (see above). On a practical note, 
when collecting plasma in connection with studies with the.lanthanides it should be borne in 
mind that many of the calcium chelating agents e.g. EDTA, oxalate, used to prevent 
coagulation, will also strongly bind Ln; in this regard heparin, though strongly anionic, may 
be a better choice.
1.5.3.2 Tissue Uptake of Lanthanides
(a) Lanthanide Salts and Weak Lanthanide Complexes
Small (pg) doses of the light lanthanides, injected i.v. as the soluble citrate, rapidly 
leave the blood in rats; the plasma half life of cerium is about 17 min (Durbin et ah, 
1956a). Heavier lanthanides, also as the citrates, are retained for longer than the lighter Ln; 
the plasma Xy2  of thulium was 66 min. The main tissues involved in Ln uptake after i.v. 
injection of soluble salts at acidic pH or the citrates are bone and liver and some Ln is 
excreted in the urine (Aeberhardt et al., 1962; Magnusson, 1963; Table 1.5). Lanthanide 
injected as hydroxy colloids are more rapidly removed from the blood than "Free" Ln^+ 
(Aeberhardt et al., 1962) because of the rapid sequestration of particulate material by 
phagocytic cells of the liver and spleen.
With increasing atomic number, there is a switch from liver uptake of Ln to bone 
uptake (Table 1.5; Durbin et al, 1955; Durbin et al., 1956a; Aeberhardt et al., 1962; 
Magnusson, 1963; Berke, 1968). At higher doses, liver, spleen and lung content increase 
due to greater uptake by the phagocytic cells of insoluble and colloidal material from the 
blood (cited in Evans, 1987).
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Table 1.5 Distribution and Excretion of Lanthanide Citrates 24 hr after i.v. Injection.
Tissue Distribution 
(% of dose)
Excretion 
(% of dose)
Lanthanide Liver Skeleton Spleen Urine Faeces
58^® 63.2 20.3 0.02 3.1 2.7
63EU 41.7 24.8 0.15 10.6 3.7
65Tb 11.0 5K3 0.09 13.8 3.3
egTm 4.4 66.5 0.11 13.0 5.2
From Durbin et al. (1956a).
Hepatocytes and sinusoidal cells, most probably Kupffer cells, of the liver sequester 
lanthanides (Aeberhardt et al, 1962; Berry et al., 1989). When cerium chloride was injected 
in colloidal form at alkaline pH, the uptake after 1 day was predominantly in sinusoidal cells, 
as visualized by autoradiography (Aeberhardt et al., 1962). In contrast, cerium chloride 
injected at acid pH, and so present as free ions initially, was visualized throughout the liver. 
Colloidal Ce phagocytosed by sinusoidal cells redistributed over 20 days to hepatocytes and 
bone. The redistribution of particulate lanthanide (Gd20g) between non-parenchymal cells 
and hepatocytes has also been visualized with magnetic resonance imaging (Wolf et al., 
1985). Liver Ln is excreted in the bile but it may also be released from the liver and excreted 
through the gastrointestinal mucosa (Magnusson, 1963). The rate of loss of lanthanide from 
the liver is relatively rapid, with a t j /2 of 10 - 20 days (Durbin et al., 1955; Shysh et al., 
1969).
Bone accumulates large amounts of the heavier Ln immediately after dosing (Table 
1.5). The peak accumulation of light and transitional Ln in bone may not be complete until 10 
- 60 days after dosing as a result of the release of Ln from the liver (Aeberhardt et al., 1962;
16
Berke et al., 1968). Both mineral and osteoid components of bone bind Ln (cited in Evans,
1990). Cerium has also been found in the lysosomes of bone marrow reticular cells (Berry et
al., 1989) following 4 weeks of i.p. injection of cerium chloride to rats.
Loss of Ln from bone is very slow. Berke (1968) calculated that 16% of bone Eu was
lost with a ty 2 of 52d whilst the remainder was retained with a l y 2  of 2.7 years. Durbin et
al. (1955) also estimated the Ln bone i y 2  to be in the order of years.
The kidney also contains significant amounts of injected Ln (0.9 to 1.6%/g) and is the
major soft tissue for the uptake of heavy lanthanides (Magnusson, 1963; Durbin^f à/., 1955;
et al.
Berke, 1968). While most of this metal is lost, Berke (1968) and Durbin](1955) report that 
about 20% of the kidney Ln content was still retained after several months. Small to 
moderate amounts of Ln also appear to be present in the pituitary, thyroid, adrenal glands, 
pancreas and ovaries (cited in Evans, 1990). However these observations have not been 
confirmed in some studies (Berke, 1968). Other tissues that contain Eu above blood 
concentrations were tail, pelt, heart, lower and upper gastrointestinal tract (values not given; 
Berke, 1968). Ln do not appear to pass through the blood-brain barrier or placental barriers 
(Berke, 1968).
(b) Strongly Complexed Lanthanide
Fomasiero et al. (1987) investigated the distribution of 5 Ln complexes 1 hour after 
injection into mice, where ligand was present at least 3 fold excess concentration. Complexes 
of stability constant of log Kg greater than 18, i.e. the CDTA and DTP A complexes, were 
judged as stable m vivo because they were almost fully excreted (85 % and 91 % of dose 
respectively) in the urine one hour after injection. The NTA and EDTA complexes which 
form complexes of Log Kg of 11 and 17 respectively were partially (between 50 % and 75 % 
of dose) excreted in the urine and as expected the chloride salt was almost fully retained in 
the tissues. Thus, complexation of lanthanide into stable water soluble complexes promoted
17
urinary excretion and reduced tissue uptake of the metal.
The stable water-soluble complex Gd-DTPA is currently in u s^a  paramagnetic 
contrast agent in MRI and other complexes e.g. Gd-DOTA are currently under investigation 
(details of investigation of Gd-complexes in MRI are in section 8 of this chapter).
Gd-DOTA and Gd-DTPA are not sequestered into tissues but rapidly excreted in the urine 
(Wedeking & Tweedle, 1988). Gd-DTPA has a plasma t^2 in rats of 20 mins (Weinmann et 
al., 1984). The rapid urinary excretion of these metals is due to the high hydrophilicity and 
poor cell membrane penetration of these complexes. The stability of the Gd-DTPA and Gd- 
DOTA complexes (log Kg of 22.5 and 28; Lauffer, 1987) means that little Gd dissociates in 
vivo', very low concentrations of Gd have been detected in bone following administration of 
Gd-DTPA in mice (Wedeking & Tweedle, 1988). A small amount of Gd could also be 
released from DTPA due to Cu competition for DTPA (Tweedle et al., 1988).
1.5.4 Membrane Transport and Subcellular Distribution of the Lanthanides
Most experimentalists, using Ln as their salts in vitro as research tools, attest to the 
impermeability of cell plasma membranes to Ln. In electron microscopy, lanthanides have 
been used to stain cell membranes and epithelial surfaces to the tight junctions; they bind 
strongly to stain the plasma membrane with an electron dense deposit (Flatt, et al., 1980; 
Hambly and dos Remedios, 1977; Nell & Rummel, 1984). It should be noted that damage to 
the cells e.g. ischaemic damage to cardiac tissue or fixation prior to lanthanum staining, 
renders the cell permeable to the ions (Harper et al., 1990). A disadvantage of electron 
microscopy as an analytical tool is that it may not be sufficiently sensitive to detect low intra­
cellular Ln and the processing of the specimens prior to visualization may remove 
intracellular metal.
When used as NMR or spectroscopic probes of phospholipids in liposomes, Ln bind
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to the phospholipid moiety of the membrane but cannot move across the membrane (Bystrov 
et al., 1971), confirming the expected impermeability of pure phospholipid membranes 
towards metal ions.
Studies investigating calcium physiology in isolated tissues suggest that Ln displace 
cell surface calcium and inhibit calcium fluxes but are apparently not internalized themselves 
(Flatt et al., 1980; Langer & Frank, 1972). The interaction of lanthanides with calcium trans­
port mechanisms is discussed later in Section 6 of this chapter. The removal of sialic acid 
residues from cardiac muscle is reported to permit entry of Ln (Frank etal., 1977). Some 
reports, however, suggest that Ln do enter muscle cells. After incubation of La with isolated 
uterine smooth muscle, Hodgson et al. (1972) found La in the plasma membrane, 
endoplasmic reticulum and mitochondrial subcellular fractions, which apparently could not 
be explained by redistribution of La after homogenisation. In addition, Peeters et al. (1989), 
using embryonic chick ventricular cells loaded with the fluorophore Indo-1, have detected 
cellular influx of La, probably via the Na'^-Ca '^*” exchanger.
Purified preparations of membrane vesicles appear to be able to transport Ln to some 
degree. At high concentrations (ImM), Ln enter vesicles prepared from synaptic plasma 
membranes; this appeared to be not via the Na'*’-Ca^‘^  transporter (Rahamimoff & Spanier, 
1984). Lanthanides, at mM concentrations, stimulate glucose transport across intestinal 
brush-border membrane vesicles (BBMV) and glucose and amino-acid transport across renal 
BBMV (Ste y ens & Kneer, 1988; Bimir et al., 1987). It is thought that the lanthanides are 
replacing Na"*" on the Na*^-glucose and Na'^-amino acid transporters. It is difficult to 
extrapolate the in vitro results shown above with Ln^*  ^to in vivo experiments because the 
chemical spéciation of Ln in blood and biological fluids is not known but it is likely that free 
concentrations of Ln^ "*" are very low (Chapter 1.5.3.1).
As noted in Section 5.3.2 of this chapter, lanthanides probably gain entry to cells 
following phagocytsis of Ln precipitates in blood. Consistent with this. Berry et al. (1989), 
following i.p. injection of CeClg to rats, co-localized Ln and phosphate in the lysosomes of 
Kupffer cells, using ionic microanalysis and electron microprobe analysis. Ln was also
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visualized with phosphate in lysosomes of hepatocytes and bone marrow reticular cells, 
suggesting that Ln, in some form, is endocytosed by these cells also. Other reports of the 
subcellular distribution of Ln in liver ascribe uptake to the cellular cytosol and organelles. 
Tuchweber et al. (1976) noted a diffuse electron-dense material in Kupffer cell cytosol that 
was presumed to be Ln; the electron dense material was also found in vacuoles in pericanal­
icular areas of hepatocytes. Ando & Ando (1990), surveying the relative tumour and liver 
uptakes of many metals, report that Yb and Tm are distributed into the lysosomes but also 
other fractions of liver and tumour cells; the subcellular distribution was determined by 
centrifugation of homogenized tissue and possibly some redistribution of Ln between 
organelles may occur. Arvela (1979) reports that Ln is present with the high molecular 
weight component of the soluble fraction of liver cytosol.
1.5.5 Excretion of Lanthanides
(a) Lanthanide Salts and Weak Lanthanide Complexes
Rare earths given in the form of soluble citrates, are eliminated from the body in two 
phases. Initially, urinary excretion is relatively high then faecal excretion predominates as Ln 
is released from the liver (Tables 1.5 and 1.6). The net total excretion of heavier lanthanides 
and yttrium is less than for light lanthanides because of their greater bone deposition, from 
which site loss occurs slowly (see Section 5.3.2 (a) of this Chapter). The faecal excretion is 
composed of biliaiy excretion and also excretion from the gastrointestinal tract (Magnusson, 
1963). Ln, injected as hydroxy colloids, are more slowly excreted in faeces and urine than Ln 
injected as soluble salts at acidic pH (Aeberhardt et al., 1962).
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(b) Strongly Complexed Lanthanide
Gd-DTPA and Gd -DOTA are rapidly and almost completely excreted in the urine 
following i.v. injection in all mammalian species tested (Weinmann et al., 1984; Wedeking & 
Tweedle, 1988). The elimination t^2  Gd-DTPA is about 80 to 90 mins in man. Smaller 
mammals tend to excrete the complex more rapidly and upto 95% is excreted from mice Ihr 
after injection. Administration of the high affinity ligand DTPA following rare earth salt 
administration can also promote urinary and biliary excretion and reduces retention of 
lanthanide in the body. DTPA is always superior to EDTA in mobilizing lanthanides from 
tissues but with increasing atomic No. of the Ln mobilisation by EDTA increases (Catsch & 
Harmuth-Hoene, 1979); this is consistent with the strength of complexes formed, as judged 
from stability constants.
Table 1.6. Excretion of the Lanthanides following i.m. Injection of Ln-Citrates.
5 8 ^ 63^" 69Tm
Days after 
Injection Urine Faeces
(% of dose) 
Urine Faeces Urine Faeces
1 6 2 11 3 17 5
4 6 6 13 5 24 8
32 10 46 16 30 27 9
256 10 62 19 43 32 11
One day data taken from Durbin et al. (1956a) and the other time points from Durbin et al. 
(1956b).
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1.6 Effect of Lanthanides on Calcium Homeostasis
Most calcium (> 99%) in the body is immobilized in the form of hydroxyapatite in 
bones and teeth. However, the small, rapidly exchangeable fraction in extracellular and intra­
cellular fluid plays an important role in physiology, for example blood coagulation and 
cellular biochemistry, with a diverse range of effects through its role in intracellular 
signalling. The actions of Ln on calcium homeostasis are most easily discussed following a 
review of the mechanisms of cellular calcium homeostasis.
1.6.1 Cellular Calcium Homeostasis
The role of free intracellular cytosolic calcium ( Ca "^^  ^) as a signal inside cells is the 
subject of much current research. The importance of Ca "^^  ^is revealed by the large number 
of functions it has been linked with (Table 1.7). In order to act in a trigger capacity free 
intracellular cytosolic calcium concentrations ( [Ca^"^^ ) are maintained at lO'^M to 10"^M 
compared with extracellular free calcium concentrations of 10‘^M; upon cell stimulation they 
rapidly rise, set in train biochemical processes and are rapidly returned to basal values. The 
maintenance of calcium concentration inside cells at low levels also prevents precipitation of 
Ca with the high levels of cytosolic phosphate. The in/out Ca gradient is maintained by 
Ca^*^-transporting systems of the plasma membrane, mitochondria and endoplasmic 
reticulum/sarcoplasmic reticulum (Fig 1.2; for a review see Carafoli, 1987; Carafoli & 
Penniston, 1985); the importance of other organelles is poorly characterized.
The plasma membrane ATP-driven Ca^^ pump, that extrudes Ca^*^ from the 
cytoplasm, has a high affinity (K ^ < 1 p,M) for Ca^"  ^and thus readily restores to
very low levels. The plasma membrane Na'^/Ca^’*' exchanger is of lower affinity but higher
22
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Fig 1.2 Mechanisms of cellular calcium homestasis.
PM plasma membrane 
ER endoplasmic reticulum
MTT mitochondrion 
SR sarcoplasmic reticulum.
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capacity and is particularly active in excitable tissues. Mitochondria and endo(sarco)plasmic 
reticulum act as intracellular buffers of Ca^* .^ Mitochondrial uptake of Ca^"  ^by the calcium 
uniport, driven by the negative potential of the mitochondrial matrix, proceeds at a slow rate 
because the uptake is of low affinity but it may be important in the regulation of some Ca- 
sensitive matrix dehydrogenases. Mitochondria also respond to abnormal increases of cell 
Ca '^*' with the accumulation of Ca^*’’ and as precipitates, as observed in the lethal phase of 
cell death. Calcium may be released from mitochondria by the Na'^/Ca^'*' exchanger. 
Endoplasmic reticulum (the mechanism is common to sarcoplasmic reticulum) sequesters 
calcium by a membrane-bound Ca^'^-ATPase, which has different properties to the plasma 
membrane Ca^’^ -ATPase. Calcium channels in plasma membrane, endoplasmic reticulum
94-and sarcoplasmic reticulum permit Ca entry into the cytosol upon cellular stimulation. 
This is an overall view of calcium signalling but the detailed picture is more complex with 
spatial heterogeneity of Ca^ "*"^  in the cytosol (Frausto da Silva & Williams, 1991) and 
oscillations in [Ca^ "*"]^  in response to stimuli, or even whilst at rest (Berridge & Galione,
1988).
When acting in its signalling capacity, cytosolic calcium may directly affect the
change in biochemistry but more usually this is transduced through calcium binding protein,
da Silva «
the most common of which is calmodulin (Fraust^& Williams, 1991). Ca^ -calmodulin can
activate a variety of enzymes e.g. some protein kinases, plasma membrane Ca^'^-ATPase (but
not in liver) thus leading to the removal of Ca^*  ^from the cytosol and the end of the Ca^*^
signal. Troponin C, which binds Ca '^*' and allows actin and myosin interaction and hence
da Silva
muscle contraction, is similar in structure to calmodulin (Fraustcy& Williams, 1991).
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Table 1.7 Examples of Calcium-Controlled Events in Cells
Activity Controlled Event or System
Muscle contraction Actin - myosin interaction
Synaptic transmission Vesicle exocytosis
Exocytosis Vesicle exocytosis
Receptor responses Protein phosphorylation
Cell shape Cytoskeletal - membrane interactions
Oxidative phosphorylation Mitochondrial dehydrogenase function
Metabolism e.g. glycogen breakdown
Cell division S -100 proteins
Cell death Internal proteases
Based on Frausto da Silva & Williams (1991).
1.6.2 Effects of Lanthanides on Calcium Homestasis
Ln have been used to study Ca^"*"-transport mechanisms in purified preparations of 
cell membranes (Table 1.8). Lanthanides are inhibitory to most of these mechanisms but 
don’t appear to be transported by them. Ogurusu et al. (1991), observed that La^'^-binding 
sites on Ca^"^-ATPase are not the Ca transport sites
Lanthanum disturbs calcium homeostasis in cells and tissues, by binding to the out­
side of cells, displacing superficial calcium and blocking transmembrane calcium fluxes 
without itself being internalized (Langer & Frank, 1972; Flatt et al., 1980). The effect of this 
in muscle is to inhibit contraction though excitation may still occur (dos Remedios, 1981;
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Hambly & Dos Remedios, 1977; Langer & Frank, 1972). It is effective at jiM to mM 
concentrations to cardiac and smooth muscle where inflow of sarcolemmal bound Ca is 
important for contraction (dos Remedios, 1981). Kolbeck & Spiers, (1986) found that 
perfusion of the cardiac vasculature with 5 mM La caused a loss of contraction pressure and a 
decrease in total heart calcium content of 50 %. The cellular distribution of calcium was 
altered, sarcolemmal Ca was reduced compared to untreated hearts but mitochondrial 
calcium; this was detected by rapid freezing techniques. As discussed in Chapter 1.5.4, some 
studies question whether the inhibitory actions of lanthanides on function are fully explained 
by actions on the plasma membrane.
94-In isolated pancreatic islets, in the presence of physiological concentrations of Ca 
outside cells, La^ **" suppresses ^^Ca fluxes and inhibits insulin release but does not affect 
glucose oxidation or general ultrastructure, consistent with effects at the plasma membrane 
(Flatt et ah, 1980). In perfused liver. La displaced surface Ca and inhibited Ca uptake/efflux 
(Claret-Berthon et a l, 1977). Interestingly, in contrast with the effects of Ln on other tissues, 
Parker & Barritt (1981) reported that La increased Ca uptake into isolated hepatocytes; this 
was due to a stimulation of Ca influx rather than inhibition of Ca extrusion and was not due 
to increased cell death.
In contrast to their in vitro actions of Ca antagonism, local tissue becomes calcified 
after the subcutaneous injection of lanthanides (Garrett & M cClure, 1981). A fter 
intraperitoneal injection of terbium chloride to mice, the tissues (liver, spleen, seminal 
vesicles, all of which are in contact with the peritoneal cavity) of Tb localization were 
correlated with increased concentrations of calcium (Shinohara & Chiba; 1991). Possibly 
increases in tissue calcium may be through extracellular precipitation of lanthanide, calcium 
and phosphate. Lanthanides produce hypercalcaemia and hyperphosphataemia at low doses 
but hypocalcaemia and hypophosphataemia at higher doses (Johansson et al., 1968). It was 
proposed that the dual effect may be due to low doses of Ln displacing calcium and 
phosphate from bone but that at higher doses aggregates of lanthanide, calcium and 
phosphate are sequestered by the reticuloendothelial system.
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1.7 Pharmacology and Toxicology of the Lanthanides
The differing toxicity of Ln when given by oral, intraperitoneal and intravenous 
injection reflects the absorption of Ln from the site of administration (Table 1.9; the 
availability of Ln from routes of administration is discussed in Section 5.2 of this chapter). 
There is no consistent pattern in potency along the Ln series. Mice and rats grew normally 
with addition of Ln oxides at concentrations of 36, 120,400 and 800 ppm for Eu, Yb, La, Sm 
and Dy to the diet respectively to three generations; however, Tm as the chloride at 1 % 
stunts growth (Venugopal & Luckey, 1978). The presence of Ln in the diet has also been 
found to be beneficial, retarding the development of atherosclerosis in rabbits (Gillies et a l, 
1989; Evans, 1990). Other calcium antagonists also have antiatherosclerotic properties but 
the action of La is surprising because of the very small quantities that are absorbed. Perhaps 
unsurprisingly, there are no reported cases of Ln poisoning from dietary or environmental 
exposure to Ln. However, workers exposed to fumes containing Ln, for example from 
carbon-cored arc lamps, retain Ln in the lung and may develop pneumoconiosis (Sabbioni et 
al, 1982; Sulotto et a l, 1986).
When administered i.p. to mice, citrate complexes are more toxic (LD^q of 150 mg 
complex/kg) than the chloride salts (LD^q of 300 - 500 mg LnClg/kg), due to the greater 
mobilisation of the citrate from the site of injection (Graca et a l, 1957). EDTA complexes of 
the light lanthanides, injected i.p. to mice and guinea pigs, are more toxic (LD^q of 40 mg 
complex/kg) than the corresponding citrates but with increasing atomic number the toxicity of 
the EDTA complexes decreases, consistent with the stability of the complexes formed (Graca 
et a l,  1962). The LD^Q of Gd-DTPA, used clinically as a contrast agent, is reported to be 
greater than 1000 mg Gd/kg when injected i.v. into mice and rats (Weinmann et a l, 1984).
When injected intravenously, lanthanides become less toxic above an upper threshold 
dose; this may be due to reduced concentrations of free Ln^ "*" because of Ln aggregation in
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blood. Female mice and rats are more sensitive to the toxicity of light Ln than males 
(Magnusson, 1963; Tuchweber et al., 1976).
Table 1.9 Route-dependent Toxicity of the Lanthanides
Compound Species Index of 
Toxicity
oral
Dose 
(mg metal/kg) 
i.p. i.v.
LaClg rat ^ 5 0 2380 74
Ce(N03)3 rat 1360 94 16
Ne(NOg)g rat 905 89 22
ErCIg mouse ^ 5 0 2720
Er(N03)3 rat ^ 5 0 83 19
LD^q dose causing mortality in 50 % of animals. 
Venugopal & Luckey (1978).
At autopsy, following injection of fatal doses of Ln salts and citrates, there is oedema, 
particularly of the lung, a generalized hyperaemia and hepatic congestion (Graca et al., 1957; 
Graca et al., 1962). After injection of light Ln, the liver is soft and yellow but the livers from 
rats treated with the heavier lanthanides have a mottled appearance (Magnusson, 1963); this 
is consistent with the different hepatoxicities of light and heavy Ln (see below). Deaths occur 
in two phases, within a few hours of dosing and 24 - 48 hours later (Graca et al., 1957; Graca 
et al., 1962). However, Ln injected i.v. to dogs and cats in some cases causes an immediate 
and fatal hypotension (Graca et al., 1964).
The most significant histopathological change that occurs is fatty infiltration of the 
liver (Magnusson, 1963; Arvela, 1979); this is only caused by the light lanthanides and has 
been observed in rats, mice, hamsters and rabbits but not in guinea pigs and dogs (cited in
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Evans, 1990). Hepatocytes of affected livers are filled with lipid droplets and there are signs
of necrosis. The ultrastructural changes that are observed in hepatocytes include the presence
of dense lipid droplets, rough E.R. degranulation and dilatation with parallel stacks of E.R.
encircling mitochondria, smooth E.R. accumulation, mitochondrial swelling and irregularly
shaped nuclei (Magnusson, 1963; Tuchweber et a l, 1976). Consistent with the histological
observations of fatty infiltration, liver concentrations of fatty acids and phospholipids are
raised. Ln-induced fatty liver is associated with alteration of fat metabolism; uptake of fatty
acids from plasma is increased but oxidation of lipids by mitochondria and synthesis and
secretion of lipoproteins is suppressed (Evans, 1990). The mechanism of Ln-induced fatty
liver is not known. Ml hypothesis is that inhibition of transcription by Ln, observed in vitro 
is involved;
and in v/v<9,jjhowever, it is not clear if the changes in transcription are the primary action of 
the lanthanides responsible for changes in metabolism (Arvela, 1979; Evans, 1990). Another 
hypothesis is that Ln-stimulated catecholamine release from the adrenal gland is the basis of 
the action (Evans, 1990); this hypothesis more readily explains why the fatty liver is reversi­
ble despite continuing presence of Ln in the liver (Evans, 1990).
Heavy lanthanides do not produce steatosis of the liver but a patchy necrosis 
(Magnusson, 1963) which is not understood. The lanthanides also induce other changes in 
liver metabolism. Liver glycogen stores are depleted and blood glucose levels fall; this effect 
is reversible (Magnusson, 1963). Microsomal enzymes involved in drug metabolism are 
inhibited, perhaps not surprisingly in view of the changes in rough e.r. morphology (Evans, 
1990).
In addition to their effect on hepatocytes, lanthanides block Kupffer cell phagocytosis 
and pinocytosis at low concentrations (20 p,M Gd/kg i.v. = 3 mg/kg; Lazar, 1973; Hustzik et 
al., 1980). However, Ln do not have any effect on endothelial and hepatocyte endocytosis 
(Bouma & Smit, 1989).
There is a single report of Ln-induced nephrotoxicity. Some small lesions of the 
proximal convoluted tubule in the kidney have been noted after bi-weekly i.p. administration 
of CeClg to rats for four weeks (Beny et al., 1989).
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The decreases in blood lipid and glucose levels following injection of Ln reflects the 
changes in hepatic metabolism (see above) but Ln also have intrinsic effects on blood 
components. Blood clotting times are prolonged, Ln probably acting at one or more of the 
Ca^'^-dependent steps in the coagulation cascade (Hunter & Walker, 1956; Evans, 1990). 
The anticoagulant properties of Ln compounds and complexes have been clinically evaluated 
(Evans, 1990); unfortunately after i.v. injection of the salts, subjects reported chills, fever, 
haemoglobinaemia and haemoglobinuria (Evans, 1990). Effective inhibition of clotting 
without adverse reactions were reported following intravenous injection of 5 mg/kg of the 
lanthanide complex, neodymium 3-sulpho-isonicotinate, to a group of over 50 patients 
(Hunter & Walker, 1956). The use of this complex has evidently not become established. 
The effect of Ln on calcium levels in blood and tissues has been previously dealt with (Sec­
tion 6.2 of this chapter).
1.8 Clinical Applications of Lanthanides
One of the useful properties of the Ln is that they are paramagnetic (especially 
gadolinium) and thus provide resolution in analytical techniques involving nuclear magnetic 
resonance (NMR) spectroscopy. In whole body NMR, magnetic resonance imaging (MRI), 
paramagnetic compounds can enhance the contrast in tissues where they are localized provid­
ing better visualization of anatomical features (Wolf etal., 1985; Lauffer, 1987; Tweedle et 
al., 1988). The paramagnetic lanthanide, Gd, as Gd-DTPA (Magnevist), is the only MRI 
contrast agent at present licensed for human use. Gd-DTPA is useful for detection of brain 
tumours, métastasés, lesions of the spine and multiple sclerosis. The complex is restricted to 
the bloodstream and extracellular fluid though it does not pass the blood-brain barrier; as 
outlined previously it is rapidly and completely excreted. An increased permeability of 
capillaries and enhanced perfusion in cancerous tissue probably explains the contrast it 
produces in these lesions. The compound has a very favourable therapeutic index (normal
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dose 0.1 mmol/kg; LD^q/ED^q of about 100) compared with contrast agents in other 
imaging techniques (Tweedle et al., 1988). Expanding the use of this agent to the imaging of 
other lesions is under way as is the development of new Gd containing compounds that might 
usefully diagnose other lesions. Gd-DOTA appears to be even more stable than Gd-DTPA 
and so should have an even more favourable therapeutic index (Meyer et al., 1989; Caille et 
al., 1989). Gd-DTPA has also been incorporated into liposomes to try to obtain an agent 
useful in diagnosing hepato-biliary diseases (Kabalka etal., 1987; Schwendener et al, 1989). 
Gadolinium oxide produces good contrast of the liver in experimental studies because of the 
liver uptake of colloidal material (see 1.6) but the potential toxicity and retention of Gd 
probably precludes its clinical use (Wolf et al., 1985).
At present, Gd-DTPA in MRI imaging appears to be the only clinical use of 
lanthanides. Historically they have been tested as anticoagulants (section 7 of this chapter), 
antiemetics and astringents (Evans, 1990). Radioisotopes of lanthanides e.g. insoluble ^^^Dy 
compounds, have been tested as agents for radiosynovectomy, non-surgical destruction of in­
flamed synovial tissue (Sledge et al., 1984, Evans, 1990).
Evans (1990) offers several possible future clinical applications, as antiatherosclerotic 
agents, as antiinflammatory agents and as antiarthritic agents, of the lanthanides based on in 
vitro and in vivo observations of Ln activity. The observation that La retards atherosclerosis 
has previously been discussed (section 7 of this chapter). The antiinflammatory properties of 
the lanthanides originates from a range of biological activities of lanthanides in animals 
observed in vivo and in vitro e.g. inhibition of lymphocyte activation (Yamage & Evans,
1989), inhibition of phagocytosis (see section 7 of this chapter), inhibition of polymorphonu­
clear leukocyte chemotaxis (Evans, 1990). Inhibition of neutral metalloproteinases e.g. 
collagenase, observed in vitro, combined with the antiinflammatory properties and ability to 
localize insoluble Ln in joints, forms the basis of proposed antiarthritic properties (Evans,
1990).
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1.9 Aims and Approaches
A point of controversy in Ln biology is whether, in the ionic state, Ln can cross cell 
membranes (Chapter 1.5.4). Consequently, at present, it is not clear whether Ln^'^ exert their 
biological activity whilst bound to the outer membrane or through small amounts that have 
been internalized. In vivo, resolution of whether Ln cross cell membranes transport is 
complicated by the formation of Ln precipitates in biological fluids. As a first step in 
understanding the effects of Ln, this project will investigate the binding and transport of 
LnClg across intestinal brush-border membranes (BBMV), a well characterized plasma 
membrane preparation. The intestinal brush-border membrane plays an important role in the 
absorption of essential metals; the results of Ln transport across this membrane will indicate 
if brush-border membrane impermeability contributes to the low oral absorption of this metal, 
or if, in common with other non-essential metals, small amounts of metal can be absorbed 
(Foulkes, 1984; Foulkes, 1988). A component of the study will also investigate if the 
membrane action of Ln results in a perturbation of cellular calcium transport. This hypothesis 
will be tested in BBMV and also in isolated hepatocytes, which are a target for Ln toxicity.
Ligand molecules can have a profound effect on the distribution of Ln (for examples 
see Section 5.3.2 (a) and (b) of this chapter). Thus ligands present an opportunity to develop 
Ln compounds that have specific cellular uptake and biological (therapeutic) activity. The 
effect of a range of ligands on donation of Ln to BBMV will be studied. Ln-ligand 
complexes which appear to have interesting properties will then be examined in an in vivo 
distribution study.
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CHAPTER 2
MATERIALS AND METHODS
2.1 Sources of Metals and Ligands
2.1.1 Lanthanides
EUCI3.6H2O (99.99 %), H0CI3.6H2O (99.9 %) and CeCl3.7H2 0  (99.99 %) were 
purchased from AlcMch Chemical Co. (Gillingham, UK). The metal chlorides were stored 
with desiccant at room temperature.
To minimize the formation of hydrolyzed Ln species and Ln-carbonates (see also 
Chapter 1.3), Ln stock solutions (1 to 100 mM) were freshly prepared in aqueous acid 
solution (20 mM PIPES pH 6.1 or 1 mM HCl) on the day of experimentation. The stock 
solutions were prepared in acid washed volumetric flasks. Radioactive ^^^EuCl3 (1.0 
mCi/ml, 0.078 mg Eu/ml) in O.IM HCl was obtained from Amersham International pic 
(Amersham, UK).
H0CI3 stock solutions (0.1 to 500 mM), for addition to incubation medium containing
hepatocytes, were prepared in 20 mM PIPES pH 7.4 in order to maintain the pH of the
incubation medium (Chapter 6).
Water used in the preparation of reagents was purified by reverse osmosis (R.O.) or 
double distillation.
2.1.2 Calcium and Iron
Stock solutions of CaCl2 (from 1 to 10 mM) in 0.15 M choline chloride, 20 mM
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PIPES pH 6.8 or 1 mM HCl were prepared from CaCl2-2H2 0  (AnalaR grade; BDH, 
Eastleigh, UK). '^^CaCl2 (1 -5  mCi/ml, 10-40 mCi/mg Ca) was obtained from Amersham. 
^%eClg (1 mCi/ml, 0.11 mg Fe/ml) was purchased from Amersham.
2.1.3 Preparation of Europium-Ligand Complexes
The ligands were purchased from the sources listed in Table 2.1; free acids, where 
applicable, of the ligands were used. Stock solutions (5, 10 or 100 mM) of the ligands were 
prepared in R.O. water; if required, dilute KOH was added to aid dissolution.
In the BBMV uptake experiments (Chapter 4), concentrated solutions (about 10 times 
the required concentration) of ^^^Eu-ligand complexes were formed by mixing stock 
solutions of EuClg, ^^^uClg and ligand; the formation of Eu hydroxides is minimized under 
these acidic conditions. The solutions were then diluted with the appropriate experimental 
incubation buffer (Section 2.2.3.3). The final amount of radioactivity present was 10 jiCi/ml. 
The amount of Eu contributed by ^^^Eu was accounted for in the total Eu present.
For example, to prepare 400 p.1 of 100 |iM Eu-DTPA (Eu:DTPA) in incubation buffer, 
4 pi of ^^%u (2 X 10"^ mol Eu) were mixed with 38 pi of 1 mM EuClg (38 x 10"^mol Eu) in 
1 mM HCl in an acid washed test tube. DTPA (16 pi of 5 mM DTPA in RO water; 80 x 10" 
^ mol DTPA) was added and the solution vortexed. The volume was made to 400 pi by the 
addition of 342 pi of incubation buffer and mixed.
In the experiments with hepatocytes in cell culture medium (Chapter 4.5), Eu was 
mixed with crystalline bovine serum albumin before the addition of cell-culture medium so 
that complex formation was not inhibited by precipitation with phosphate etc.
Preparation of the Eurligand complexes for the in vivo study is described in Section 4 
of this chapter.
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Table 2.1 Sources and Purity of Ligands
Ligand Purity Supplier
Albumin (Bovine Serum) 96-99% Sigma
Albumin (Bovine Serum) globulin-free Sigma
Albumin (Rat) globulin-free Sigma
L-Ascorbic acid A.R. grade Fisons
L-Aspartic acid AnalaR BDH -
Catechol 99+% Aldrich
Citric acid AnalaR BDH
Cryptand [2.2.2.] 99% Aldrich
Dimethyl phosphate Mixture of dimethyl and monomethyl
phosphoric acid esters Pfalz & Bauer
DPA 99% Aldrich
DTPA 98% Aldrich
EDTA 99% Sigma
NTA 99% Aldrich
Transferrin (Rabbit) Sigma
DPA dipicolinic acid DTPA diethylenetriaminepentaacetic acid
EDTA ethylenediaminetetraacetic acid NTA nitrilotriacetic acid
The structure of some of the ligands are shown in appendix 3
Pfalz & Bauer chemicals were purchased from Phase Separations (Clwyd, UK).
Fisons are located in Loughbrough, UK.
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2.1.4 Procedure for Loading Transferrin with ^^Iron or ^^^Europium
^^Fe-transferrin complex was prepared as per Van Renswoude et al. (1982; see 
below). was substituted for ^^Fe in an attempt to prepare ^^^Eu-transferrin complex.
The protocol for Fe can be briefly described as follows. Initially contaminating iron was 
removed from transferrin (Tf) by ascorbate at acidic pH. Then the metal, as its NTA complex 
to prevent the formation of insoluble hydroxides and carbonate, was incubated with 
transferrin in the presence of bicarbonate. Bicarbonate is required by Tf to bind iron. 
Unreacted metal was separated from complexed metal using a typical desalting gel exclusion 
method (see below).
(a) Reagents 
O.IM Tris pH 8.0
0.25 M Tris/10 pM NaHCOg pH 8.0 
0.15 M NaCl/0.02 M Tris pH 7.4 
^^Fe 0.11 mg Fe/ml (0.2 mCi/ml)
0.078 mg Eu/ml (0.2 mCi/ml)
100 mM NTA
Column A: PDIO column (Pharm acia LKB Biotechnology, Uppsala, Sweden)
equilibriated with 0.25 M Tris, 10 pM NaHCOg pH 8.0
Column B: PDIO column equilibriated with 0.15 M NaCl, 0.02 M Tris pH 7.4.
(b) Method
1) Rabbit transferrin (5 mg) was dissolved in 0.5 ml 0.1 M Tris pH 8.0.
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2) Sodium ascorbate (4 mg) was added, the solution was acidified to pH 5.8 with dilute 
HCl and left for 30 min at 37°C.
3) The solution was passed down column A and the eluate containing Tf collected 
following instructions supplied with the desalting column.
4) 100 |Lil of ^ %e or ^^%u were added to 500 p.1 of ICO mM NTA (final concentrations; 
0.32 mM Fe or 0.086 mM Eu and 83 mM NTA). The metal-NTA complex was then 
added to the Tf.
6) After incubating at room temperature for 1 hr, the solution was passed down column
B and the eluate collected following instructions supplied with the desalting column 
(the elution profile of ^ %e and ^^^Eu are shown in Fig.4.8.
2.2 Preparation and Use of Intestinal Brush-Border Membrane Vesicles
2.2.1 Preparation of Brush-Border Membrane Vesicles
There are several published methods for preparing intestinal BBMV (for reviews see 
Kessler et al., 1978 and Murer & Kinne, 1980; Murer & Hildemann, 1984; Weiser et al., 
1986), differing mainly in approach e.g. density gradient centrifugation, free-flow 
electrophoresis, metal ion precipitation, to purifying the brush-border membrane from other 
membranes. The chosen method (Simpson & Peters, 1984 which is adapted from Kessler et 
al., 1978) separates BBMV from other basolateral plasma membranes and other organelles on 
the basis of their differing reactivity towards divalent cations. A high concentration of 
divalent cations (Mg^ "*") cross-link basolateral membrane fragments but BBMV shield the 
charge within their own membrane because they are more electronegative. Thus the BBMV 
can then be pelleted at higher centrifugal forces than the large aggregates of basolateral 
membranes and heavier organelles. This method was chosen because it is relatively simple to 
perform with satisfactory purification of the brush-border membranes (Chapter 3.2).
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Rabbit intestines were used because the BBMV can apparently be stored frozen with 
only small loss of function, unlike rat BBMV (Kessler et al., 1978; the function of frozen and 
fresh BBMV is compared in Chapter 3.2.3). In addition the BBMV can be prepared when 
convenient from frozen intestinal material (Kessler, 1978; see also Chapter 3.2). The cost 
and undesirablility of buying rabbits for their intestines was avoided by obtaining intestines 
from rabbits which were used in antibody production.
(a) Reagents
Intestinal wash:
Thawing solution:
Homogenizing solution:
Resuspension buffer (A)
(B)
0.15 M NaCl (May & Baker, Dagenham, U.K.).
300 mM mannitol (Sigma, Poole, U.K.), 12 mM Na-HEPES 
(Sigma), pH 7.1 at room temperature.
50 mM mannitol, 0.2 mM PMSF (Sigma), 2mM HEPES free 
acid, pH to 7.1 at 4°C with KOH.
100 mM mannitol, 100 mM NaCl, 0.1 mM MgSO^, 20 mM 
Na-HEPES, pH 7.4 at room temperature.
300 mM mannitol, 20 mM HEPES free acid, pH to 7.4 at room 
temperature with KOH.
The homogenizing solution and resuspension buffer (A or B) were prepared in bulk 
(2.5 litres) and 250 ml portions filter sterilized into sterile bottles. The solutions were stored 
at 4°C until required.
Resuspension Buffer A is the buffer used by Simpson & Peters (1984) but was found 
not to be convenient here because Na*^-dependent glucose transport cannot be measured in 
BBMV prepared in this buffer (Chapter 3.2.3). Buffer B was preferred because it did allow 
measurement of Na'^-dependent glucose transport.
Intestinal material was from male or female New Zealand White rabbits.
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(b) Method
(a) The rabbit was killed by cervical dislocation; in most cases the rabbit had been bled 
prior to death.
(b) A long incision was made in the abdomen to expose the intestines and stomach.
(c) Beginning at the stomach (proximal) end, the small intestine was carefully dissected 
out. Care was taken not to pierce the intestine
(d) The intestine was severed a few centimetres short of the caecum.
(e) The intestine was cut in half and the distal (ileal) region discarded. The proximal 
(duodenal, jejunal and some ileal) half was cut into smaller strips of 10-20 cm in 
length.
(f) Each strip was washed out with about 60 ml of ice-cold saline using a 20 ml syringe. 
The segments were then utilized as described in (g) below unless they were to be 
frozen for later use. To freeze the intestinal material, the strips from each intestine 
were bagged separately and placed immediately into a dewar flask containing solid 
CO2. Frozen material was transferred to a freezer at -70°C.
When required, frozen segments were thawed in 5(X) ml of thawing solution at room 
temperature and then processed as below.
(g) All segments were kept on ice. Any adherent fat or connective tissue was removed 
and the segment cut open longitudinally to expose the mucosa and placed on a plate of 
glass over ice. The mucosa was gently wiped with soft tissue paper to remove mucus 
or food particles.
(h) The mucosal tissue was removed by running the edge of a microscope slide over the 
mucosa. Scrapings were suspended in 75 ml of ice-cold homogenizing buffer
(i) The scrapings were homogenized at full speed for 2 min in a MSE blender, the 
homogenising flask surrounded by ice.
All subsequent separation procedures were carried out at 0-4®C.
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(j) The volume of the homogenate was made to 150 ml with resuspension buffer and 
solid MgCl2.6H20  added to a final concentration of 10 mM.
(k) The homogenate was gently stirred for 15 min then placed in centrifuge tubes.
(1) The vesicles were separated from other cellular constituents by the following
centrifugation steps.
Homogenate
Spin
Pellet discarded
3000 g^y for 10 min
Supernatant
2"‘iSpin 40000 g^y for 30 min
BBMV pellet
(m)
(n)
(o)
(P)
The vesicle pellets were resuspended in a small volume ( 3 - 4  ml) of resuspension 
buffer in the centrifuge tube using 3-retum strokes with a motor-driven potter type 
homogenizer rotating at KXX) rev/min.
The resuspended vesicles were pooled and the volume made to 75 ml. MgCl2.6H20  
(10 mM final concentration) was added.
Steps (k) to (1) were repeated to further purify the vesicles but the 1^  ^spin was for 15 
min at 6(XK) g^y.
The final BBMV pellet was resuspended in 3 - 5 ml of resuspension buffer by 
aspirating through a 21 g needle.
Procedures for assessing the purity of the vesicles (assays for maltase, Na'^/K'*’-
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ATPase and electron microscopy are described in Section 2,2 of this chapter and the results 
given in Chapter 3.2 ;). Vesicle function was determined by Na‘‘‘-dependent glucose 
transport (see below and Chapter 3.2.4). The protein concentration of the vesicles was 
determined by the BioRad protein assay with y-globulin as a standard (Section 5.2 of this 
chapter).
2.2.2 Validation of BBMV
The composition, in terms of plasma membranes, of the intestinal homogenate and the 
membrane suspension were determined by assaying for dissacharidase (maltase) and Na'^/K'^ 
ATPase activity. Disaccharidases are located exclusively on the brush-border membrane and 
Na'^/K'*’ ATPase is only found on the basolateral membranes (Murer & Hildmann, 1984; 
Weiser et al., 1986; Madara & Trier, 1984).
2.2.2.1 Maltase Assay
Maltase was assayed by the method of Messer & Dahlqvist (1966) with reagent 
volumes multiplied by five. Glucose liberated from maltose by intestinal disaccharidase is 
oxidized by glucose oxidase with hydrogen peroxide formed; peroxidase catalyzes the 
oxidation of dianisidine by hydrogen peroxide to the coloured product.
(a) Reagents
0.031 M glucose-free maltose. Details for the preparation of this from maltose (Sigma) are 
given in Messer & Dahlqvist (1966).
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0.5 M sodium phosphate buffer pH 6.0.
Phosphate-glucose oxidase reagent (PGO): 0.3 ml of o-dianisidine dihydrochloride, 0.3 ml 
of 0.1 % peroxidase and 0.3 ml of glucose oxidase (Boehringer Mannheim) were added to
29.1 ml of phosphate buffer.
Glucose standard (1.1 mM)
5 0 % v/v H2SO4
The assay was performed on homogenate and vesicle extracts that had been stored at -20°C 
and were diluted in distilled water 5(X) and KKXK) times respectively.
(b) Method
All standards and samples were assayed in duplicate.
(1) Diluted sample or water blank (100 p,l) were added to 500 |il of PGO reagent and 
warmed at 37°C for 5 mins. This was repeated for an identical set of solutions.
(2) The reaction in both sets of samples was started by adding 500 ill of 0.031 M maltose.
(3) The reaction in one set of samples was stopped after 15 min and in the other set after 
75 min by adding 500 |xl of H2SO4.
(4) The standards (0,50,75 and 100 pi of glucose standard with 500 pi of PGO and water 
to 1100 pi) were incubated at 37®C for 15 min and the reaction stopped as above. 
The standards contain 0,10,15 and 20 pg glucose respectively.
(5) The absorbances of samples and standards were read at 530 nm.
Glucose formation in samples and blanks was estimated from the glucose calibration 
curve. Maltase activity (maltase hydrolyzed, one maltase releases two glucose molecules) 
was calculated per mg protein/min. From this the enrichment on a per mg protein basis in the 
vesicles over the homogenate was calculated as well as the total amount of maltase in the 
vesicles compared to the homogenate.
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2.2.2.2 Na^/K^-ATPase Assay
Na'^/K'*’-ATPase was assayed by the method of Forbrush (1982). The 
samples were solubilized with SDS to enable substrate to be available to all membrane 
surfaces. Na’^ /K'^-ATPase is inhibited in one set of sample by ouabain.
(a) Reagents
Incubation medium (A): 144 mM NaCl, 30 mM KCl, 4.8 mM ATP, 4.8 mM MgCl2, 72 mM 
Tris, 1.2 mM EDTA, pH 7.5
Incubation medium (B): as above + 2.4 mM ouabain (an inhibitor of Na’^ /K'*' ATPase), pH
7.5
0.3 % BSA in 25 mM imidazole buffer, pH 7 
0.13%BSAinH2O
Solubilizing agent: 0.65 mg/ml SDS, 1 % BSA in H2O
For the determination of inorganic phosphate (Pp: ascorbic acid (3 g) was dissolved in 35 ml 
H2O; 50 ml 1 M HCl were added and the solution cooled to 0°C. When the solution was 
cold, 5 ml of 10 % ammonium molybdate and 15 ml of 20 % SDS were slowly added with 
stirring. The colour should be yellow, not blue-green. A solution of 2 % sodium arsenite 
(w/v), 2 % trisodium citrate (w/v) and 2 % acetic acid (v/v) was also required.
A range (0 to 1 mM) of inorganic phosphate standards were prepared from a 50 mM 
KH2PO4 stock standard (stored frozen at -20®C).
(b) Method
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(1) 100 pi of solubilizing agent was added separately to 20 pi of homogenate, 10 pi 
BBMV and 20 pi of resuspension buffer.
(2) After 10 min incubation at room temperature, 600 pi of 0.3% BSA in imidazole was 
added to dilute the SDS.
(3) In duplicate, 100 pi aliquots of the tubes were pipetted into 2 plastic test tubes.
(4) Reaction was started in one set with 500 pi of prewarmed buffer A, the other set with 
500 pi of prewarmed buffer B.
(5) After 10 minutes reaction, 1 ml of ascorbate/molybdate was added and the samples 
placed on ice. The ascorbate/molybdate was also added to Pj standards (300 pi 
standard had been diluted with an equal volume of 0.13 % BSA).
(6) Arsenite/citrate/acetate solution were added after 10 min on ice and the solutions 
incubated for 10 mins.
(7) Pj was assayed as the absorbance at 705 nm.
Na'^/K'*’ ATPase activity was the difference between total ATPase activity and 
ouabain-inhibited ATPase activity. It was expressed as pmol P^  formed/mg prot/min.
2.2.2.3 Electron Microscopy of the BBMV
(a) Reagents
Buffer stock solution: 0.2 M sodium cacodylate pH 7.4
Fixative: 4 % glutaraldehyde in 0.1 M sodium cacodylate pH 7.4 (with dilute
HNOgorNaOH).
Counterfixative: 1 % Osmic acid in 0.1 M cacodylate pH 7.4
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Solvents 96 % ethanol
absolute ethanol 
propylene oxide
Embedding resin Epon 812: Solution A 62 ml Epon + 100 ml DDSA, mixed well.
Solution B 100 ml Epon + 89 ml MNA, mixed well.
The resin was prepared by mixing 150 ml of solution A with 150 ml of
solution, then adding 5.25 ml of DMP.30 with stirring. The resin was
stored at -20^C until required.
(b) Method
(a) To 1 ml portion of BBMV (5 -10 mg/ml) were added 3.2 ml of 0.16 M cacodylate pH 
7.4.
(b) Glutaraldehyde (0.8 ml of a 25 % solution; final concentration of 4 %) was added 
dropwise with vortexing.
(c) After 1 hr fixing at room temperature, the mixture was centrifuged at 25000 g for 30 
min to pellet the membranes.
(d) The supernatant was poured off, the pellet scraped from the wall of the 
centrifuge tube and washed in 5 ml of 0.1 M cacodylate for 1 to 18 hours.
(e) The cacodylate was poured off and the pellet counterfixed in 1 % OsO^, 0.1 m 
cacodylate for 1 hr.
(f) The pellets were dehydrated for at least 10 min in each of the following solutions 
25 % v/v ethanol - 2 changes
50 % ".....................
75 % ".....................
90%"  " " "
absolute ethanol
propylene oxide/absolute ethanol (1:1)
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propylene oxide - 2 changes
(g) The pellet was then left for at least 20 min in a 1:1 mixture of propylene oxide and 
Epon 812 resin.
(h) The pellets were transferred to capsules full of resin.
(i) The resin was polymerised for 48 hr at 60°C.
Ultrathin sections of the blocks were cut and mounted onto copper grids. The were 
counterstained with uranyl acetate and lead citrate. The sections were examined using a 
Phillips 400T transmission electron microscope.
BBMV filtered onto cellulose filters (see Chapter 2.2.3) were also prepared for e.m. as 
above with slight differences in the method. Small sections of the filters (about 15 mm )
were fixed in 4% glutaraldehyde. 0.1 M cacodylate, pH 7.4. The protocol then continued
from step (c) but pelleting of the material by centrifugation was not required. The filters were 
not dehydrated in propylene oxide as this was found to dissolve the filters but were given an 
extra dehydration step in absolute alcohol prior to the resin. If the BBMV were filtered onto 
PTFE filters propylene oxide could be used but the sections were difficult to cut because the 
resin easily detached from the specimen.
2.2.3 Transport Studies with Intestinal BBMV
Briefly, ^^^Eu, ^^Ca, ^%e or (^H)D-glucose were incubated with the BBMV. The 
binding and transport of metal or glucose by BBMV was determined by capturing the BBMV 
onto filters and washing. The corresponding radioisotope on the filters was then measured by 
counting the gamma or beta activity with solid or liquid scintillation counting (Section 5.1 of 
this chapter).
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2.2.3.1 Equipment
12 - port filtration manifold (1225 filtration manifold; Millipore, Watford, UK).
Filters of mixed acetate and nitrate esters of cellulose, 0.22 pm pore size, (GSWP02500, 
Millipore).
Vacuum pump: Speedivac High Vacuum pump (BDIOO; Edwards Vacuum Components, 
Crawley, UK) or Compton compression/vacuum pump (model D/2760; Dawson, McDonald 
& Dawson, Ashboum, UK).
5 Litre Buchner flask.
Microman positive displacement pipettes (Gilson, c/o Anachem Ltd, Luton).
The equipment was set up as shown in Fig.2.1. The "0"-rings on the filtration 
manifold were lightly lubricated with vacuum grease. The filtrate from each filter could be 
collected into test tubes inside the manifold or as waste in the manifold and trap. The 
equipment was decontaminated by soaking in a weak solution of detergent or in a weak acid 
solution if contaminated with metals.
Filtration ports
_rLrLn_rL_rL_
Filtration manifoldTrapVacuum pump
Fig.2.1 Layout of filtration apparatus.
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2.2.3.2 Determination of Na^-Dependent Glucose Transport by BBMV
Na'^-dependent glucose uptake was measured in order to verify BBMV function. In 
the presence of an out/in Na"  ^concentration gradient, D-glucose transport into the brush- 
border membrane vesicles is facilitated by a Na’^ /glucose transporter (Hopfer et al., 1973; 
Kessler era/., 1978).
The assay incubation medium was 0.9 mM D-(^H)glucose (10 pCi/ml), 0.15 M NaCl, 
20 mM HEPES, pH 7,4. D-(^H)glucose (1 -5  Ci/mmol) was purchased from Amersham. 
Occasionally, D-(U-^^C)glucose (300 mCi/mmol; Amersham) was used instead of D- 
(^H)glucose.
7
# W
u
u
1 An aliquot (200 pi) of incubation medium was pipetted 
into an acid washed plastic test tube (LP3, Luckham). Incuba­
tion was started by adding 200 pi of BBMV and vortexing.
2 At timed intervals, 50 pi of reaction m ixture was 
withdrawn and placed onto a 0.22 pm filter, prewetted with 1 
ml of wash solution (see below) in the filtration manifold 
(vacuum on).
3 The filters were immediately washed with 2 x 5 ml of 
ice-cold 0.7 mM phloridzin, 0.15 M NaCl, 1 mM HEPES, 1 
mM Tris, pH 7.4. Phloridzin is an inhibitor of the Na'^-glucose 
transporter.
Steps 1 to 3 were repeated with 200 pi of incubation medium 
and 200 pi of vesicle resuspension buffer (no vesicles) in order 
to determine D-(^H)glucose retained by the filters.
On completion of the assay, the vacuum on the manifold was 
released.
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4 The filters were removed from the manifold with forceps and placed in plastic 6 ml 
scintillation vials. Scintillation fluid (5 ml; Optiphase Safe) was added and the vial was 
shaken. After about 30 min, when the filters were transparent, the vials were counted in the 
scintillation counter (see Section 5.2 of this chapter). An aliquot (25 pi) of the incubation 
medium was counted in duplicate to determine the total amount of radioactivity present.
The assay was repeated so that there were 3 to 4 replicates of each data point.
The above protocol was repeated with an assay incubation medium of 0.9 mM D-(^H)glucose 
(10 pCi/ml), 0.15 M choline chloride, 20 mM HEPES (potassium salt), pH 7.4 to determine 
the rate of passive glucose influx.
For routine validation of intestinal function, Na'^-dependent glucose uptake was assayed after 
2 min 15 sec, judged to be the peak of glucose uptake.
2,233 Determination of Europium Uptake by BBMV
The methodology of measuring Eu uptake by BBMV was the same as used to measure 
uptake of D-glucose. The following incubation buffers were employed: (a) ^^^EuClg, 0.1 M
mannitol, 0.1 M NaCl, 20 mM PIPES pH as given in text and (b) ^^^EuClg or ^^%u-ligand,
20 mM PIPES, 159
0.15 M choline chloride JpH 6.0 or 6.1. ^“^ ^Eu, as its salt or as a complex, was present at 10
pCi/ml. The final pH of the incubation medium after adding vesicle resuspension buffer (no
vesicles) was checked with a pH meter. The filter wash solution was ice-cold 0.15 M NaCl,
2 mM PIPES, pH 6.8 unless otherwise stated.
To assay filters for ^^^Eu, they were folded into a small cone and placed at the
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bottom of a 4ml transparent plastic test tube. The tube was then counted in the gamma 
counter (Chapter 2.5.1). Aliquots (25 pi) of the incubation medium were counted to 
determine total radioactivity. The results are expressed as the percentage of the total amount 
of ^^^Eu retained by the filters with and without BBMV. The results are also expressed as 
the amount of Eu, in moles, bound per mg of BBMV protein, corrected for the ^^^Eu 
retained by the filters.
2.2.3.4 Determination of Calcium Uptake by BBMV
Calcium uptake was assayed in an identical manner to Eu uptake. The incubation 
medium was ^^CaCl2» 0.15 M choline chloride, 20 mM PIPES, pH 6.1. The filter wash 
solution was ice-cold 0.15 M NaCl, 2 mM PIPES, pH 6.8.
2.2.3.S Differentiation of External and Internal Vesicular Europium
Radioactivity retained with the vesicles on filters may be bound to the exterior of the 
BBMV, internalized or bound internally. In order to remove Eu bound to the membrane 
exterior, the BBMV were washed with the strong Ln chelating agent DTPA or with an acidic 
wash solution (details in Chapter 3.3.2 and 4.3.1).
An attempt was made to directly measure intravesicular Eu by loading BBMV with 
DPA, which strongly enhances the fluoresence of Eu. The details of this procedure are 
described in Chapter 4.3.3.
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2.3 Preparation of Isolated Hepatocytes
Isolated rat hepatocytes were prepared for uptake studies of Eu-ligands (Chapter 4) 
and to investigate the effect of holmium on calcium levels in isolated cells (Chapter 6). The 
isolation procedure was also used to separate and collect parenchymal cells and non- 
parenchymal cells from the liver of rats administered Eu compounds (Chapter 5).
The method (Lawrence & Benford, 1991) involves in vitro perfusion of rat liver.
(a) Reagents
Calcium-free bicarbonate buffer: 142 mM NaCl, 4.37 mM KCl, 1.24 mM KH2PO4, 24
mM NaHCOg, 0.62 mM MgSO^, 0.62 mM MgCl2 and 
0.125 mM EDTA.
Collagenase buffer: calcium-free bicarbonate buffer without EDTA with 5
mM CaCl2 and collagenase (0.5 mg/ml buffer).
PBS ’A’ (calcium-free phosphate buffered saline; Flow Labs, Irvine, UK): 140 mM NaCl, 2.9
mM KCl, 8.1 mM Na2HPO^, 0.1 mM KH2PO4.
(b) Method
(1) The animals (200 - 300 g male Wistar albino rats) were killed by suffocating with
C02-
(2) The abdomen was swabbed with 70% ethanol and an incision made to expose the liver 
and intestines.
(3) Grasping a converging point of connective tissue and vessels, the liver was carefully 
dissected away from adhering connective tissue.
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(4) The liver was removed and placed in about 50 ml of PBS ’A’. All solutions were at 
37°C.
(5) The left lateral lobe was severed from the rest of the liver.
(6) The lobe was laid flat and the cut edge trimmed with a microtome blade to expose the
blood vessels- the lobe was temporarily returned to the PBS while the same procedure 
was repeated in the median and right lateral lobes.
(7) The lobes were emptied onto a grid that was held by a retort stand and an exposed 
vessel on each lobe cannulated with an 18g plastic cannula.
(8) The lobes were perfused with Ca^‘*’-free bicarbonate buffer at 10 ml/min. The lobes 
were massaged gently to free blood clots and optimize the blanching of the tissue
(9) When the liver was optimally perfused, the perfusion rate was increased to 25 ml/min. 
On correct positioning of the cannulae, the liver was seen to swell when the flow rate 
was increased.
(10) The rate of perfusion was decreased to 20 ml/min.
(11) When the bicarbonate buffer was exhausted the perfusate was exchanged to the 
collagenase buffer. This was collected as it drained from the liver and recirculated
(12) The liver was perfused for about 10 min or until soft to touch.
(13) The lobes were placed in about 30 ml of PBS*A' and the capsule gently teased away 
from the tissue. The isolated cells became suspended in solution; gentle stirring aided 
dissociation.
(14) The suspension was filtered through bolting (Nybolt, 125 pm) to separate large 
aggregates of cells.
(15) The filtrate containing the isolated cells was poured into a 50 ml Falcon tube and the 
volume made upto about 50 ml with PBS‘A‘ with gentle mixing.
(16) The tube was centrifuged at 50 g for 2 min to sediment viable hepatocytes.
(17) The supernatant containing non-parenchymal cells, non-viable cells and cell debris 
was poured off. This was resuspended in 50 ml of PBS‘A‘, adding a small volume 
initially to disrupt the pellet.
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(18) The cells were centrifuged at 50 g for 2 mins.
(19) Steps (17) and (18) were repeated.
(20) The pelleted cells were resuspended in 10-20 ml of incubation medium.
Cell yield and cell viability after isolation was assessed by Trypan Blue dye exclusion 
(see Section 3.1.1 below). Leakage of the cytosolic enzyme lactate dehydrogenase (LDH) 
was used to assess cell viability during some experiments (see Section 3.1.2 below).
2.3.1 Assessment of Hepatocyte Viability
2.3.1.1 Trypan Blue Dye Exclusion
A 100 pi aliquot of the suspended hepatocytes was added to 100 pi of 0.5 % Trypan 
Blue dye in 0.9 % saline (Flow Labs). After incubation for 2 mins at room temperature, a 
portion of the mixture was transferred to a haemocytometer with the coverslip already in 
place. The total number of cells and the number of unstained (viable) cells in 0.1 mm^ were 
counted (in duplicate). This was repeated for another sample of cells.
The number of viable cells per ml and as a percentage of the total number of cells was 
calculated.
2.3.1.2 Enzyme Leakage
The leakage of cytosolic enzyme, lactate dehydrogenase (LDH), due to membrane 
permeability was used to assess cell viability (Benford & Hubbard, 1987).
Hepatocytes were pelleted at 50 g and the supernatant transferred to a clean tube. An 
equal volume of new medium was added to the cells. An aliquot of the cells was solubilized
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by adding an equal volume of solubilizing agent (0.9 % NaCl, 0.1 % Triton X-100). In 
duplicate 25 - 200 pi of solubilized cells or supernatant were added to a cuvette containing 
0.61 mM pyruvate and 0.32 mM NADH in 44.6 mM K2HPO4 and 7.3 mM KH2PO4. The 
change in A^4q was followed for 3 mins; if, at the start, the optical density was below 1 then 
the assay was repeated using less sample.
Cell viability (enzyme leakage) was calculated as the rate of change of absorbance of 
the supernatant as a percentage of the rate of change of the supernatant and the cells (cell 
activity was multiplied by two to allow for dilution).
2.3.2 Determ ination of the Total Calcium and Holmium Content of
Hepatocytes
The experimental protocol for the treatment of cells with Ca^*  ^and Ho^"^ prior to 
analysis of metal levels is given in Chapter 6.2.1.
Total cell calcium was assayed by flame atomic absorption spectrophotometry 
(Instrument Lab., model 353), using an air/acetylene flame; absorbances were measured at 
422.7 nm with a band pass of 0.9 nm. Ca^*  ^standards (1-5 mM) and samples of cell 
supernatant were diluted 1:100 with 0.1 % LaClg prior to assay; lanthanum was added to the 
diluent to minimize interference from phosphate. Vortexed suspensions of the cells were 
diluted 2-fold with 10 % LaClg prior to analysis.
The holmium content of cells was also determined by flame AAS (Pye-Unicam SP9). 
The flame was fuelled by nitrous oxide and acetylene. An absorbance wavelength of 410.4 
nm and bandpass of 0.2 - 0.5 nm was used. Ho standards (1-25  pg/ml = 6.06 - 151.6 pM) 
and samples (if required) were diluted in 0.2% w/v KCl, 20 mM PIPES pH 6.1.
The calcium and holmium content of the cells was expressed as a percentage of the 
total amount of the respective metal recovered from the cells and supernatant and also on a 
per mg protein basis, as determined by the manual Lowry assay (see Chapter 2.5.2).
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2.3.3 Measurement of Hepatocyte Cytosolic Calcium Concentration
9  I 9  I
The protocol for measuring the concentration of free cytosolic Ca ( [Ca ] j ) with 
the fluorescent indicator quin2 was based on that used by Charest et al. (1983).
(a) Reagents and Equipment
Quin2/AM and quin2 (Aldrich).
Fura-2 and fura-2/AM (Novabiochem; Nottingham, UK).
Krebs-Henseleit: 118 mM NaCl, 4.8 mM KCl, 1.2 mM MgS0 4 .7H2 0 , 1.0 mM
KH2PO4, 16.9 mM PIPES-Na and 3.1 mM PIPES free acid.
Minimum Essential Medium Eagle (MEM) with Earle’s salts, sodium bicarbonate (2.2 g/1) 
and non-essential amino acids.
L-glutamine (Sigma).
Earle’s buffered salt solution (EBSS, Sigma) with sodium bicarbonate (2.2 g/1).
Triton X-100 (6% solution).
Digitonin (250 jjM).
EGTA(0.2M).
Silanized conical flasks.
Perkin Elmer LS5 fluorimeter, equipped with magnetic stirrer and jacketed cuvette for 
temperature control.
The quin2/AM and fura-2/AM were dissolved in DMSO (dried with Drierite, Aldrich) 
and stored as 50 mM and 1 mM stock solutions at -20®C under deaccant.
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(b) Methodology
(1) Isolated hepatocytes were prepared as described and resuspended in Krebs-Henseleit 
(supplemented with 0.1% glucose and 2% BSA) or MEM (supplemented with 2 % 
BSA and 2 mM L-glutamine). The cell suspensions were periodically gassed with 
95% O2, 5% CO2.
(2) Quin2/AM (20 p.1 of 50 mM; final concentration of quin2/AM was 200 p.M) was
added to an aliquot of the cells in a conical flask (5 ml at 4 x 10^ cells/ml) ).
(3) As a control, 20 pi of DMSO was added to another aliquot of cells.
(4) The cells were incubated for 15 min with shaking at 37®C, then centrifuged at 50 g 
and resuspended in Krebs-Henseleit (no BSA) or EBSS at 1 x 10^ cells/ml.
(5) A sample (3 ml) of the cell suspension was pipetted into a quartz cuvette with a 
stirring bar and placed in the fluorimeter. The temperature was maintained at 37®C 
and the cells were slowly stirred.
(6) The emission spectrum (excitation wavelength 339 nm, excitation slit width 5 nm) 
from 400 - 550 nm was recorded to check that the emission peak was at about 490 nm 
(the peak emission wavelength of quin2).
(7) The quin2 signal (F) was recorded at the fixed excitation wavelength of 339 nm (slit 
width 5 nm) and emission wavelength of 490 nm (slit width 10 nm).
(8) Additions of holmium and ATP (an agent that increases [Ca^’*’]p to the cuvette were 
made using a mechanical pipette.
(9) The signal from extracellular quin2 (F^^^) that had leaked from the cells was 
quenched by adding MnCl2 (final concentration about 100 pM).
(10) The Mn was chelated by adding DTPA (final concentration about 200 pM).
(11) The cells were lysed with triton detergent (final concentration 0.1% to 1%) or with 
digitonin (final concentration 4 - 1 0  pM). This gave the maximum fluorescence 
reading (F ^3x).
(12) The minimum fluorescence (F ^^) was obtained by chelating the calcium with 125 pi
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of 0.2 M EGTA (final concentration approx. 8.3 mM).
(13) The above procedure was repeated with DMSO-loaded cells to determine the effect of 
the reagents on the background fluorescence of the hepatocytes.
(c) Calculations
Concentrations of [Ca^ "*”]^  were calculated from the following formula (Charest et ah, 
1983; Rink & Pozzan, 1985):-
[Ca2+]j = K ^ (F -F ^ „)
^max ■ ^
The of the quin2-Ca complex is 115 nm.
The fluorescence signals where corrected for the contribution from extracellular quin2
as following.
F— — F - F max ^max ^ext
F =F-Fext
^min ~ ^min ” ^ext
Also, if the detergent caused a change in the signal of control DMSO-treated cells, 
this was subtracted from the signal recorded with quin2 loaded cells.
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2.4 In Vivo Distribution Study of Europium Compounds
2.4.1 Preparation of Europium Compounds
Table 2.2 Europium Doses for Injection
Group Compound Eu:ligand
ratio
Dose
mgEu/kg
Solution 
mg Eu/ml
Activity
pCi/ml
A pH 7.4 0.1 0.1 25
B IS^EuClgpHS.O 0.1 0.1 25
C l^^Eu-albumin pH 7.4 1:4 0.1 0.02 5
D 152eu-DTPApH7.4 1:3 0.1 0.1 25
E pH 7.4 1:4 0.1 0.02 approx. 340
Solutions for groups A, B and D were made by adding ^^^Eu (final activity 25 
pCi/ml) to EuClg and ligand (if present) in 0.15 M NaCl, pH about 4. The pH values were 
then adjusted to their correct values by adding NaOH/HCl. The Eu-albumin complexes (see 
Section 4.2 for labelling albumin with ^^^I) were prepared in the same manner but in 5-fold 
greater volume so that albumin was injected at roughly physiological concentrations (0.53 
mM albumin; 5.5 % solution).
2.4.2 Labelling of Albumin with
Rat albumin was labelled with ^^^I by the method of Fraker et al. (1978).
59
(1) Coating of tubes with iodogen.
lodogen (l,3,4,6-tetrachloro-3a,6a-diphenylglycouril. Sigma) was dissolved into 
dichloromethane at a concentration of 250 pg/ml. Aliquots (1 ml) of the solution were 
apportioned into 2 ml polypropylene microcentrifuge tubes and evaporated to dryness under N2.
(2) Reaction of albumin, and iodogen.
In duplicate, rat albumin (125 mg at about 50 mg/ml in NaCl pH 5) and then 0.5 mCi 
of 12^1 were added to an iodogen-coated tube. After a few minutes reaction, the mixture 
was passed down a PDIO column that had been equilibr ated with 0.15 M NaCl pH 5. The 
eluate was captured in fractions of 10 drops and assayed for radioactivity. The fractions 
from the first eluting peak of radioactivity, corresponding to (^^^I)albumin were pooled.
The final albumin concentration of the (^^^I)albumin was determined by the BioRad 
protein assay with bovine serum albumin as standard (Section 5.2 of this chapter).
2.4.3 Experimental Protocol
The compounds (A to E above) were injected, using a 21g butterfly cannula, into the 
ventral tail vein of groups of 4 male Wistar albino rats (200 - 250g). After dosing the animals 
were placed in aluminium metabowls with food and water freely available; urine and faeces 
were collected.
After 24 hours, the animals were anaesthetised by overdose of phenobarbitone (Saga- 
tal; May & Baker, Dagenham; 0.2 ml/100 g body weight) and bled out by cardiac puncture. 
An aliquot (0.5 ml) of blood was placed into an heparinized tube (Teklab) and the rest was 
allowed to clot. Plasma and serum were collected from the heparinized and clotted blood 
respectively by centrifugation at 3000 rpm for 10 mins (Beckmann TJ-6).
The following tissues were removed and weighed at autopsy. Weighed samples of 
each (if not the whole organ) were placed into test tubes for assay for ^^^Eu or ^^^I.
60
(a) Liver: an aliquot was taken for counting; the remainder placed into PBS‘A‘ for 
fractionation of cell types.
(b) Kidney: one for counting,the other was placed in ice-cold homogenizing solution for 
subcellular fractionation.
(c) Spleen (g) Testes
(d) Sternum (h) Small intestine (first 5 cm)
(e) Lung (i) Pancreas
(f) Heart (j) Thyroid (taken from animals dosed with ^^^I)
The volume of urine collected was recorded. A 1 ml sample was assayed for 
radioactivity. The faeces were divided into small portions because of the geometry of the 
gamma counter (section 5.2 of this chapter) and the individual totals summed.
2.4.4 Hepatic Distribution of ^ ^^Eu and
Hepatocytes were isolated from other liver cells essentially as in Chapter 2.3. Non- 
sedimenting material at 50 g was kept as the non-parenchymal cell fraction and sedimenting 
material as the hepatocytes. Hepatocyte viability was checked by Trypan Blue Dye exclusion 
(Chapter 2.3.11). The radioactivity in 1 ml aliquots of the cell fractions was assayed. The cell 
fractions were assayed for protein by the BioRad protein assay having been solubilized in 0.1 
M NaOH (final concentration); standards were also diluted into 0.1 M NaOH (final 
concentration).
2.4.5 Subcellular Fractionation of the Kidney
The kidney was fractionated into classical subcellular fractions by differential
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pelleting according to the method of Andersen et al. (1987). The distribution of ^^^Eu and 
amongst the lysosomal subfractions was examined by further subfractionating the ML 
fraction by rate sedimentation. The method was adapted for a swing-out rotor (M. Dobrota, 
personal communication) whereas originally the fractionation was performed in a zonal HS 
type rotor.
(a) Reagents
Sucrose stock solution:
Homogenizing solution: 
Buffer stock solution:
2 M sucrose
0.25 M sucrose, 
lMTris-HClpH7.4
5mMTris-HClpH7.4
(b) Method
(a) One kidney was taken from each animal of the group.
(b) The kidney cortex was carefully excised and the weight of the pooled cortices was 
recorded (approx. 2.5 g).
homogenizing solution
(c) The cortices were homogenised in j  using a Potter-Elvehjem type
homogeniser motor-driven at 1000 r.p.m. The homogenate was made up to 20 - 25 ml 
solution and filtered through a coarse sieve (tea strainer). An aliquot o f the 
homogenate and other subcellular fractions below were retained for later analysis.
(d) The filtered homogenate was centrifuged at 700 g^y for 3 mm to sediment the nuclear 
fraction.
(e) The nuclear fraction was resuspended in homogenizing medium and spun again as in
(c). The pellet was retained as the nuclear fraction (N).
(f) The supernatants from (d) and (e) were combined and centrifuged at 9200 g^y for 3 
min to pellet the mitochondrial/lysosomal (ML) fraction. The supernatant from this
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was centrifuged as lOOOOOg^y for 1 hour and the sedimented microsomal (mic) 
fraction and supernatant (Sup) collected.
(g) The sedimented ML fraction was resuspended in about 6 ml of the homogenising 
medium using a hand-operated Potter-Elvehjem type homogeniser.
(h) Aliquots (1.5 ml) of the fraction were very slowly and carefully layered onto the 
sucrose gradients (see Fig.2.2) by holding the pipette tip against the wall of the 
centrifuge tube.The sucrose gradients were buffered with 5 mM Tris-HCl.
(i) The tubes were centrifuged in a 6 x 38 swing out rotor (Kontron TST 28.38) at 6400 
rpm for 1 hr.
(g) The fractions from the spin were collected by upward displacement of the tube 
contents by 2 M sucrose using a "Gradient extraction unit" (MSB).
1.5 ml of ML fraction
25 ml of 0.5 -1.7 M sucrose
2.5 ml of 1.75 M sucrose
3.5 ml of 2 M sucrose
Fig 2.2 Sucrose gradient for subfractionation of mitochondria and lysosomes.
The subfractions from the ML fraction were analyzed for protein, using the BioRad 
protein assay having been solubilized in 0.1 M NaOH. Aliquots (1 ml) of the subcellular 
fractions and the subfractions were assayed for ^^^Eu or activity.
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2.4.6 Trichloroacetic Acid Precipitation of Protein in Plasma and Urine
In duplicate, an equal volume of ice-cold 10 % (w/v) TCA was added to aliquots of 
plasma and urine. Precipitated protein was sedimented by centrifuging at 3000 rpm for 10 
min and the supernatant decanted off. activity was counted in the supernatant and pellet, 
reflecting free and albumin-bound respectively.
2.5 Miscellaneous Methods
2.5.1 Counting of Radioactivity
(a) Detection of Gamma Emitters
^^%u was counted in the channel of a Searle (1185R) gamma counter. Upto
2.5 ml volume could be counted in a counter tube (1 ml in an LP4, Luckham) without loss of 
activity; above this volume there was a gradual loss of activity because the source was 
outside the crystal. The counter was linear from 5000 to 670000 cpm of ^^^Eu with an 
average efficiency of 30.7 ± 0.7% (mean ± s.d. of 6 observations).
125i  also counted in the preset channel of the Searle counter.
(b) Detection of Beta Emitters
^^Ca, ^% e and were counted in an LKB Rackbeta "Spectral" 1812 liquid 
scintillation counter. Optiphase Safe (LKB) was used as the scintillant. The instrument was 
programmed to calculate the specific activity of the isotopes.
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2.5.2 Protein Determination
(a) BioRad Protein Assay
BBMV protein was assayed using a commercially available protein assay (BioRad, 
Hemel Hempstead, UK).
Reagents
Diluted dye reagent: dye concentrate was diluted 1 in 5 with distilled water. Dilute dye 
reagent was stored at room temperature and used within two weeks. 
Protein standard: gamma-globulin (BioRad; 0 - 1.4 mg/ml prepared in dist. H2O).
Method
Diluted dye reagent (5.0 ml) was added to 0.1 ml of standards and appropriately 
diluted samples ( 1 in 10 dilutions with dist. H2O were suitable for BBMV and intestinal 
homogenate). The samples were vortexed and their absorbances at 595 nm read from 5 to 60 
min later. The concentration of protein in the samples was estimated from the standard curve.
Where given in the methods, the samples and standards were solubilized into 0.1 M 
NaOH (final concentration).
(b) Manual Lowry Method
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The Lowry method (Lowry et al., 1951) was used to determine the protein content of 
isolated hepatocytes treated with holmium (Chapter 6) but was not routinely used because it 
was less convenient than the BioRad assay.
Reagents
Sodium carbonate (3 % w/v in 0.1 M NaOH).
Copper tartrate:- to 40 ml of sodium potassium tartrate (4 % w/v) add 92 ml of sodium 
carbonate (3 % w/v in 0.1 M NaOH) and 40 ml of copper sulphate (2 % w/v).
Folin & Ciocalteau Reagent (BDH):- dilute 1 in 3 with dist. H2O.
Protein standards:- 0.2 - 1 mg/ml BSA.
Method
(1) To 0.3 ml sample and standards were added 0.3 ml of sodium carbonate and 2 ml of 
copper tartrate; the mixture was shaken.
(2) After 10 min at room temperature, 200 pi of Folin reagent was added and the solution 
vortexed.
(3) After a further 30 min incubation, the absorbance of the protein was read at 660 nm. 
The concentration of protein in the samples was read from the standard curve.
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2.5.3 Determination of Inorganic Phosphate Content of BBMV
Inorganic phosphate was determined using the reaction of phosphomolybdate complex 
with malachite green dye, as described by Itaya and Ui (1966).
Reagents
4.2 % (w/v) ammonium molybdate in 5 M HCl.
0.2 % (w/v) malachite green in R.O. H2O.
1.5 % (w/v) tween 20 in R.O. H2O.
One volume of molybdate was mixed with 3 volumes of malachite green and filtered after 30 
min.
Phosphate standards (5 to 200 |iM) were prepared from a 2 mM KH2PO4 stock solution.
Method
To 0.4 ml of sample, standard or water blank were added 2 ml of molybdate/malachite green 
reagent and 0.1 ml of tween with gentle mixing. After 5 min the absorbance was read at 660 
nm.
2.5.4 Thin-Layer Chromatography of Phospholipids and Europium
(a) Reagents
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Phospholipids (Sigma): L-a-phosphatidylcholine (PC)
L-a-phosphatidyl-L-serine (PS)
Sphingomyelin (SM)
L-a-phosphatidylinositol (PI)
Incubation medium: ^^^EuClg (4.5 pM), 20 mM PIPES pA 6.1
Solvent: Chloroform: methanol: acetic acid: water (25: 15:4:2 by volume)
TLC plates: Merck 60p254 dried at 60°C for 2 hr.
(b) Method
The individual phospholipids (2.5 mg PC, 0.25 mg PI, 1 mg PS) and a mixture of
them all were dried under N2 to remove chloroform in which they were dissolved. The 
and sphingomyelin (1 mg)
samplesjwere resuspended in 100 pi of incubation medium and sonicated for 1 min to aid
dissolution. ^^^EuClg and phospholipids were incubated for 5 min at room temperature.
About 6 pi of the solutions were spotted onto the TLC plates. The plate was run in the
solvent; the atmosphere in the chromatography tank had been pre-saturated with solvent using
filter paper.
The position of the phospholipids were located under a U.V. lamp and recorded 
relative to the solvent front.
2.5.5 Preparation of Liposomes
Liposomes were prepared from phophatidylcholine using reverse-phase evaporation 
technique as described by New (1990).
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Reagents
Egg phosphatidylcholine (PC)(Sigma).
0.15 M NaCl, 20 mM HEPES, pH 7.4, gassed with N2. 
Diethyl ether.
Method
(1) PC (20 mg) was dissolved in 10 ml of diethyl ether in a 3 cm diameter glass boiling 
tube with a B24/B29 ground-glass quickfit neck.
(2) Buffered saline (1 ml) was rapidly injected into the lipid solution through a 21 g 
hypodermic needle; the needle tip was below the surface of the solution.
(3) The tube was flushed with N2 and stoppered.
(4) Quickly, the tube was transferred to a bath sonicator filled with a weak detergent 
solution to the same level as the mixture in the tube. The tube was sonicated for 2 
min.
(5) Directly after sonication, the diethyl ether was slowly evaporated off at 37%  and low 
vacuum in a rotaiy evaporator.
(6) When a gel was formed, the vacuum was released, the tube removed from the rotary 
evaporator and subjected to vigorous vortexing. The gel collapsed to form a fluid, but 
viscous suspension of liposomes. If the gel did not collapse the drying and vortexing 
was repeated.
(7) The fluid suspension of liposomes was dried for a further 5 - 1 0  min on the rotary 
evaporator. The last traces of diethyl ether were removed by dialysing against 
buffered saline overnight.
The liposomes were visualized by negative staining transmission electron microscopy.
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A drop of the liposomes (diluted from 1 in 5 to 1 in 20) was placed on a flat, clean, plastic 
surface. A carbon-coated copper grid (shiny side up) was placed onto the drop for about 1 
min. The grid was transferred to a drop of phosphotungstic acid (3 % solution in distilled 
water, pH adjusted to 6.3 using fresh aqueous 10 % KOH) for about 2 min to stain the 
vesicles; the grid was gently blotted dry on filter paper.
When the vesicles were examined by transmission electron microscopy, many intact 
membrane vesicles were seen.
2.5.6 Determination of Partition Coefficients of Europium-Ligand Complexes
Assessment of the partition coefficients, between organic and aqueous phases, of 
europium chloride and europium complexes was performed as in Endo et al. (1988).
(a) Reagents
Organic phase: n-octanol (1-octanol; Sigma).
Aqueous phase: 0.15 M choline chloride, 20 mM PIPES, pH 7.3.
Stock solutions of ligands in distilled water: 1 mM albumin, 5 mM NTA, 10 mM DPA,
10 mM citric acid, 10 mM maltol.
Eu stock solution: 1 mM EuClg in 1 mM HCl.
152EuCl3
70
(b) Method
Eu-ligands were preformed by adding the required amount of ligand to ^^%uClg to
1
form 1:2 complexes; the solution contained 0.5 |xCi Eu/ml.
n-Octanol (10 ml) was presaturated with choline chloride buffer (10 ml less volume of 
Eu-ligand solution to be added) in glass sterilins.
^^^EuClg or ^^^Eu-ligand mixture was added to n-octanol/buffer mixture (final 
concentrations of 50 |xM ^^^EuClg, 100 p.M ligand except for 5 }xM ^^^EuClg, 10 pM 
albumin) and the mixture shaken for 30 min. Each Eu-ligand combination was assayed four 
times.
The contents were allowed to settle and 2 ml aliquots of the upper (organic) and lower 
(aqueous) phases removed for ^^^Eu analysis.
2.5.7 Assay of Blood Coagulation Activity
The effect of EuClg on blood coagulation in plasma in vitro was tested using a 
commercial kit that determines activity of the intrinsic coagulation system. The effect of 
heparin was also assessed.
Reagents
Cephotest test kit (Nycomed AS, Torshov, Norway).
Control plasma (Nycomed); contains 11 mM citrate.
20 mM CaCl2-
Heparin (2 to 10 units/ml in R.O. water; from porcine intestinal mucosa. Sigma). 
1 to 1000 |iM EuClg in 1 mM HCl.
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Method
(1) All tubes and reagents were prewarmed to 37%  in a water bath. All incubations were 
performed at 37%.
(2) The control plasma (100 |il) and 10 pi of addition (water, 1 mM HCl, heparin, or 
EuClg) were placed in a plastic 2 ml test tube and incubated for 5 min.
(3) Cephotest reagent (100 pi) was added and the tubes incubated for a further 6 min.
(4) Coagulation was started by adding 0.1 ml of CaCl£ (20 mM) and quickly shaking.
(5) The tube was left undisturbed for 20 sec and then gently tilted in the water bath to
observe when clotting occurred. The time taken from addition of calcium to clotting 
was recorded.
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CHAPTER 3
ASSESSMENT OF EUROPIUM UPTAKE BY INTESTINAL VESICLES I
UPTAKE OF EUROPIUM CHLORIDE
3.1 Introduction
The intestinal bnish-border membrane plays an important role in absorption from the 
intestinal tract and is the focus of many studies into mechanisms of ion transport. Intestinal 
brush-border membrane vesicles (BBMV) are a preparation of luminal epthelial cell mem­
branes derived from the small intestine. The membranes form intact vesicles which retain the 
essential property of transport. BBMV have been used in studies investigating the absorption 
of glucose (Hopfer et al, 1973; Kessler et al, 1978), iron (Simpson & Peters, 1984), calcium 
Miller & Bronner, 1981; Miller e ta l, 1982)^mercury (Endo et al., 1988) and other compounds (some are 
listed in Murer & Kinne, 1980). Distinguishing features of this epithelial membrane include 
(a) specialized systems for the absorption of many substrates e.g. sugars, amino acids, (b) 
membrane bound enzymes involved in digestion e.g. disaccharidases and (c) the glycocalyx 
coat formed from glycolipids (Madara & Trier, 1987). An advantage of BBMV over other 
isolated membrane preparations is the relative ease with which they can be prepared (Chapter 
2.2.1).
As previously discussed (Chapter 1.5.2), the lanthanides ^ e  very poorly absorbed 
after oral administration probably because of the very insoluble nature of their hydroxides, 
phosphates and carbonates. However, under ideal conditions where free Ln^"^ is available, 
there may be some transfer of Ln across cell membranes.
Ln have previously been employed in studies with BBMV as probes of Ca^"  ^and Na"** 
transport mechanisms. Lanthanum was reported to inhibit Ca^ "*" uptake by BBMV (Miller &
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Bronner, 1981). In BBMV pre-loaded with ^^Ca, lanthanum was used to displace "^^Ca from 
internal binding sites after the vesicles were lysed (Miller et ah, 1982; Shibita & Ghishan, 
1990). Lanthanides also substitute for N a \  at the Na'^-glucose and Na‘*'-amino acid trans­
porters, stimulating, at millimolar concentrations of Ln, glucose and proline transport uptake 
by renal and intestinal BBMV (Bimir et al., 1987; Stevens & Kneer, 1988). From studies of 
BBMV enhancement of Tb fluorescence (Ohyashiki etal., 1979; Ohyashiki et al., 1985) Ln 
appear to bind to BBMV at two (protein) sites, one of which is a high affinity site (K ^ about 
10 |iM for BBMV and terbium); whether these two protein sites are involved in Ln effects on 
Ca^*^  and glucose transport has not been investigated. However, reports of effects of lantha­
nides on brush-border membranes should perhaps be treated with caution because there 
appears to be no data on how lanthanides themselves are handled.
The lanthanide europium (Eu) was chosen as a representative of the lanthanide series 
in these experiments because it is positioned in the middle of the Ln group and has a long 
lived (half-life of 12 years) gamma-emitting isotope (^^^Eu) that facilitates analytical deter­
mination.
In the context of BBMV used in subsequent discussions, "uptake" by vesicles can 
mean either binding to the vesicle exterior or transport into the vesicles.
Methods for the preparation, validation and use of BBMV are described in Chapter
2.2.
3.2 Validation of BBMV Integrity and Purity
3.2.1 Gross Morphology of Rabbit Intestines at Autopsy
The general appearance of the small intestinal wall differed greatly between animals at 
autopsy; in some it was thick and contracted but thin and flaccid in others. After thawing 
frozen intestines, the mucosal surface varied from white and intact to more fluid in nature.
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There was normal activity in BBMV prepared from thinner mucosal scrapings compared to 
those from thicker scrapings, as judged by sodium-dependent glucose transport (see Section
2.4 of this chapter) but there was a lower yield of BBMV in thinner mucosal scrapings, as 
measured by protein determination.
3.2.2 Assay for Marker Enzymes
The composition, in terms of plasma membranes, of the intestinal homogenate and the 
brush-border membrane suspension were determined by assaying for disaccharidase (maltase) 
and Na* /^K**'-ATPase activity. Disaccharidases are located exclusively on the brush-border 
membrane and Na'^/K‘*'-ATPase is localized predominantly on the basolateral membranes 
(Weiser et al., 1983; Murer & Hildmann, 1984; Madara & Trier, 1987).
Maltase was enriched 14 to 40 fold (on average 24 fold, results from 5 intestines) in 
the vesicles preparation compared to the mucosal homogenate. The activity of the enzyme in 
the homogenate (0.232 + 0.092 pmol hydrolyzed/mg prot/min) varied more than the activity 
in the BBMV (4.87 ± 0.94 pmol/mg/min), this is probably due to differing depths of scrap­
ings between intestines. Approximately 70% of the enzyme in the homogenate was recov­
ered in the vesicle fraction. Other workers, using similar methodology, report vesicles en­
riched 10 to 20 fold in intestinal disaccharidases (Simpson & Peters, 1984; Kessler et al., 
1978).
Na'^/K'^ ATPase was enriched from 1 to 5 fold in the vesicles compared to the 
homogenate and 6 to 22% of the homogenate activity was accounted for in the vesicles (re­
sults from 2 experiments). Na' /^K'*' ATPase activity was measured as the difference between 
total ATPase activity and ouabain insensitive ATPase activity; total ATPase activity was 
always high (0.15 p,mol P^/mg prot/min and 0.6 |Xmol/mg/min in homogenate and vesicles 
respectively) compared to Na'*‘/K'*’ ATPase activity (0.04 and 0.1 jimol/mg/min in homoge­
nate and vesicles) which made accurate determination of activity difficult
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These results showed that the BBMV preparation contained a high concentration of 
luminal BBMV but also contained some basolateral membranes. These might be retained as 
fragments of lateral membranes joined to microvilli (Murer & Kinne, 1980).
The orientation of the membrane was not tested here but these separation procedures 
produce predominantly right-side out vesicles (Kessler et al., 1978; Murer & Hildmann, 
1984; Shibita & Ghishan, 1991). Membranes that are right-side out display different func­
tional characteristics from the relatively few inside-out vesicles e.g. only the luminal brush- 
border membrane face has disaccharidase activity.
3.2.3 Electron Microscopy of the BBMV
BBMV were embedded in Epon resin and examined by transmission electron micros­
copy. The brush-border membrane preparation contained vesicles of various shapes and sizes 
with varying amounts of electron dense material (Figs.3.1 and 3.2) which are probably 
microvillar core proteins. The presence of core proteins in BBMV is a feature of BBMV 
preparations prepared by the isolation procedure (Chapter 2.2) employed here (Murer & 
Hildmann, 1984). The maximum diameter of vesicles was 0.3 - 0.4 pm. The fuzzy surface 
of some membrane vesicles is the glycocalyx on the surface of brush-border membranes 
(Madara & Trier, 1987). There were also particulates, broken membranes, circles of light- 
grey staining material in the picture, contaminating the preparation. Some membranes did 
not seem to be fused into a vesicle but appear open-ended. The implication of the hetero­
geneity of the BBMV preparation is that uptake by the BBMV preparation cannot be assumed 
to be wholly due to intact brush-border membranes and evidence e.g. of internalization 
dependent upon membrane fluidity, is required to substantiate brush-border membrane vesi­
cle uptake.
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Fig.3.1 Electron micrograph (transmission) of BBMV (magnification x 30000).
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Fig.3.2 Electron micrograph (transmission) of BBMV (magnification x 50000).
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3.2.4 BBMV Function Measured By Na^-Dependent Glucose Transport
BBMV prepared from fresh or frozen rabbit intestines showed a Na'^-dependent 
overshoot of glucose uptake (Figs.3.3 and 3.4) which is characteristic of brush-border 
membranes (e.g. Hopfer et al., 1973; Kessler et al., 1978). If the choline cation was substi­
tuted for Na"*" then glucose only slowly entered the BBMV (Figs.3.3 and 3.4). The overshoot 
is caused by an initial rapid movement of Na**" and glucose, via the Na*^-glucose cotransport­
er, into the vesicle interior; the diffusion of Na"  ^in is driven by the high [Na"**] outside the 
BBMV compared to the BBMV interior. Following the initial rise in glucose content driven 
by an excess of Na" ,^ glucose levels then equilibr ate until they are at the same concentration 
on both sides of the membrane.
In BBMV from frozen intestines, the peak glucose uptake, taken to occur 2 min 15 sec 
after the addition of sodium and glucose, ranged from 3.4 to 6.6 nmol/mg protein (4.16 ± 
0.83, mean ± s.d.; n = 6 intestines). The peak glucose uptake (2.96 nmol/mg protein) meas­
ured in BBMV from a single fresh intestine (Fig.3.3) was slightly lower than that of the 
frozen intestines but this probably reflects the variability in results from different intestines. 
Kessler et al. (1978) previously reported that BBMV made from frozen rabbit intestines were 
of similar activity to those from fresh intestines. The length of time over which the intes­
tines had been stored did not seem to determine the final activity of the membranes. Out of 
over 30 intestines in which Na"^-dependent glucose overshoot was measured, 3 sets of BBMV 
had distinctly reduced activities (one tenth to one fifth of average values). The cause of 
reduced function in these vesicles, which were not used for transport studies, is not known 
but possible explanations are (a) microbial contamination of the BBMV isolation media, (b) 
poor preservation and (c) pathology or lower rates of Na'^-glucose uptake in the source intes­
tinal material.
The vesicles were slightly damaged by freezing (stored at -80°C) and thawing, as
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Fig.3.3 Na'^'-stimulated glucose uptake by BBMV prepared from fresh rabbit intestine.
25 \l\ of BBMV were added to 25 p.1 of 0.9 mM D-(^H)glucose, 150 mM 
NaCl, 20 mM HEPES, pH 7.4. Final protein concentration 2.64 mg/ml.
X Fresh BBM V prepared from fresh rabbit intestine 
□ BBMV frozen for 1 week
■ BBMV frozen for 5 weeks
A  150 mM choline chloride was substituted for 150 mM NaCl.
Each point is mean ± s.d. of 3 - 4 determinations.
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Fig.3.4 Na"*’-stimulated glucose uptake by BBMV prepared from frozen rabbit 
intestine.
25 |xl of BBMV were added to 25 |Xl of 0.9 mM D-(^H)glucose, 150 mM 
NaCl, 20 mM HEPES, pH 7.4. Final protein concentration 3.90 mg/ml.
X Fresh BBMV prepared from frozen rabbit intestine 
□ BBMV frozen for 1 week
■ BBMV frozen for 5 weeks
A 150 mM choline chloride was substituted for 150 mM NaCl.
Each point is mean + s.d. of 3 - 4 determinations.
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revealed by a reduction of about 26% (mean of two intestines) of the peak rate of Na" -^ 
dependent glucose uptake (Figs.3.3 and 3.4). Length of storage from one to five weeks made 
little difference to the capacity of BBMV to transport glucose (Figs.3.3 and 3.4).
BBMV, if not frozen, were used on the day of preparation and one day post­
preparation, as there was no observed change in function, as judged by Na"^-stimulated glu­
cose uptake over this period (peak glucose uptake of 4.16 ± 0.83 and 4.37 ±1.14 nmol/mg 
protein on day of preparation and day following preparation respectively; mean ± s.d.; n = 6 
intestines). After 2 days at 4°C, however, the activity was reduced by 30% (result of a single 
experiment), so vesicles were then not used.
In the experiments with Eu described in this Chapter, the vesicles were isolated into a 
solution that contained sodium, so it was not possible to measure Na'^-stimulated glucose 
transport because out/in sodium gradient could not be developed. However, BBMV were 
assumed to be viable as they were prepared in the same way as those in Chapter 4, where 
function of each intestine was routinely verified (see above).
3.2.5 Retention of Vesicles and Contents By Filters
In agreement with Simpson & Peters (1984), BBMV were almost fully retained by 
filters of 0.22 p,m pore diameter, with only 0.7 % (average of 5 determinations, s.d. of 0.4 %) 
of BBMV applied to the filters present in the filtrate; the presence of BBMV was measured as 
maltase activity. Filtration of the wash solution (10 ml) took 25 - 30 sec when about 0.2 mg 
of BBMV protein, which is equal to or more than amounts routinely used, was applied to the 
filters. When 0.5 - 0.8 mg of BBMV protein were applied to the filters, filtration of the wash 
solution took several minutes and the filters were completely blocked by 1.5 mg of BBMV 
protein.
As the BBMV were filtered, there was a loss of vesicle contents, as judged by a fall in 
the D-(^H)glucose content of D-(^H)glucose loaded vesicles (Fig.3.5). A low vacuum pres-
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Fig.3.5 Loss of vesicle contents during filtration.
BBMV were loaded with D-(^H)glucose for 2 mins 15 secs (see Fig.2.1 for 
conditions) and then filtered through 0.22 |im filters. The vacuum was 
released from the manifold after the filtration times shown on the graph. 
Filter activity is expressed as percentage of the value after 3 min.
▲ High vacuum: 40 - 80 mm Hg pressure in the filtration manifold.
X ■ Low vacuum: ICX) -140 mm Hg pressure in the filtration manifold.
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sure (100 - 140 mm Hg in the filtration manifold) produced as much damage to BBMV as 
high vacuum (40 - 80 mm Hg; Fig 3.5). Filtration times were kept to a minimum to lessen 
BBMV damage and several replicates performed.
3.3 Europium Uptake by Brush-Border Membranes
3.3.1 Experimental Protocol
The “Ideal" conditions, mentioned in the Introduction (Section 3.1) to this chapter, 
were to work with europium in a phosphate-free solution containing buffer and other ingredi­
ents that would not interact with Eu^"^ in solution. The incubation medium for these experi­
ments consisted of ^^^EuClg (at concentrations given in the text), 0.1 M mannitol, 0.1 M 
NaCl, 20 mM PIPES, pH as given in the text; 5 pi of BBMV (resuspended in 0.1 M mannitol, 
0.1 M NaCl, 0.1 mM MgSO^, 20 mM HEPES pH 7.4; final protein concentration is stated in 
the text) were added to 50 pi of incubation medium, unless otherwise stated.
Following incubation, BBMV and medium were separated by filtration and washing 
(the methodology is described in Chapters 2.2.3.2 and 2.2.3.3). Experiments were performed 
in parallel with solutions containing no BBMV; these were used to account for the capture of 
Eu microprecipitates ("unfilterables") by the filters.
3.3.2 Binding to BBMV
(91 (iM, 0.42 mg prot/ml, pH 7, 37°C, filter wash solution 0.15 M NaCl) 
bound very rapidly to the BBMV and uptake was maximal after 10 sec, the shortest incuba­
tion period that could be measured manually. The binding remained constant over 60 min; 
about 80% of the Eu was retained on the filters with the vesicles. It was difficult to ascribe
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retention with BBMV on filters to binding specifically to BBMV because even in the 
absence of BBMV, a sizeable proportion of the Eu (23%) could not be filtered (referred to as 
Eu "unfilterables"). Experiments with EuClg and BBMV from other intestines, at differing 
pH values, gave essentially the same result (Figs.3.6 and 4.1); veiy rapid maximal binding of 
^^%uClg to BBMV and retention of ^^^Eu on the filters even in the absence of vesicles.
The formation of "unfilterable" Eu was unexpected because the incubation medium 
did not contain added anions e.g. phosphate, bicarbonate, that would precipitate with Ln. The 
^^^Eu "unfilterables" might originate from (a) ^^^Eu species in solution that have formed 
complexes of size greater than 0.22 pm (b) binding of ^^^Eu species to the the filters. In 
order to test if the latter was responsible for Eu "unfilterables", the filters were soaked in non­
isotopic EuClg to saturate filter Eu binding groups, prior to addition of ^^^Eu. Following 
incubation of ^^^EuClg (91 pM) at pH 7, presoaking the filters with unlabelled 1 mM EuClg, 
did not prevent retention of ^^^Eu by the filters (Table 3.1); the filters were washed with 
solutions with/without Eu at neutral or slightly acidic pH. When filters were presoaked and 
washed with 10 mM EuClg to ensure saturation of the filters with Eu, then the amount of Eu 
"unfilterables" was the same as with 1 mM EuClg soak and wash solution (98% of 1 mM 
value, 4 observations). Using PTFE-based filters (Millipore GSWP 02500) instead of nitro­
cellulose acetate filters did not prevent the retention of ^^^Eu (89% of values with nitrocellu­
lose acetate filters, 3 observations). It thus appeared that Eu was not directly binding to the 
nitrocellulose filters but rather forming species that were retained by filters of 0.22 pm pore 
diameter.
In order to distinguish between ^^^Eu which was weakly bound to the BBMV exteri­
or and strongly bound and/or internalized ^^^Eu, BBMV and blanks were washed with 
DTPA, a very strong chelating agent for Ln. Even following DTP A (1 mM) washes, Eu 
"unfilterables" were still present (10 % of total Eu) on the filters, suggesting that once formed 
"unfilterables" were stable (Table 3.2). Washing the filters with an acidic solution (pH 1.8), 
dissolved Eu "unfilterables". Even after washing the BBMV with the acidic wash solution, 
about 17 % of Eu was still bound to BBMV, compared to washing with saline wash solutions.
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Fig.3.6 (8.7 nM) binding to BBMV at pH 6.8.
With membranes: 5 |il of BBMV (frozen) were incubated at room temper­
ature with 50 |il of 9.6 p.M 0.1 M NaCl, 0.1 M mannitol, 20 mM
PIPES, pH 6.8.
Without membranes: (no BBMV).
Final protein concentration = 0.23 mg/ml. Final [Eu] = 8.7 }iM.
Filter wash solution: 0.15 M NaCl, 20 mM PIPES pH 6.8.
Each point is mean ± s.d. of 3 - 4 determinations.
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Thus, there appears to be a fraction of Eu strongly bound to BBMV. However, use of acidic 
wash solutions to determine BBMV uptake of Eu is problematic because the acid conditions 
may cause damage to vesicle structure (Chapter 4.3.1).
Table 3.1 ^^^Eu "unfilterables" After Soaking and Washing Filters with Unlabelled
EuClg.
Filter Soak Filter Wash Filter ^^^Eu
Solution Solution (% of total ^^%u)
0.15 M NaCl 0.15 M NaCl, pH 5.4 23.4
0.15 M NaCl 0.15 M NaCl, ImMEuClg, 
2 mM PIPES, pH 6.7
18.4
0.15 M NaCl, ImMEuClg 
20 mM PIPES, pH 7
0.15 M NaCl, pH 6.4 38.3
0.15 M NaCl, ImMEuClg 
20 mM PIPES, pH 7
0.15 M NaCl, ImMEuClg, 
20 mM PIPES, pH 7
34.5
A 5 fil aliquot of vesicle resuspension buffer without vesicles was incubated with 50 |il of 
^^^EuClg (final concentration 91 p.M) at pH 7.0 for 1 min. A 50 |il aliquot was placed onto 
prewet filters (as above) and washed with 2 x 5 ml of ice-cold solution (as above). Results
are the average of two measurements.
With the formation of Eu "unfilterables" in solution, it was obviously difficult to 
quantitate Eu, (as EuClg), uptake by BBMV because concentrations of available Eu '^*' in 
solution were probably low. The experiments with EuClg were carried out initially to get to 
know the methodology but proved invaluable in exposing the limitations and difficulties of 
working with Ln salts at physiological pH values. However, it did appear worthwhile to do 
some experiments of the uptake of Eu as EuClg by BBMV. To circumvent formation of Eu
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microprecipitates, ligands are used to donate Eu to BBMV in a soluble form (Chapter 4).
Table 3.2 Displacement of BBMV-Bound Eu by DTPA and Acidic Conditions
Wash
Solution
Unfiltered Eu 
with BBMV 
(% of total Eu)
Eu
"unfilterables" 
(% of total Eu)
BBMV Bound Eu corrected for 
"unfilterables"
(% of total Eu) (nmol/mg prot)
A 64.8 23.4 41.4 89.1
B 56.0 18.4 37.6 - 81.1
C 42.3 11.6 30.7 66.2
D 16.2 1.1 15.1 32.5
BBMV (0.42 mg/ml) or resuspension buffer (in duplicate) were incubated in 91 |iM 
^^^EuClg at pH 7.0 for 1 min. A 50 p.1 aliquot was placeqjprewet filters and washed with 2 x 
5 ml of ice-cold:-
A 0.15 M NaCl, pH 5.9
B 0.15 M NaCl, 1 mM EuClg, 20 mM Pipes, pH 6.7
C 0.15 M NaCl, 1 mM DTPA, pH 6.6
D 0.15 M NaCl, 1 mM EuClg, pH 1.8.
3.3.2.1 Uptake of EuClj by BBMV at Varying EuCl^ Concentrations
Reducing the pH of the incubation medium and the filter wash solution (0.15 M NaCl, 
1 mM EuClg, 20 mM PIPES) from pH 7 to 6.1, lessened Eu formation of Eu "unfilterables" 
from 23 % to 3.2 % of the total Eu (91 pM Eu) present. A reduction in the amount of Eu 
"unfilterables" retained in the absence of brush-border membranes with lower pH values was 
also found in the other experiments (Figs 3.6 and 3.7). Thus, an experiment on Eu uptake at 
different EuClg concentrations by the vesicles was performed in slightly acidic solution 
incubation buffer (pH 6.1) and a slightly acidic wash solution (ImM EuClg, O.IM NaCl,
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Fig.3.7 binding to BBMV at pH 6.1.
Conditions as for Fig.3.6 but incubation medium and wash solution at pH 6.1.
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20mM PIPES, pH 6.1), to diminish the formation of Eu "unfilterables". As ^^^Eu binding to 
the membranes essentially did not change after 10 sec, a convenient period of 2.5 minutes 
was chosen to measure Eu binding. ^^%u uptake by BBMV was not saturated at the highest 
concentration of employed (450 |xM; Figs.3.8 and 3.9). These results were corrected for 
the formation of Eu "unfilterables". Values for the and V^^^ of Eu were not calulated 
because of the difficulty in estimating the maximimum binding value and the complex nature 
of Eu in solution, as revealed by Eu "unfilterables". Judged from the shape of the curve of 
EuClg uptake by BBMV at different EuClg concentrations, there appear to be at least two 
sites for Eu binding to BBMV, one of which is saturated below 100 nM EuClg.
Aluminium, like Ln, forms very insoluble phosphate salts. To test if inorganic phos­
phate (Pp associated with the BBMV was responsible for BBMV binding of Eu, aluminium 
was added to the BBMV incubation medium. Aluminium, as Al(NOg)g, partially inhibited 
Eu binding to BBMV (Fig.3.9). The chelating agent DTPA (1 mM, added to the wash solu­
tion), removed bound Eu at higher concentrations of EuClg (Fig 3.9) suggesting that these Eu 
binding sites were perhaps of lower affinity. The small amount of displacement by Al^"  ^and 
DTPA confirm that ^^^Eu was strongly bound to the BBMV.
When BBMV were saturated with a high concentration of non-isotopic EuClg (0.89 
mM), then^^^Eu (19 |iM) only slowly exchanged onto membranes (Fig.3.10), suggesting that 
most sites were saturated at this concentration of Eu.
The BBMV preparation is not a pure preparation of intact brush-border membrane 
vesicles but is contaminated with a number of different structures, as revealed by e.m. (Sec­
tion 2.3 of this Chapter). Possibly these may contribute to Eu binding to BBMV. Also, any 
inorganic phosphate (Pp present on the vesicle exterior may readily precipitate and trap Eu. 
The P | content of the BBMV, assayed by the Malachite Green assay (see Materials and 
Methods), was 34 nmol P^/mg protein (mean of two preparations). Thus amount of P| present 
appears to be of the same magnitude as the high affinity binding site for Eu on BBMV 
(F%^ 3jO. '
Frank et al. (1977) reported that the removal of terminal sialic acid groups from
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Fig.3.8 retained by 0.22 |im filters at different concentrations of
With membranes: 5 |il of BBMV were incubated for 2.5 min with to 50 }il
of incubation medium (^^^uC y , 0.1 M NaCl, 0.1 M mannitol pH 6.1). 
Without membranes: no BBMV.
Final [BBMV] = 0.28 mg/ml. Graph shows mean ± s.d. of 4 - 5 replicates 
from the same intestine.
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Fig.3.9 The effect of Ap"*" and DTPA on Eu binding to BBMV.
Experimental conditions as for Fig.3.8. Eu bound to BBMV is corrected for 
the formation of Eu "Unfilterables".
X EuCy only (4 - 5 replicates).
▲ 1 mM AKNO^)^ added to the incubation medium (in duplicate).
■ the filters were washed with solution containing 1 mM DTPA (in 
duplicate).
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Fig.3.10 exchange onto BBMV.
BBMV were pretreated with non-isotopic EuClg (0.89 mM) before the 
addition of EuClg (19 pM). The proportion of the added activity that is re­
tained with BBMV is shown.
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membrane glycoproteins with neuraminidase enhanced La entry into muscle. In order to test 
if sialic acid residues were involved in BBMV uptake of EuClg, BBMV were incubated with 
0.1 U/ml of neuraminidase (Clostridium Perfringens, Sigma; prepared as 1 U/ml stock solu­
tion in 0.15 M NaCl, 20 mM Pipes, pH 7 and stored at -20®C) for 30 min at 37°C. The 
uptake of ^^^EuClg (9.1 pM) was 15.6 ± 0.7 nmol Eu/mg protein in neuraminidase-treated 
BBMV and 15.8 ± 1.5 nmol Eu/mg protein in BBMV treated with 0.15 M NaCl, 20 mM 
PIPES, pH 7. Thus sialic acid residues appear not to be involved in EuClg uptake by BBMV.
3.3.3 Electron Microscopy of EuCI^ Treated BBMV
BBMV treated with EuClg (50 pM) appeared more condensed and electron dense 
(Fig.3.11) than untreated vesicles (Figs.3.1 and 3.2). The darker appearance of the BBMV is 
perhaps not surprising, considering the high electron density of Ln and affinity of Ln for cell 
membranes and that Ln are routinely used as stains for cell membranes (e.g. Platt et al.y 
1980). No statistical comparison of vesicle size in EuClg treated and untreated BBMV prepa­
rations is available, but the EuClg treated BBMV preparation seems to contain fewer large 
membrane vesicles than the untreated preparation. Thus EuClg may induce alterations in 
membrane structure.
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Fig 3.11 Electron micrograph of BBMV (3.5 mg prot/ml) treated with 50 pM EuClg for 
5 min at room temperature. Magnification x 30000.
3.4 Interaction of Europium with Phospholipids
Studies using physical methods of measurement, e.g. NMR and optical spectroscopies 
(Hauser et a/.,1977; Chrzeszczyk et al.y 1981; Herrmann et al., 1986; Petersheim et al., 1989) 
have shown that Ln, used as analogues for calcium, interact with the phosphate head group of 
phospholipids. Ln are most strongly bound by headgroups that are negatively charged e.g. 
phosphatidylserine (Herrmann et al., 1986). In attempt to determine if phospholipids were 
candidates for Eu membrane binding in these studies, (a) pure phospholipids were incubated 
with ^^^EuClg and separated by thin-layer chromatography and (b) phosphatidylcholine
1 C'y
liposomes were incubated with ‘^^ ^Eu and separated by centrifugation.
Pure phospholipids i.e. phosphatidylcholine (PC, 2*5 mg), phosphatidylserine (PS, 1 
mg), phosphatidylinositol (PI, 0.25 mg) and sphingomyelin (SM, 1 mg) were incubated with
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(4.5 }XM) in 20 mM PIPES, pH 6.1 for 5 min at room temperature (the full experi­
mental method is described in Chapter 2.5.4). Aliquots (approx. 6 jxl) of the mixture were 
run on thin layer chromatography plates in a chloroform: methanol: acetic acid: water (25: 
15: 4: 2 by volume) eluant. The values for PC, PI, PS and SM were 0.4, 0.6, 0.6 and 0.2
respectively. ^^^Eu did not move from the baseline with any of the phospholipids; the loca-
^^Eu was a
tion ofjdetermined by the probe of^TLC linear analyzer (Berthold LB 2842), However, the
acidic conditions that the chromatography was performed under may dissociate phospholipid-
bound Eu.
In order to separate Ln-phospholipid mixtures more gently, ^^^Eu was incubated with 
phospholipid as liposomes (the preparation of liposomes is described in Chapter 2.5.5). It 
was then attempted to separate and wash the liposomes by centrifuging in sucrose. PC lipo­
somes (500 |xl, approx 50 p.g phosphorus in 0.15 M NaCl, 20 mM HEPES, pH 7.4) were 
added to 500 |il of 100 jiM ^^^Eu, 200 p,M DPA (a ligand which solubilizes Eu but permits 
donation to BBMV, described in more detail in Chapter 4), 0.15 M choline chloride pH 6.8 
(final pH of mixture 7.25). After 10 min incubation at room temperature, the mixture was 
layered onto 5 ml of 0.5 M sucrose, 20 mM HEPES, pH 7.25 and centrifuged at 50000g^y for 
20 min. The vesicles did not pellet into the sucrose nor into a lower concentration of sucrose 
(0.25 M). As the vesicles appeared to be too light, to pellet into sucrose, the opposite ap­
proach, of centrifuging into an water layer, was attempted. The procedure was as above but 
the liposomes were in 0.25 M sucrose, 20 mM HEPES, pH 6.8 and 5 ml of water were lay­
ered onto the incubation mixture. Only a proportion of the liposomes moved into the aqueous 
layer, perhaps due to a heterogeneity in liposome size. Subsequently discovered methods 
suggest that density gradient media fractionation of liposomes may permit estimation of 
^^%u bound to liposomes.
From the above results of Eu binding to phospholipids and liposomes, no definitive 
conclusion on the importance of phospholipids in Eu binding to BBMV could be reached.
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3.5 Europium "Unfilterables”
Studies of BBMV uptake of EuClg were technically difficult because the formation of 
Eu "unfilterables" was concentration- and time-dependent (Figs.3.8 and 3.12); also, as previ­
ously noted (Section 3.3.2 of this chapter) the availability of Eu^"^ in solutions containing 
"unfilterables" was likely to be low.
Eu was incubated in various different components of the incubation medium and then 
filtered through 0.22 pm filters, to determine if any of components of the solution, or an 
impurity present with them, were responsible for the Eu microprecipitates. The components 
of the incubation medium were individually incubated with ^^%uClg (5 pM; Fig.3.13). The 
pH of the solutions varied (except for the PIPES) because they were unbuffered. Even in 
water (purified by reverse osmosis) alone, a large proportion of Eu was trapped onto the fil­
ters. NaCl appeared to be the solute in which least precipitation occurred. After the first 
filtering, the Eu concentration of the filtrate was restored to 5 pM and the solutions left for a 
further 36 hours before filtering again; more precipitates had formed, suggesting that the 
precipitates were not due to contamination by low concentrations of an impurity e.g. phos­
phate.
Solutions containing NaCl were studied further because NaCl appeared to induce least 
Eu precipitation (see above). When various buffers were added to the NaCl to control the 
pH, precipitates formed in solution except when DTPA was present to chelate Eu (Fig.3.14). 
The duplicates for any solution, except the DTPA-containing solution, were very variable. 
Overall, no solute/buffer combination could prevent Eu precipitation at near neutral pH; 
probably the Eu "unfilterables" are insoluble Eu hydroxides formed at neutral pH or insoluble 
carbonates; the carbonate may be derived from CO2 dissolved in solution.
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Fig.3.12 Time-dependent formation of  ^ "Unfilterables" at pH 6.8.
5 ml of aqueous solution (0.1 M NaCl, 0.1 M mannitol, 20 mM PIPES, pH 
6.8) containing ^^%uClg (5 |iM) was filtered through 0.22 jim filters (0 min 
incubation time). The filtrate was refiltered after 30 min and this filtrate 
refiltered 30 min later. The cumulative retention of ^^^Eu on the filters is 
shown (4 replicates).
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Fig.3.13 Retention of (5 |iM) by filters in the presence of various solutes.
Incubation medium: 5 |iM ^^^EuClg, other as in A to F below.
In duplicate, the solutions (5ml) were filtered through 0.22 p,m filters after 1 hr 
incubation at room temperature. The Eu concentration of the filtrate was 
restored to original value with stock solution and refiltered after a further 36 
hr.
Number at top of bar indicates pH value.
A Water B Water at raised pH by addition of NaOH
C 0.1 M NaCl D 0.1 M mannitol
E 20 mM PIPES
F 0.1 M NaCl, 0.1 M mannitol, 20 mM PIPES.
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Fig.3.14 Retention of by filters in the presence of various buffers.
Upper figure: after 1 hr incubation.
Lower figure: after 36 hrs incubation. The concentration of Eu was restored 
to the original value by the addition of extra stock solution.
Incubation medium: 5 pM ^^^EuClg, 0.15 M NaCl, other as in A to I below. 
The solutions were filtered through 0.22 pm filters after incubation at room 
temperature.
Number at top of bar indicates pH value.
A No buffer(NaOH/HCl)
B 5 mM PIPES E 10 mM Imidazole G 10 mM HEPES
C 10 mM PIPES F 20 mM Imidazole H 20 mM HEPES
D 20 mM PIPES I 20 mM HEPES and 1 mM DTPA
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3.6 Discussion
The data presented in this chapter clearly illustrates that the formation of unfilterable 
microprecipitates at physiological pH is a serious limitation in studying the biological activity 
and possible cellular uptake of lanthanides as the amount of free Ln^"  ^cannot be predicted or 
easily quantitated. Ln in aqueous solution at neutral pH do not form a single species of 
hydrated Ln^"^ and from the stepwise hydrolysis of Ln^ "*" can form insoluble Ln hydroxides 
(Ln(OH)g) (Baes & Mesmer, 1976; Choppin, 1989; Evans, 1990) which may be responsible 
for the microprecipitates observed in this study. Seidell (1958) reports that the solubility of 
Eu(OH)g in water at 25°C is very low, 0.8 pM. The remaining Eu in solution will consist of 
a mixture of soluble hydrolysis products, Ln(OH)^'^ and Ln(OH)2^ as well as the free hy­
drated Ln(H20)jj^'^ (Choppin, 1989; Evans, 1990). Carbonate complexes of Ln may also be 
important if appreciable amounts of CO2 are dissolved into solution and Ln(CO)g is very 
insoluble (log K^p = - 32.2). The presence of trace amounts of phosphate may also be suffi­
cient to precipitate Ln (log Kg p of - 22.3 for LnPO^). The formation of microprecipitates 
of Ln in aqueous solutions has also been observed by Kanapilly (1980) who captured on 0.3 
pm pore diameter filters, between 7 and 13 % of Ln (330 pM) in distilled water at pH 7.3 - 
7.4. Once formed, these microprecipitates are relatively stable, as demonstrated by the inabil­
ity of DTPA to dissolve them, and thus may be regarded as an inert form of Eu. Evans 
(1990) observed that the contribution of Ln hydroxides to the biological activity of Ln in vitro 
is rarely considered, even though under many conditions of biochemical assay they are likely 
to exist.
Despite the precipitation problem, some data with BBMV were obtained. EuClg 
becomes associated maximally with the BBMV very rapidly (within 10 sec), which compares 
with the much slower association of its essential metal analogue, calcium (Chapter 6). The 
rapid time course of Eu uptake by BBMV is perhaps not surprising in view of the tripositive 
charge of Eu and the many charged anionic groups present on the brush-border membrane 
(Hauser et o/., 1980). The association of Eu with BBMV is not a weak adsorption phe­
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nomenon because a fraction of the BBMV-associated Eu is very strongly bound, as revealed 
by DTPA and acid (pH 1.8) washing of the vesicles. As judged by incubating BBMV with 
different concentrations of EuClg and washing with DTPA, the high affinity binding sites on 
BBMV for Eu appear to be saturated at about 40 nmol Eu/mg BBMV protein. Aluminium, 
which exhibits a similar chemistry to Ln in forming very insoluble phosphates and hydrox­
ides, partially inhibits Eu binding to high affinity sites on BBMV, suggesting that inorganic 
phosphate associated with the BBMV is responsible for some of the Eu binding. Inorganic 
phosphate derived from residual substrates and the activity of brush-border membrane 
phophatases e.g. alkaline phosphatase, 5’-nucleotidase etc. (Murer & Hildmann, 1984) could 
effectively dump Eu on the brush-border membrane in an insoluble form. There is sufficient 
inorganic phosphate associated with the BBMV preparation (about 34 nmol Pj/mg BBMV 
protein) to account for some of the Eu binding. Terminal sialic acid residues on membrane 
glycoproteins do not appear to be important for Eu uptake because neuraminidase treatment 
of the BBMV had no effect on Eu uptake. Possibly Eu binding to contaminating components 
of the BBMV preparation, e.g. broken vesicles, microvillar core proteins, may be responsible 
for some of the observed Eu binding.
Kirschbaum (1982) observed that LaClg (at concentrations greater than 25 |iM) 
aggregated renal BBMV, as measured by optical density of BBMV solutions. Although 
intestinal BBMV aggregation was not observed using electron microscopy in this study, 
EuClg (50 |liM) significantly altered BBMV structure, with the BBMV becoming smaller and 
more condensed following exposure to EuClg. The mechanism of the Ln-induced shape 
change is unclear but Ln can alter membrane organization in liposomes via interactions with 
phospholipid head groups (Petersheim et al., 1989). Calcium, which possesses very similar 
chemical properties to the Ln, is important in determining membrane organization (Shinitzky, 
1984), suggesting that Ln may exhibit similar properties.
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CHAPTER 4
ASSESSMENT OF EUROPIUM UPTAKE BY INTESTINAL VESICLES H
UPTAKE OF EUROPIUM-LIGANDS
4.1 Introduction
Low availability of metal ions in physiological solutions, due to precipitation of 
insoluble salts or insoluble hydroxides, is common to many metals. Whilst controlled 
deposition of metal precipitates is an important reaction in biology in the formation of 
biominerals e.g. calcite of shells, hydroxyapatite in bone, iron hydroxide in ferritin stores and 
prevents uptake by organisms of many toxic non-essential elements (Frausto da Silva & 
Williams, 1991), inadvertent precipitation hampers research into biological activity of the 
metal ions. A method of circumventing the problem of metal insolubility, as adopted 
frequently in biology and here for the lanthanides, is to introduce into the system a ligand 
molecule, that binds to the metal and forms soluble metal-ligand complexes.
Ligands solubilize metals by sequestering free metal ions and thus reducing the 
formation of insoluble species to below concentrations at which precipitates form. However, 
ligands that form very stable complexes will also effectively abolish biological activity from 
free metal ions. The strength of ligand-metal complexes can be expressed as the stability 
constant (or its logarithmic value) for the metal-ligand reaction:-
+ L ML
where the stability constant Kg = fMLl
[M^+][L]
Ligands with a range of affinities for Eu will be tested (Table 4.1) as donors of
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Table 4.1 Eu-Ligand Stability Constants.
Ligand log of Stability Constant * (IgKg) Reference
EuL EuL2 EUL3
Ascorbic acid 0.8 ** d
Dimethyl phosphate 1.9 2.5 g
Hydroxide 5.6 a
Aspartic acid 5.6 c
Cryptand [2.2.2.] 5.9 b
Albumin 6.4 e
Maltol 6.7 12.0 15.8 c
Transferrin 6.8 *** f
Citric acid 7.5 d
DPA 8.8 15.9 21.3 c
Catechol 11.2 c
NTA 11.3 20.6 a
EDTA 17.3 a
DTPA 22.4 c
Stability constants for reaction Eu + ligand = Eu-ligand
K„ = lEti-ligandl 
[Eu^-^ [ligand]
K„ = lEuHL^+1 
[Eu^+].[HL-]
Ig K for Gd-transferrin N.A. = not available
References
a Bunzli & Choppin (1989), b Burns & Baes (1981), c Martell & Smith (1974),
d Perrin (1983), e Schomacker ef û/. (1988), f Zak&Aisen (1988),
g Chrzeszczyk era/. (1981).
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europium to BBMV. Generally, Ln prefer to bind to ligands with oxygen, rather than 
nitrogen or sulphur, donor atoms (Chapter 1.4) and this is reflected in the structure of the 
ligands that have been chosen (see Appendix 3 for the structural formula of some of these 
ligands). Transferrin and albumin have been proposed as carriers of Ln in plasma following 
administration of soluble Ln complexes (Chapter 1.5.3.1).
4.2 A Survey of Ligands for Europium Donation to BBMV
The method of preparation of ^^%u-ligand complexes is described in Chapter 2.1.3.
The complexes were formed with a small excess of ligand (Eudigand ratio; 1:2).
, Eu-ligands were incubated with an equal volume 
of BBMV in a phosphate-free, bicarbonate-free solution at room temperature; the final 
composition of the medium was 50 pM Eu, 100 pM ligand, 3 - 4  mg protein/ml BBMV, 150 
mM mannitol, 75 mM choline chloride, 10 mM HEPES, 10 mM PIPES, pH 7.2 - 7.3. After 
timed incubation at room temperature, the uptake of Eu by BBMV was determined by the 
filtration method (Chapter 2.2.3), as used to study uptake of ^^^uClg in Chapter 3.
In order to measure the non-specific retention of microprecipitates of ^^^Eu under 
exactly the same conditions, the above procedure was carried out in the absence of BBMV.
Prior to observing the effects of ligands on Eu uptake by BBMV, the uptake of 50 pM 
Eu as its chloride salt, under the experimental conditions employed in this experiment, is 
shown in Fig.4.1. This is similar to the results obtained in Chapter 3 with EuClg.
The stable Eu-EDTA and Eu-DTPA chelates released practically no Eu to the 
membranes and completely prevented the formation of Eu "unfilterables" in solution (e.g. 
Fig.4.2).
The NTA, DPA, citrate and maltol complexes appeared to be suitable donors of Eu 
because they donated Eu to the BBMV over the ten minute incubation period and also pre-
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Fig.4.1 ^^%uCl3 Uptake by BBMV.
Incubation conditions with membranes: 50 p.M ^^^EuClg, BBMV (3.25 mg 
prot/ml), 150 mM mannitol, 75 mM choline chloride, 10 mM HEPES, 10 mM 
PIPES, pH 7.29, room temperature.
Without membranes (no BBMV).
Filter wash solution: 150 mM NaCl, 2 mM PIPES, pH 6.8.
Results are the mean ± s.d. for 3 - 4 replicates from a single intestinal 
preparation.
Note: differences in scale of y - axis in Figs.4.1 to 4.7.
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Fig.4.2 l^^Eu-DTPA Uptake by BBMV.
Incubation conditions as Fig.4.1 but 50 pM ^^^Eu, 100 pM DTPA, BBMV 
(3.54 mg prot/ml), pH 7.26, room temperature.
The apparently high uptake after 2 min 15 sec incubation compared to 
other time points was due to a single experimental value in the replicates. 
The uptake after 2 min 15 sec incubation was not significantly 
different from other incubation periods.
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vented Eu colloids depositing on the filter (e.g. Figs.4.3 and 4.4). BBMV uptake of Eu was 
characterized by an initial rapid phase that was complete within 45 sec. Eu then accumulated 
more slowly with the vesicles during the ten minute incubation periods. However, maltol 
donated all the Eu to the vesicles within 45 sec. The second phase of Eu accumulation, 
perhaps corresponding to Eu internalization by vesicles (Section 4.7 this chapter) was slow 
with DPA and NTA but much larger with citrate.
Ascorbic acid, aspartic acid, cryptand [2.2.2.], catechol and dimethylphosphate 
(Dim?) at Eurligand ratios of 1:2 did not prevent Eu (50 p,M) "unfilterables” forming in the 
solution (e.g. Fig.4.5) and hence under these conditions were not suitable donors of Eu. In 
this form, Eu was rapidly and almost completely retained with the BBMV onto the filters.
Bovine serum albumin (BSA, 2.44 p.M; approx. 0.02 % compared with plasma 
concentration of about 4.5 %) kept Eu (1.25 |xM) in solution and donated it to the membranes 
(Fig.4.6). At higher concentrations, BSA (100 p-M, approx. 0.7 %) inhibited the binding of 
Eu (50 pM) to the membranes without preventing the formation of "Insolubles". These 
insolubles may have formed because the Eu-albumin was not preformed as a concentrated 
stock solution at low pH before addition of incubation medium. Eu-albumin complex 
donation of Eu is investigated more fully in Section 4.5.
Rabbit transferrin (Tf; 2.5 pM, approx. 0.1 mg/ml compared with plasma 
concentration of about 2.3 mg/ml) did not solubilize Eu (l,25pM; Fig.4.7); EuClg at the same 
concentration is present as "unfilterables" (Chapter 3.3.2). However, transferrin requires 
bicarbonate to bind Fe '^*', so an attempt was made to incorporate Eu^"^ into transferrin using 
a technique developed for Fe '^*’; the method is described in Chapter 2.1.4. Following 
incubation of 0.32 mM Fe(III), 83 mM NTA, 10 pM NaHCOg and 5 mg of rabbit transferrin, 
when free metal and protein were separated on a Sephadex PDIO column, iron eluted in early 
fractions with the protein and then in later fractions as free metal (Fig.4.8). When 0.086 mM 
Eu was incubated in the same conditions, it eluted in one band just after the protein peak, 
probably because it had formed aggregates, possibly with the bicarbonate in solution 
(Fig.4.8).
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Eu-NTA Uptake by BBMV.
Incubation conditions as Fig.4.1 but 50 pM ^^%u, 100 pM NTA, BBMV 
(3.66 mg prot/ml), pH 7.28, room temperature.
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Fig.4.4 ^^^Eu-Citrate Uptake by BBMV.
Incubation conditions as Fig.4.1 but 50 pM ^^^Eu, 100 pM citrate, BBMV 
(3.25 mg prot/ml), pH 7.25, room temperature.
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Fig.4.5 Aspartate Uptake by BBMV.
Incubation conditions as Fig.4.1 but 50 |iM ^^^Eu, 100 |iM aspartate, BBMV 
(3.05 mg prot/ml), pH 7.28, room temperature.
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Fig.4.6 152Eu-Albumin Uptake by BBMV.
Incubation conditions as Fig.4.1 but 1.25 )iM ^^^Eu, 2.4 p,M albumin, 
(3.65 mg BBMV prot/ml), pH 7.28, room temperature.
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Fig.4.7 ^^^Eu-Transferrin Uptake by BBMV.
Incubation conditions as Fig.4.1 but 1.25 p,M ^^%u, 2.5 p.M transferrin, 
BBMV (3.65 mg prot/ml), pH 7.28, room temperature.
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Fig.4.8 Gel Chromatography of and after Transferrin Incubation.
^^Fe and ^^%u were incubated with transferrin under the conditions 
described in the text. Protein- and unbound metal were separated by exclusion 
chromatography on a Sephadex GIO column with an eluant of 0.15M NaCl, 
0.02 M Tris pH 7.4. The eluate was collected in fractions of 10 drops and 
aliquots assayed for radioactivity.
Dextran Blue (M.Wt. 200000) eluted in fractions 2 -4 .
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4.2.1 The Relationship between Europium Complex Stability
and BBMV Uptake
The competition between Eu "unfilterables", ligand and BBMV for Eu was assessed 
after incubation for 5 min; at this point the rapid uptake of Eu by BBMV is complete and 
further uptake is proceeding at a relatively slow rate (Figs. 4.1 to 4.7; see also Section 4.2.2). 
Eu-ligand stability is judged as the the log for 1:1 Eu-ligand complexes (EuL; Table 1.1) 
because of the low Eurligand ratio (1:2) employed in the experiments. Eu (50jiM) was 
solubilized by complexes of Ig Kg greater than 6, as seen by the steep decline in the formation 
of "unfilterable" Eu (Fig.4.9; results "Without membranes"). Catechol (the outlier at log Kg 
of 11) appears to be a weaker chelator than its stability constant suggests, possibly because at 
pH 7 it is less ionized (pK^ of 9.2 and 13.0 for the hydroxyl groups; Martell & Smith, 1974) 
than other ligands.
The total amount of Eu retained with BBMV by the filters falls at log Kg of about 7 to 
8 (Fig.4.9; results "With membranes"). As might be expected from its poor binding of Eu, 
catechol does not follow the trend.
Overall, Eu donation to the membranes corrected for Eu "Unfilterables", is relatively 
consistently described by log Kg (Fig.4.10). Intuitively, the reverse-sigmoidal type 
relationship between stability of Eu complex, as judged by log Kg, and binding to the BBMV 
appears to make sense, explaining the competition between Eu "Unfilterables", Eu-ligand and 
Eu-BBMV.
For the purpose of choosing ligands to donate Eu to BBMV in studies of membrane 
transport, the relationships (Figs.4.9 and 4.10) suggest that ligands with log Kg of about 7 to 
12 e.g. citrate, DBA and NTA, are suitable to deliver Eu in a soluble form to BBMV.
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Fig.4.9 Eu-ligand Stability vs Eu-Binding to BBMV
Incubation time 5 min.
X Incubation conditions with membranes: 50 jiM ^^^Eu, 100 fiM ligand, 
BBMV (3 - 4 mg prot/ml), 150 mM mannitol, 75 mM choline chloride, 10 
mM HEPES, 10 mM PIPES, pH 7.28.
A Without membranes (no BBMV).
Filter wash solution: 150 mM NaCl, 2 mM PIPES, pH 6.8.
Results with ligands that did not solubilize Eu (>10% Unfilterable) 
are from triplicate determinations on a single intestinal 
preparation but other results are average values of from at least 3 
different intestinal preparations.
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Fig.4.10 Eu-ligand Stability vs Donation of Europium to BBMV.
Experimental details as in Fig.4.9. The binding of Eu to the BBMV has been 
corrected for the formation of Eu "Unfilterables".
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4.2.2 Equilibriation of Eu-Ligands with BBMV
In order to study the equilibrium between BBMV and ligands for Eu, BBMV were 
incubated with "Stable" Eu-ligands for longer periods. Eu from Eu-citrate, is rapidly released 
to BBMV (see Fig.4.4 and 4.11). For experimental periods of longer than 10 min, the citrate 
complex appears to be a poor ligand for use with Eu, as demonstrated by a decrease in Eu 
solubility in the absence of BBMV. The decrease in Eu solubility with time probably results 
from Eu hydrolysis and aggregate formation around particles in the solution.
Over 60 mins, Eu was slowly released from DPA (Fig.4.12) and NTA (Fig.4.13) to 
bind to the membranes without a corresponding change in Eu "Unfilterables".
4.2.3 The Effect of Ligand Concentration on Europium Uptake by BBMV
4.2.3.1 Eu-NTA
There is an apparently high value for uptake of Eu (5 and 50 jxM) by BBMV in the 
absence of NTA (Fig.4.14), despite the high level of Eu "unfilterables" (38 and 16 % of total 
Eu for 5 and 50 |xM Eu respectively). Eu (50 |iM) uptake by BBMV, was reduced by about 
50 % at NTA:Eu of 1:1 and was almost abolished at NTA:Eu of 3:1 (Fig.4.14). At a lower 
Eu (5 pM) concentration but same BBMV concentration, the ratio of NTA:Eu that reduced 
BBMV-bound Eu by half was increased to S: 1 , probably because the relative
proportion of membrane present was greater.
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Fig.4.11  ^^ ^Eu-Citrate Uptake by BBMV.
Incubation conditions with membranes: 50 |xM 100 |iM citrate, BBMV
(3.50 mg prot/ml), 150 mM mannitol, 75 mM choline chloride, 10 mM 
HEPES, 10 mM PIPES, pH 7.22, room temperature.
Without membranes do not contain BBMV.
Filter wash solution: 150 mM NaCl, 2 mM PIPES, pH 6.8.
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Fig.4.12 ^^^Eu-DPA Uptake by BBMV.
Incubation conditions as Fig.4.11 but 50 |iM ^^%u, 100 pM DPA, BBMV 
(3.50 mg prot/ml), 150 mM mannitol, pH 7.22, room temperature.
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Fig.4.13 l^^Eu-NTA Uptake by BBMV.
Incubation conditions as Fig.4.11 but 50 |iM ^^^Eu, 100 nM NTA, BBMV 
(3.50 mg prot/ml), pH 7.22, room temperature.
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Fig.4.14 (5 |iM & 50 |iM) binding to BBMV at Vaiying NTA:Eu ratio.
A
X BBMV were incubated with Eu-ligand for 5 min (50 jiM Eu) or 15 min 
(5 jiM Eu) at room temperature. Incubation conditions: 5 |iM or 50 
jiM ^^^Eu, [NTA] as given, BBMV (3.50 mg prot/ml), 150 mM mannitol, 
75 mM choline chloride, 10 mM HEPES, 10 mM PIPES, pH 7.15.
Filter wash solution: 150 mM NaCl, 2 mM PIPES, pH 6.8.
Results are mean ± s.d. of triplicated determinations from a single 
intestinal preparation.
The binding has been corrected for the formation of Eu "Unfilterables".
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4.2.3.2 Eu-AIbumin
When bovine serum albumin was tested as a potential Ln ligand it bound Eu (5 |iM) 
more weakly than NTA because it required higher concentrations of albumin to reduce 
membrane Eu binding (Fig.4.15). Despite an apparently low log (6.4) for Eu, BSA 
effectively prevented the formation of Eu "Unfilterables", even at low ligandimetal ratios.
In case Ca^"  ^present in the BSA reduced Eu^ **" binding to albumin, the albumin was 
dialyzed against EDTA and washed by dialysis against 0.15 M choline chloride, 2 mM 
PIPES, pH 6.8 to remove bound cations. Somewhat surprisingly, dialyzed albumin donated 
more Eu to the membranes than untreated albumin (Fig.4.16), suggesting dialyzed albumin 
formed weaker Eu-albumin complexes than undialyzed albumin. A larger amount of 
formation of Eu "Unfilterables" with undialyzed albumin partially accounts for the smaller 
net donation of Eu to BBMV compared to dialyzed albumin.
If Ca (55 p-M) was added to dialyzed BSA (from 50 to 400 pM), it had no effect on 
Eu exchange between albumin and the BBMV (Fig.4.17), suggesting that Ca and Eu bind to 
different sites on albumin.
BSA, assigned as 95 - 99 % pure (Sigma Cat. No. A 9418) and BSA free of v- 
globulins (Sigma Cat. No. A 4161) had similar affinity for Eu, as judged by Eu uptake by 
BBMV (Fig.4.18); both samples had been dialyzed against EDTA and buffers. This suggests 
that high molecular weight contaminants of albumin are not responsible for binding of Eu. 
Eu-complexes with rat albumin are found to be stable in vivo in later experiments (Chapter 5).
4.2.4 Europium Affinity for Membranes at Varying Protein Concentrations
When checked over a range of protein concentrations, it was found that Eu (as 50 pM 
Eu, 100 pM NTA) binding to the membranes was linearly related to the amount of vesicles 
added at final protein concentrations of 1 to 6 mg/ml (Fig.4.19). The amount of Eu:NTA
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Fig.4.15 (5 jiM) binding to BBMV at Varying Albumin:Eu ratio.
BBMV were incubated with Eu-ligand for 15 min at room temperature. 
Incubation conditions as in Fig.4.14 but 5 jiM ^^%u, [albumin] as given, 
BBMV (3.50 mg prot/ml), pH 7.20.
Filter wash solution: 150 mM NaCl, 2 mM PIPES, pH 6.8.
The 2 curves represent results from 2 separate intestinal 
preparations.
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Fig.4.16  ^ donation from EDTA-dialyzed albumin.
■ □ Albumin was dialyzed against 10 mM EDTA, 2 mM PIPES and
then dialyzed against 0.15 M choline chloride, 20 mM PIPES, pH 6.8 (3 
changes).
X A  Albumin was suspended into 0.15 M choline chloride,
20 mM PIPES, pH 6.8.
BBMV were incubated with Eu-albumin for 15 min at room temperature. 
Incubation conditions as in Fig.4.14 but 50 jiM ^^%u, [albumin] as given, 
BBMV (3.50 mg prot/ml), pH 7.20.
Filter wash solution: 150 mM NaCl, 2 mM PIPES, pH 6.8.
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Fig.4.17 The Effect of Calcium on Europium Donation to BBMV by Albumin.
BBMV were incubated with Eu-albumin (EDTA-dialyzed; see Fig.4.16) 
for 15 min at room temperature.
X Incubation conditions as in Fig.4.14 but 50 pM ^^^Eu, [albumin] as 
given, BBMV (3.50 mg prot/ml), pH 7.20.
▲ CaCl2 ( final concentration 55 pM) was present.
Filter wash solution: 150 mM NaCl, 2 mM PIPES, pH 6.8.
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Fig.4.18 Eu Donation to BBMV by Albumins of Different Purity.
BBMV were incubated with Eu-albumin (EDTA-dialyzed; see Fig.4.16) 
for 15 min at room temperature.
Incubation conditions as in Fig.4.14 but 50 pM ^^^Eu, [albumin] as given, 
BBMV (3.50 mg prot/ml), pH 7.20.
X 95 - 99 % pure (Sigma Cat. No. A 9418).
A BSA-free of v-globulins (Sigma Cat. No. A 4161).
Filter wash solution: 150 mM NaCl, 2 mM PIPES, pH 6.8.
Results show mean ± s.d of 3 determinations.
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Fig.4.19 The Effect of Protein Concentration on ^^^Eu-NTA Uptake by BBMV.
Incubation conditions as Fig.4.14 but 50 (iM ^^%u, 100 p.M NTA, [BBMV] 
as given, pH 7.20, room temperature.
R esults from 2 in testinal preparations are shown; each po in t is the 
mean ± s.d. of three determinations.
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required to saturate the BBMV is not known. However, the high affinity BBMV binding 
sites for Eu, as EuClg, were saturated at about 40 nmol Eu/mg protein (Chapter 3.3.2.1, 
Fig.3.9) which compares with about 1.5 nmol Eu/mg protein donated to BBMV from Eu- 
NTA (50 |iM Eu:l(X) |iM NTA). Thus 50 jiM Eu 100 p.M NTA is probably less than 1/20^  ^
of the amount required to saturate BBMV binding sites.
4.2.5 pH Dependence of Europium Binding
When the pH of the incubation medium was reduced from pH 7:25 to 6.9, BBMV 
uptake of Eu from Eu-citrate and Eu-NTA was reduced by 24 % and 15 % respectively 
(Fig.4.20). In contrast, the uptake of EuClg is increased under more acidic conditions 
(Fig.4.20) but this is due only to the reduced formation of Eu "unfilterables". Fig.4.20 also 
shows the contrast between Eu-citrate and Eu-NTA in time-dependent donation of Eu to 
BBMV.
4.3 Assessment of BBMV Internalization of Europium
4.3.1 BBMV Binding vs Internalization
In order to distinguish between external bound and internalized Eu, the BBMV were 
washed with the powerful chelating agent DTPA to displace externally bound Eu. To ensure 
maximum displacement of external Eu, BBMV which had been incubated with Eu for 5 min 
(50 pi total volume; 50 pM Eu, 100 pM ligand, 3.5 mg prot/ml) were soaked in a high 
concentration of DTPA (0.95 ml of ice-cold 5 mM DTPA, 0.15 M NaCl, 2 mM PIPES, pH 
6.8) for 5 min prior to filtration. The filters were washed with 2 x 5 ml of this wash solution. 
The same protocol but with saline wash solution (0.15 M NaCl, 2 mM PIPES, pH 6.8) was
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uptake at pH 7.25 and pH 6.9.
152iIncubation conditions as Fig.4.14 but 50 |iM EuCl^, 100 |iM citrate or 
NTA as indicated, BBMV (3.50 mg prot/ml), pH 7.25, room temperature. 
Results are corrected for the formation of Eu "Unfilterables".
Filter wash solution for pH 7.25 incubation medium: 150 mM NaCl, 2 mM 
PIPES, pH 6.8.
Filter wash solution for pH 6.9 incubation medium as above but pH 6.1.
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employed to determine the total (external and internal) Eu content. 1-butanol (1.5 % v/v), 
which permeabilizes membranes, was used in conjunction with DTPA in the wash solution to 
extract both external and internal BBMV Eu (Bevans & Foulkes, 1989). The fraction of Eu 
that was internalized into the vesicles was also determined using acidic wash solution (0.15 
M NaCl, pH 2) to displace Eu bound to the membrane exterior; acidic conditions and 1- 
butanol (1.5% v/v 1-butanol, 0.15 M NaCl, pH 2) were employed to displace internal and 
external Eu. BBMV were undamaged and were retained by the filters after treatment with the 
saline, DTPA and DTPA/l-butanol wash solutions, as revealed by the recovery of less than 1 
% of maltase activity (BBMV localized marker enzyme) in the filtrate. The acidic wash 
solutions inhibited assay of maltase but judged by the absence of protein in the filtrate, 
BBMV appeared to be fully retained by the filters after treatment by acidic wash solutions.
Citrate and NTA were chosen as donors of Eu because they are examples of donors 
that release larger and smaller amounts of Eu to BBMV (Section 2 this chapter; Fig.4.10 and 
Fig.4.20). Incubating/washing the BBMV in saline solution removed a portion (22 %) of 
loosely BBMV-bound Eu donated by citrate but not NTA complex, as revealed by 
comparison with results o f BBMV placed directly on the filters and washed. Thus 
incubating/washing the BBMV in wash solutions gave results consistent with placing vesicles 
directly on the filter. DTPA (5 mM) removed 65% of bound Eu-citrate but 74% of bound 
Eu-NTA, suggesting that Eu from citrate was better internalized or more strongly bound than 
Eu from NTA but that in either case most Eu appeared to be external (Fig.4.21). If the Eu- 
citrate and Eu-NTA vesicles were permeabilized with butanol (1.5% v/v) then only a further 
1% of Eu-citrate and 3% of total BBMV-bound Eu were removed by DTPA, suggesting that, 
if it is transported across the brush-border membrane. Eu is not freely available. Soaking the 
vesicles in acidic conditions removed 91 and 94 % of the bound Eu donated by citrate and 
NTA, however this may have damaged the vesicle structure as revealed by a prolonged 
filtration time. Under acidic conditions in combination with 1-butanol almost all Eu (95 and 
96% of bound Eu form Eu-citrate and Eu-NTA) was displaced from the BBMV.
Because only small amounts of Eu are found in the interior of permeabilized
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Fig.4.21 Assessment of Eu-citrate (a) and Eu-NTA (b) Internalization by BBMV
BBMV (25 p.1) were incubated with 25 jil of incubation medium (100 |iM Eu, 
200 pM ligand, 150 mM choline chloride, 20 mM PIPES, pH 6.8) for 5 min at 
room temperature. Final [BBMV] was 3.5 mg/ml and pH 7.20.
Ice-cold wash solution (0.95 ml; see 1-5 below) was added, the solution mixed 
and left for 5 min at room temperature. Reaction was stopped by filtering 
through preweted 0.22 pm filters and the filters washed with 2 x 5 ml of the 
stop solution.
Wash solutions:
1 0.15 M NaCl, 2 mM PIPES, pH 6.8.
2 0.15 M NaCl, 5 mM DTPA, 2 mM PIPES, pH 6.8.
3 0.15 M NaCl, 5 mM DTPA, 1.5 % v/v l-butanol,2 mM PIPES, pH 6.8.
4 0.15 M NaCl, pH 2.
5 0.15 M NaCl, 1.5 % v/v 1-butanol, pH 2.
Results are the mean + s.d. of trip licate  determ inations from  a 
single intestine.
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membranes, it appears that Eu is very poorly internalized into brush-border membranes, 
although it is very strongly bound to them.
4.3.2 Temperature Dependence of Europium Uptake
The uptake of Europium from Eu-NTA by BBMV was markedly enhanced by per­
forming the experiments at 37°C compared to 0°C (Fig.4.22); only a very slight increase in 
Eu unfilterables was observed (0.15, 0.16 and 0.24% of total Eu at 0, 19 and 37°C 
respectively) with temperature.
The response to increased temperature is attributable to enhanced amount of DTPA- 
resistant Eu, as determined by the ice-cold DTPA washes described in Section 3.1 of this 
chapter, with 46 % of bound Eu at 37°C removed by DTPA compared to 83 % removed at 
20°C (Fig.4.23). However, if transported across the brush-border membrane. Eu at 37°C is 
not released into the BBMV interior, as demonstrated by 50% of bound Eu remaining 
attached to BBMV after treatment with 1-butanol and DTPA.
It has been reported that the lanthanides stimulate the uptake of glucose in BBMV 
(Stevens & Kneer, 1988). To test the hypothesis that the Na'^'-glucose transporter may be 
responsible for Eu uptake, phloridzin, an inhibitor of the transporter was added to the BBMV 
incubation medium. Phloridzin, at 0.5 mM concentration which inhibits Na"*"-stimulated D- 
(^^C) glucose uptake by 50 %, did not affect Eu-NTA uptake at 37°C or 20°C (Fig.4.24). It 
thus appears that the uptake and transport of Eu from NTA reported here is not due to uptake 
by the Na*^-glucose transporter.
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Fig.4.22 Temperature Dependence of ^^^Eu-NTA Uptake by BBMV.
Incubation conditions: 50 jiM ^^^Eu, 100 p.M NTA, BBMV (3.50 mg 
prot/ml) 150 mM mannitol, 75 mM choline chloride, 10 mM HEPES, 10 mM 
PIPES. The pH was 7.22,7.20 and 7.12 at 0,20 and 37°C respectively.
Filter wash solution: 0.15 M NaCl, 2 mM PIPES, pH 6.8.
Each point is the mean + s.d. of three determinations.
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Fig.4.23 Assessment of Eu-NTA Internalization by BBMV at 37®C and 20°C.
Incubations of BBMV (3.50 mg prot/ml) and ^^%u (50 }xM), NTA (100 
|iM) were performed at 37®C and 20%. Other experimental conditions 
and the wash solutions are described in Fig.4.21.
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Fig.4.24 The effect of phloridzin on Eu-NTA uptake by BBMV.
Incubation conditions as given in Fig.4.22.
▲ ■ Incubation medium contained 0.5 mM phloridzin.
The pH was 7.23 and 7.17 at 20 and 37%  respectively.
Each point is the mean + s.d. of three determinations.
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4.3.3 Direct Assessment of Free Europium Inside BBMV
An attempt was made to directly measure intravesicular Eu by loading BBMV with 
DPA, which strongly enhances the fluorescence of Eu (Fig.4.25). Eu-DPA fluorescence has 
been used to follow the fusion of liposomes loaded with Eu or DPA (Wilschut et al., 1980; 
Wilschut et a l, 1983).
DPA (25mM) was added to the solutions in which the intestinal material was ho­
mogenized (see Chapter 2.2.1). It was assumed that during the subsequent spins and washes 
the free non-intemalized DPA would have been effectively washed out leaving only the DPA 
internalized within the vesicles.
Prior to studying internalization of Eu as Eu-ligand, preliminary experiments were
performed with EuClg. When EuClg was added to DPA loaded BBMV, the fluorescence
signal increased (Fig.4.26). However this was reversed when DTPA was added indicating
which was
that this fluorescence originated from Eu-DPA complex ^ present outside the vesicles 
(Fig.4.26). When digitonin (10 |iM) was added to lyse the vesicles and release internal DPA, 
there was no change in the signal, suggesting that DPA had not loaded inside the BBMV 
perhaps because the BBMV were permeable to DPA.
To investigate if loading was the problem, (^^C)Iodixanol, a large membrane 
impermeant hydrophilic molecule, was also homogenized with the intestines. The vesicles 
were calculated to entrap 39 |xl of the 10 ml volume at homogenization. This small 
proportion of solute entrapped in BBMV may account for the insensitivity of the DPA 
internalization assay. Although Eu (5 |xM) DPA (25 mM) gave a strong fluorescence signal 
(excitiation wavelength 269 nm, emission wavelength 614 nm), when this was homogenized 
with the intestines, fluorescence was not apparent above the autofluoresence of the BBMV.
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Fig.4.25 Eu-DPA fluorescence.
Incubation conditions: 0 to 10 |iM Eu, 100 [iM DPA, 0.15 M NaCl, 20 mM 
HEPES, pH 7.4, room temperature. The fluorescence was recorded at an 
excitation wavelength of 269 nm (5 nm slit width) and emission wavelength of 
614 nm (5 nm slit width).
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Fig.4.26 Fluorescence of DPA - loaded BBMV.
BBMV were loaded with DPA as described in text.
Incubation medium: 0.15 M choline chloride, 20 mM PIPES pH 7.2 
[BBMV] = 0.3 mg/ml. Other additions as shown.
Fluorescence was measured at excitation wavelength of 269 nm and 
emission wavelength of 614 nm.
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4.4 The Donation of Europium from Ligands in Complex Media
In addition to macromolecules (proteins), numerous small molecules, electrolytes, 
etc., biological fluids such as plasma (Table 1.3), contain phosphate and bicarbonate which 
form very insoluble salts with Ln^*  ^(Table 1.2). These body fluids are also maintained at a 
pH of 7.4 which promotes the precipitation of Ln as hydroxides. Thus, the ability of ligands 
to donate Eu to BBMV and isolated hepatocytes under more physiological conditions whs 
tested.
4.4.1 The Effect of Phosphate on Eu binding to BBMV
The presence of phosphate (at about half plasma concentration, 0.5 mM), to the 
phosphate- and bicarbonate free medium (Section 2 of this chapter), promoted the release and 
precipitation of Eu from weaker complexes but did not effect the equilibrium of the EDTA 
and DTPA complexes, as judged by Eu retained on filters in the absence of BBMV; the ratio 
of Eutligand was 1:2 (Table 4.3). In the presence of phosphate, the relationship between Eu- 
ligand stability and Eu uptake by BBMV is flat and bell-shaped, compared to the reverse 
sigmoidal type relationship obtained in the absence of phosphate (Fig 4.27; Table 4.3).
If citrate complex was present at a Eurcitrate ratio of 1:20 (50 p.M Eu, 1 mM citrate), 
less than 0.2 % of the Eu precipitated with the phosphate but 20 % of the Eu was donated to 
the membranes, suggesting that phosphate precipitation can be circumvented by higher ratios 
of ligand:Eu. This concentration of citrate (1 mM) is about tenfold higher than normal 
plasma values.
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Fig.4.27 The effect of phosphate (0.5 mM) on ligand donation of Eu to BBMV.
X Experimental details as in Fig.4.9 and 4.10. The binding of 
Eu to the BBMV has been corrected for the formation of Eu 
"Unfilterables".
▲ phosphate (0.5 mM) was present in the incubation medium. 
Results are the means of triplicate determinations.
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Table 4.3 The Effect of Phosphate on Europium Binding to BBMV.
Ligand 152Eu Retained on the Filters
With BBMV Without BBMV
Corrected Eu 
Bound to BBMV
-P + P -P
(% of total
+ P
IS^Eu)
-P + P
Dimethyl-
phosphate 98.4 98.9 36.3 98.2 62.1 0.6
Citrate 89.1 97.2 0.9 90.3 88.2 6.9
DPA 9.9 30.8 0.2 26.3 9.7 4.5
NTA 7.1 9.0 0.4 3.5 6.7 5.5
EDTA 0.21 0.21 0.04 0.05 0.17 0.16
DTPA 0.06 0.09 0.03 0.03 0.03 0.06
Eu-ligands (50 jLiM Eu, 1(X) iiM ligand) were incubated with or without membranes for 5 min 
and then filtered onto 0.22 pm filters. The experimental conditions are as previously given 
(Fig.4.1).
+P, incubation buffer contained 0.5 mM phosphate.
4.4.2 Europium Solubility in Complex Media
In order to check the potential bioavailability of Eu in physiological culture media, 
pre-prepared ^^^Eu-ligand complexes were incubated in a bicarbonate-buffered cell culture 
medium (Minimum Essential Medium Eagles; MEM) that contains bicarbonate and 1 mM 
phosphate for 1 hour at 37°C. Aliquots of the mixtures were then filtered through 0.22 pM 
filters and the retained ^^^Eu activity was counted to assess the unfilterable component of 
europium.
Most of the ligands did not prevent Eu precipitation at Euzligand ratios of 1:2 or 1:5 
(Table 4.4). Not surprisingly, the Eu-DTPA complex was the most stable. Also, the stability
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of the Eu-albumin complex at ratios of 1:5 was considerably better than that of ligands with 
higher stability constants. This concentration of albumin (250 pM) is less than half the 
plasma concentration of albumin (range centred about 680 pM; 4.5%) and suggests that in 
vivo albumin may be a carrier of Ln.
Table 4.4 Stability of Eu-ligands (50 pM Eu) in Cell Culture Medium.
Ligand Unfiltered ^^^Eu 
1:2 Eu:Ligand
(% of total)
1:5 Eu:Ligand
None 101.5 ----
DimP 97.0 96.4
Maltol 93.5 93.7
Citrate 94.6 94.5
Albumin 84.1 13.2
DPA 94.5 96.3
NTA 100.2 ----
DTPA 3.9 3.5
Experimental details explained in text (Section 4.4.2.).
4.5 Eu-Ligand Binding to Isolated Hepatocytes
Albumin has been proposed (Schomacker et a l, 1988) as an important endogenous 
ligand for Ln in blood, which is supported by the stable Eu-BSA complexes found here. To 
test if albumin, at approximately physiological concentrations, would donate Eu to 
hepatocytes, which sequester Ln in vivo (Chapter 1.5.3.2 and Chapter 5.2.2), freshly isolated
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hepatocytes were incubated for 15 minutes at a concentration of 0.3 x 10^ cells/ml in 
supplemented MEM containing (1) ^^^EuClg (50pM) or (2) ^^%uClg and NTA (lOOpM) or 
(3) ^^^uClg and albumin (3%, approx. 450pM).
The cells were then centrifuged at 50 g for 1 min and the supernatant decanted off and 
kept. The cells were resuspended in Earle’s buffered salt solution and re-centrifuged. The 
cells, the first supernatant and the second supernatant (wash) were counted for ^^^Eu 
activity.
Albumin did not donate Eu (<  2 % of added Eu) to the isolated hepatocytes but Eu 
present as the chloride salt or as the NTA chelate (Eu:ligand; 1:2) did bind to the cells 
(Fig.4.28). Thus pre-formed Eu-albumin appear to be stable but Eu is not donated to hepato­
cytes in this form.
Table 4.5 Hepatocyte Viability Following Various Treatments.
Treatment LDH Leakage s.d.
(%)
None 13.4 3.8
EuClg 12.7 3.4
Eu-albumin 6.0 1.7
Eu-NTA 13.6 2.0
The data presented in Table 4.5 show that the hepatocytes were most viable (6% LDH 
enzyme leakage) following the Eu-albumin treatment. The difference in cell viability 
between cells treated with Eu-albumin and other complexes is unlikely to account for the 
large difference in observed Eu uptake.
141
cg
Q .
E
â
23
ai
100
80
60
40
20
L
Chloride
Albumin
NTA
Cell Pellet Supernatant Wash
Fig.4.28 The effect of ligands on europium binding to hepatocytes.
The experimental conditions are described in the Section 4.5.
Eu was present as ^^^EuCl^ (50 pM) or ^^^Eu (50 pM), NTA (100 pM) 
or ^^%u (50 pM), albumin (3 %, approx 450 pM) in the cell culture medium. 
Following 15 min incubation the cells were pelleted, resuspended and re­
pelleted. The recovery of ^^^Eu from cell supernatant, wash solution 
supernatant and final cell pellet is shown.
Results are the mean + s.d. from 3 separate experiments.
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4.6 Lipophilicity of Eu-Ligand Complexes
Eu may not be exclusively donated to membranes in the form of Eu^+ from Eu- 
ligands complexes. It is conceivable that Eu is cross-linked to functional groups on the 
membrane and ligand, or ligand is taken up by BBMV with Eu attached, or intact complex 
enters the membrane due to lipophilic character. To test for the latter phenomenon, the 
lipophilicity of the complexes was determined as the partition of Eu into the organic 
phase of n-octanol and 0.15 M choline chloride, 20 mM PIPES, pH 7.3 in water (the method 
is described in Chapter 2.5.6). All of the EurLigand complexes tested (50 pM Eu: 100 pM 
ligand except for 5 pM Eu, 10 pM albumin) were very poorly lipophilic (Table 4.6) and thus 
their ability to cross cell membranes because of any non-polar character is very limited.
Table 4.6 The Partition Coefficients of Europium Compounds
Ligand Ratio of ^^^Eu in n-Octanol:aqueous phase
mean s.d.
Citrate 0.0004 0.0004
NTA 0.0005 0.0001
DPA 0.0007 0.0003
Albumin 0.001 0.0005
Maltol 0.006 0.0009
Chloride 0.022 0.022
The aqueous phase was 0.15 M choline chloride, 20 mM PIPES pH 7.3. 
Results are from 4 determinations.
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4.11 Discussion
From the ligands screened as potential donors of Eu (Eurligand 1:2) in phosphate- and 
bicarbonate-free solution, several ligands (e.g. albumin, maltol, citric acid, DPA, NTA), 
fulfilled the criteria of being able to keep Eu in solution and to donate it to BBMV in a 
soluble monomeric form at neutral pH. Overall, a reverse-sigmoidal type relationship was 
obtained between the stability of Eu-ligand complex, as judged by log Kg and Eu binding to 
membranes; optimal donation of Eu to BBMV occurred with ligands of log Kg about 7. 
There is a marked difference in Eu uptake by BBMV from citrate complex of log Kg 7.5 
compared to DPA complex of log Kg of 8.8. The change in extent of Eu uptake over a small 
range in log Kg may represent the difference between concentrations of free Eu at which 
internalization can occur and those at which most of the Eu is bound but not internalized. 
This is demonstrated by the small amounts of Eu donated to BBMV by NTA being mostly 
external, whilst the larger amounts of Eu donated by citrate contain proportionally more 
DTPA-resistant Eu. Also, following the initial rapid binding phase, citrate release of Eu to 
BBMV (perhaps corresponding to internalization) was rapid compared to the slow exchange 
of Eu from DPA and NTA. Similarly, Simpson and Peters (1984) reported that the 
proportion of Fe^"^ internalized into BBMV compared to the amount externally bound was 
reduced when the concentration of free Fe^ "*" was decreased by high ligand:Fe ratios. BBMV 
uptake of ligand, particularly for the natural ligand citrate, may also be important in 
determining Eu transfer to membranes.
DTPA removes a portion of Eu from BBMV which is most probably bound to the 
membrane exterior. Other essential metals e.g. Fe(III) (Cox & O’Donnell, 1981; Simpson & 
Peters, 1984) and non-essential metals e.g. Cd (Foulkes, 1988) are bound externally in 
relatively large amounts to brush-border membranes. Quaterman (1982), observing enhanced 
Zn binding to glycocalyx in fasting animals, proposed that the charged glycolipids and 
glycoproteins of the glycocalyx may be non-specifically involved in metal binding to brush- 
border membranes and could be responsible for the Ln binding to BBMV reported here.
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Binding to charged residues and the subsequent neutralization of membrane charges on these 
exterior groups may be responsible for the aggregation of renal brush-border membranes 
induced by lanthanum and many other metals e.g. lead, iron, calcium, cadmium (Kirschbaum, 
1982). Sialic acid groups in glycolipids do not appear to be important in BBMV uptake of Eu 
because neuraminidase treatment of BBMV did not affect Eu uptake (Chapter 3.3.2.1).
Assessment of the membrane transport of Eu relies upon the ability, or rather 
inability, of the chelating agent, DTPA, to sequester Eu. The presence of a DTPA-resistant 
fraction of BBMV-bound Eu is not unequivocal proof of membrane transport because Eu 
could be bound to group(s) on the membrane exterior that form thermodynamically or 
kinetically very stable compounds with Eu. The increase in the DTPA-resistant fraction with 
temperature indicates that Eu is bound/transported into BBMV by a mechanism dependent on 
membrane fluidity. The DTPA-resistant fraction of Eu remains intra-membrane or bound to 
the internal face of the BBMV because only a small amount (about 10 % or less) of DTPA- 
resistant Eu is free in the vesicle interior. Thus the ability of BBMV to internalize Eu appears 
to be very low.
The binding of the lanthanide terbium to intestinal BBMV, as measured by 
enhancement of Tb fluorescence, (Ohyashiki et a/., 1985) and the uptake of many essential 
metals e.g. Ca (Schedl & Wilson, 1985), Fe (Simpson & Peters, 1984) and the non-essential 
metal, Cd (Bevan & Foulkes, 1989), have also been observed to be temperature sensitive. 
Changes in membrane fluidity with temperature affects phospholipid, glycolipid and protein 
components of membranes (Shinitzky, 1984; Ohyashiki et ah, 1985) and mechanisms of Eu 
membrane uptake involving lipid and/or protein membrane components may be proposed.
Membrane fluidity may control Eu uptake by protein components via the movement 
of mobile carriers across the membrane. A candidate for a suitable carrier is the Na'^'-glucose 
transporter where Ln can apparently substitute for Na"  ^(Stevens & Kneer, 1988). Phloridzin, 
an inhibitor of the carrier, had no effect on the temperature dependent uptake of Eu 
suggesting that the Na'*'-glucose carrier is not involved in the Eu internalization measured 
here. Acting as a Ca analogue. Eu may utilize the carrier/channel for Ca (Bronner, 1987). In
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studies in Chapter 6, it is observed that Eu as the chloride, does not inhibit BBMV uptake of 
Ca, suggesting that the two metals bind at different sites. However, as EuClg was used to 
inhibit Ca^ "*” uptake and not a suitable Eu complex which delivers Eu to DTPA-resistant sites, 
the Ca carrier/channel cannot be excluded as the DTPA-resistant site. Perhaps, in view of 
the apparent distinction between calcium and europium uptake, it is tempting to suggest that 
the internalization of Eu is via carriers, at present of undetermined nature but not involved in 
the transport of essential metals, which have been proposed to account for BBMV uptake of 
other non-essential heavy metals such as Cd (Foulkes, 1985; Foulkes, 1988). If Ln are 
internalized by protein carriers, then because only small amounts are released internally, Ln 
must remain bound to the carrier or be strongly bound to intravesicular groups. Candidates 
for intravesicular sites of Ln binding are core proteins which are found in large amounts 
inside the vesicles (Chapter 3, Figs. 3.1 and 3.2) and inorganic phosphate derived from 
hydrolysis of nucleotides.
Membrane fluidity may also determine Eu uptake by controlling membrane lipid 
packing and thus the accessibility and orientation of membrane (protein or glycolipid) 
binding sites (Shinitzky, 1984). By washing the vesicles at 0°C in these experiments, 
following Eu-BBMV binding at 37®C, bound Eu may effectively have been trapped in the 
rigid inaccesible membrane environment and thus unavailable to DTPA. It would be 
interesting to observe if, following incubation of Eu and membranes at 37°C, DTPA could 
remove Eu from membranes when membrane fluidity was maintained by washing at 37 °C.
The models of Ln binding proposed so far have concentrated around protein or 
glycolipid binding sites. However, phospholipids, particularly negatively charged 
phospholipids, bind Ln with stoichiometry of 2 phosphate head groups bound to 1 Ln atom 
(Hauser et al., 1977; Chrzeszcyk et al., 1981; Petersheim et al., 1989) and may be suggested 
as a novel target for Ln binding. The association constants quoted for Ln-phospholipid 
complexes are low (log Kg less than 3, Table 4.1) but in view of the high concentration of 
phopholipid present in membranes, Eu-phospholipid interactions may be significant.
Whether Ln, if internalized, could ultimately be absorbed into blood will be
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dependent upon mechanisms of transepithelial transfer and mucosal retention (Foulkes, 
1984). Experiments to investigate the luminal to serosal transfer of Ln-ligands are discussed 
in Chapter 7.2.
The observation that Ln can stimulate glucose and amino acid transport in brush- 
border membranes (Stevens & Kneer, 1988) does not confound the observation of membrane 
impermeability to low concentrations of Ln because of the much higher concentrations of Ln 
involved (at least 10 mM) which could saturate non-intemalizable binding sites (Stevens & 
Kneer, 1988).
The donation of Eu to brush-border membranes from labile ligands such as citrate 
(ratio of Eurligand of 1:2) is small in the presence of phosphate due to precipitation of Eu 
phosphate, as revealed by the shape of the relationship between ligand stability constant and 
uptake of Eu by BBMV (Fig.4.27). A large excess of ligand (e.g. citrate:Eu, 20:1) solubilizes 
Eu in the presence of phosphate whilst permitting donation to BBMV and thus pre-formed 
Eu-ligand complexes containing an excess of ligand may be useful in studies of Ln in 
physiological solutions. If citrate is chosen as a complex for Ln in physiological solutions, 
the presence of large amounts of calcium (about 2.5 mM in plasma) should not displace Eu 
because the stability of Ca-citrate complexes (log Kg of 3.5; Martin, 1991) is much lower 
than of Ln-citrate complexes (log Kg Eu-citrate of 7.5; Table 4.1). Albumin also appears to 
be a potential endogenous ligand for Eu in physiological solutions because bound Eu, at 
relatively low ligand:Eu (< 10:1 ) ratios, is not susceptible to displacement by calcium or 
phosphate, as revealed in cell culture medium. Reuben (1971) has also reported that Ca does 
not compete with Gd for albumin binding. The amount of Ln donated to hepatocytes and 
BBMV, at albumin:Eu ratio of about 10:1 (50 |iM Eu) is very small and perhaps less than 
might have been expected from its relatively low stability constant (log Kg of 6.4). The 
unexpectedly high stability of Eu-albumin complexes solutions may be due to slow kinetic 
exchange of Ln from BSA due to changes in protein conformation on binding Ln (Shahid et 
al., 1982). The distribution of pre-formed Eu-albumin complex, and thus its dissociation in 
vivo is investigated in Chapter 7.
» ,
The experiments performed here use Eu-ligand complexes pre-formed at acidic pH to 
ensure that Eu is bound to complex without interference from insoluble Ln hydroxides. In 
biological fluids, despite the presence of relatively high concentration of endogenous citrate 
and albumin, the formation of Ln-ligand complexes from Ln salts may be prevented by the 
formation of stable Ln precipitates with hydroxide and phosphate, as demonstrated by the 
different in vivo distributions of EuClg and Eu-albumin (Chapter 5). If Ln is initially 
present as a complex, then it may transfer to the endogenous ligands without precipitation, 
demonstrated by the formation of Ln-albumin complexes from Ln-citrate complex in 
physiological solution (Schomacker, 1988).
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CHAPTERS
IN  VIVO DISTRIBUTION OF SOME EUROPIUM COMPOUNDS
5.1 Introduction
Brush-border membrane vesicles and isolated hepatocytes were homogeneous 
preparations, of a single membrane and cell type, in which to study the uptake of Ln salts and 
Ln complexes (Chapters 3 and 4). To complement the in vitro work, it seemed logical and 
interesting to examine the uptake of Ln salts and Ln complexes in vivo, where metal would 
interact and distribute in the veiy complex chemical and physiological environment.
Following the general approach of the in vitro experiments, the tissue distribution of 
Eu was to be compared when given as its salts, as its moderately strong albumin complex and 
as the stable DTPA complex. As Eu^"^ forms aggregates at physiological pH (Chapter 3) 
these are likely to be distributed in a different manner from "Free" Eu ions (Aeberhardt et al., 
1962). Accordingly, EuClg was to be introduced at physiological pH and also at acidic pH 
when "Free" ions, initially at least, should exist. The latter form of metal may allow the metal
U If
to bind to endogenous ligands before being dumped as the hydroxide and phosphate 
precipitates. The albumin complex was chosen because it was found to be stable in 
phosphate containing media (Chapter 4). Despite the presumed importance of albumin in 
carrying free lanthanide in the blood (Schomacker et al., 1988), the distribution of injected 
Ln-albumin complexes has not been previously examined.
In order to gain as much information as possible on the tissue uptake of these 
compounds the livers and kidney were to be more closely examined. Much of a dose of Eu is 
deposited in the liver; a component of this is due to Kupffer cell phagocytosis of Eu colloids 
but the hepatocytes also contain Eu (Aeberhardt et al., 1962; Berry et al., 1989). How much
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Eu is sequestered by each cell type is examined in these studies. As the site of excretion of 
extrahepatic free Eu^"  ^and stable water soluble Ln complexes, it was of interest to see if Eu 
would be localized intracellularly in the kidney.
5.2 The Tissue Distribution and Excretion of Europium
The doses of Eu chosen to be injected were approximately one five hundredth of the 
LD50 value for Ln salts by i.v. injection and about one fiftieth of a dose that causes 
hepatotoxicity in rats (see Chapter 1.7). A low dose was chosen to minimize liver toxicity; 
damage to the liver could cause a redistribution of Ln to other tissues.
The Eu-albumin complex was formed with a molar ratio of 4 albumins to 1 Eu be­
cause in the in vitro experiments (Chapter 4) high ratios of albumin were most effective in 
preventing Eu binding to BBMV or hepatocytes. Similarly, the Eu-DTPA complex was 
prepared with an excess of DTPA to ensure that Eu was fully complexed.
5.2.1 Experimental Protocol
The experimental protocol and relevant methods are described in full detail in Chapter 
2.4. Briefly, the following compounds, in 0.15 M saline solutions, were injected 
intravenously via the tail vein into groups of 4 rats:-
Group A 152euC13pH7.4 0.1 mg Eu/kg
Group B 15%uCl3pH3.0 0.1 mg Eu/kg
Group C ^^^Eu-albumin (Eu:albutmn; 1:4) pH 7.4 0.1 mg Eu/kg
Group D 152eu-DTPA (Eu:DTPA; 1:3) pH 7.4 0.1 mg Eu/kg
Group E Eu-(^^^I)albumin (Eu:albumin; 1:4) pH 7.4 0.1 mg Eu/kg
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The fifth group (E), was included to check on the distribution of the albumin moiety 
of the Eu-albumin complex.
After 24 hours, the animals were killed and the radioactivity measured in selected 
tissues and collected urine and faeces. From part of the liver, hepatocytes were isolated from 
the other cell types and the distribution of isotope between these was assayed. In some 
groups the cortex of the kidney was separated into subcellular fractions and the quantity of 
isotope in each fraction measured.
5.2.2 Results
An in vitro experiment was carried out prior to the distribution study to investigate if 
this dose of Eu was likely to inhibit blood coagulation, a known effect of Ln (Evans, 1990). 
In a commercially available test of blood clotting via the intrinsic coagulation system (the 
method is described in Chapter 2.5.7), Eu, added to plasma supplied as a control, at final 
concentrations from 0.09 pM to 91 |iM (equivalent to 14 jig Eu/ml) had no effect on clotting 
times. Heparin at 0.2 to 1 unit/ml inhibited clotting (at the highest dose the clotting time was 
increased from 33 sec to 2.5 min). This was not fully predictive of the in vivo situation 
because the plasma contained 11 mM citrate, which forms complexes with Eu (Ig Kg = 7.5). 
In any case, doses of Ln reported to inhibit coagulation range from 1 - 5 mg Ln/kg (Evans, 
1990; Graca et a l, 1964), about ten-fold higher than given here.
Heparin, not Ca^ "*" chelating agents was used to inhibit coagulation in blood samples 
taken for plasma in the distribution study; its affinity for Ln is not known but is probably 
much less than that of the chelating agents.
The tissue deposition and excretion of ^^^Eu after the treatments is depicted in 
Figs.5.1, 5.2 and 5.3 as percentages of the administered dose. Liver, spleen, kidney and lung
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Fig.5.1 Liver content of following i.v. administration of Eu compounds.
Mean + s.d of 3 - 4 animals.
<D
I
I
10
9
8
7
6
5
4
3
2
1
0
Spleen
Kidney
ÉmsI  ■ —
D
Treatment Group
Fig.5.2 Spleen, kidney and lung content of ^^%u following i.v. administration of Eu 
compounds.
Means + s.d. of 3 - 4 animals.
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Fig.5.3 Cumulative urinary and faecal excretion of ^^^Eu 24 hours after dosing.
Means of 3 -4  animals.
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Fig.5.4 Total ^^^Eu recovered from autopsied organs, urine and faeces.
Mean + s.d. of 3 - 4 animals.
Blood content was calculated on the basis of 4.0 ml plasma and 2.4 ml red 
blood cells per lOOg of rat (Baker et al., 1979). Bone and muscle content are 
not included in the totals.
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were the most important soft tissues in the sequestration of Eu. The relative concentrations of 
^^^Eu and in tissues, expressed as percentage of dose per unit weight or unit volume of 
tissue, are tabulated in Table 5.1.
5.2.2.1 ^^^Europium Tissue Distribution and Excretion
EuClg at physiological pH distributed in a pattern consistent with the particulate 
nature of the Eu (when an aliquot of the EuClg solution at pH 7.4 was filtered through 0.22 
pM filters, 27 % of the amount applied was retained on the filters). It was sequestered in the 
liver and spleen where there are many phagocytic cells and almost completely cleared from 
the blood in the 24 hours following injection (Table 5.1). The Eu precipitates also had been 
phagocytosed and/or become entrapped in the tortuous capillary network of the lung 
(Fig.5.2). Eu was present in the sternum and kidney at higher concentrations than in the soft 
tissues of heart, testes, small intestine and pancreas (Table 5.1). The sternum underestimates 
the concentration in bone of Eu because it contains a relatively large amount of cartilage and 
could not be cleaned of all attached muscle and connective tissue. The results for i.v. injected 
EuClg at physiological pH are in concordance with Aeberhardt et al. (1962) who observed a 
similar distribution for minute quantities (less than 1 ng/kg) of colloidal cerium injected 
intravenously.
There was much less retention, most likely because of reduced phagocytosis, of Eu by 
the spleen and lung when it was introduced as EuCl^ in an acidic (pH 3) saline solution but 
the liver burden was only slightly reduced (Fig.5.1). The concentration of Eu in bone also 
decreased, a rather surprising finding considering the bone-seeking behaviour of the heavier 
lanthanides; Berke (1968) reported about 40 % of the dose (amount not stated) deposited in 
the liver and 30 % in the skeleton after i.v. injection of 152,154g^Q2g at pH 3.5. Eu had 
almost totally cleared from the blood at the time of autopsy. Urinary and faecal excretion of 
Eu was low, at 0.13% and 0.69% of the dose respectively, but higher than in Group A at
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0.11% and 0.24% of the dose (Fig.5.3). Increased faecal excretion and higher small intestinal 
concentrations in Group B over Group A may be due to greater biliary excretion.
Eu, from Eu-albumin (ratio; 1:4 respectively), was cleared from the blood and mainly 
excreted in the urine over the 24 hour collection period. The excreted Eu was not precipitated 
by trichloroacetic acid but this is not evidence that Eu was excreted in a free form because the 
acidic conditions of the assay may cause Eu to dissociate from albumin. Only a small 
fraction of the Eu was sequestered by soft tissues. Bone appeared to contain most of the 
carcass Eu with its concentration now on a par with that in liver and kidney.
Eu was almost totally excreted in the urine when it had been administered as the stable 
Eu-DTPA complex (ratio; 1:3 respectively). Results from mice corroborate the rapid 
elimination of Ln-DTPA in urine (Weinmann et al., 1984; Wedeking & Tweedle, 1988). The 
kidney was the only organ that contained, intracellularly and/or in the filtrate, appreciable 
amounts of ^^^Eu at 24 hr after administration of the DTPA complex.
About 80% of the administered ^^^Eu as EuCl^ pH 7.4 and Eu-DTPA was accounted 
for in the tissues sampled but less for the other groups (Fig.5.4). Eu binding to bone 
(especially with respect to Eu-albumin), which was not included in the summation, probably 
accounts for part of the reduced recoveries. Possibly other tissues e.g. muscle, connective 
tissue that were not sampled could have sequestered Eu though there is no precedent in the 
literature for this.
5.2.2.2 The Distribution of the Albumin from Eu-albumin
Rat albumin was covalently labelled with ^^^I using iodogen (for fuller details see 
Chapter 2); the reaction mixture was passed down a PD-10 desalting column to separate 
unreacted ^^^I and iodogen from the albumin. The initial fractions that eluted at the void 
volume and containing labelled albumin were collected and pooled; the unreacted ^^^I eluted 
in later fractions. Approximately 20% of the added ^^^I bound to the albumin. Non-isotopic
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Eu was added (dual labelling the Eu and albumin would have complicated the measurement 
of each isotope because the emission spectrum of ^^^Eu completely overlapped with 
and the pH adjusted to 7.4.
At the time of autopsy, 8.5 % of the had been sequestered by the thyroid and 
19% excreted in the urine; only a very small proportion (4 %) of this activity in the urine was 
acid precipitable by trichloroacetic acid. The iodine in thyroid and urine is probably derived 
from free injected with the iodinated albumin or from iodinated albumin that has been 
metabolised in the body.
Unlike the Eu moiety, a substantial proportion of the dose was retained in the 
blood (Tables 5.1 and 5.2). Trichloroacetic acid precipitated 93 % of the plasma 
indicating that most of the plasma label was protein associated.
Table 5.2 Blood Retention of ^^^Eu and ^^^I-albumin 24 hours Following i.v. Injection 
of Eu-albumin (ratio; 1:4).
Proportion of the Dose in
Identifying Serum Plasma RBC
Isotope (% of dose)
152e u * Group C 0.012 0.016 0.001
125i ** Group E 11.42 11.15 1.93
* = 3 animals ** = 4 animals
Plasma, serum and red blood cell (RBC) volumes were calculated on the basis of 4.0 ml 
plasma or serum and 2.4 ml RBC per 100 g of rat (Baker et al., 1979).
Iodinated albumin, judged as the ^^^I label was present at lower concentrations, 
compared to Eu from albumin, in liver, kidney and bone (Table 5.1). In other tissues the
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(^^^I)albumin was at higher concentrations and this may in part be a reflection of the blood 
albumin content. Only a small proportion (2.5 %) of the dose was excreted in the 
faeces. Of the injected dose, 46 % was recovered in the sampled tissues; the presence of 
labelled albumin in tissues not sampled e.g. muscle, may account for the reduced recovery.
5.2.3 The Uptake of Europium and Albumin By Cells of the Liver
A portion of the liver was separated into parenchymal and non-parenchymal cells 
(Kupffer cells, endothelial cells, Ito cells, bile duct cells). Hepatocytes isolated from the 
livers were in good health with, on average, 83 % of cells excluding Trypan Blue dye. To 
isolate the cells the livers were flushed with an EDTA (2 mM) buffer to loosen cell junctions 
by removing Ca^*^; this would probably also remove any weakly bound extracellular 
lanthanide and so these results measure either strongly bound extracellular Eu or intracellular 
Eu.
l^^Eu from EuClg pH 7.4 was predominantly located in the non-parenchymal 
fractions that contained phagocytic Kupffer cells (Fig.5.5) but was also present with 
hepatocytes. The distribution of Eu was almost equally shared between the cell types when 
the EuClg was given at a low pH; Eu from Eu-albumin divided equally between the cell 
types though the total amount of metal was much less. The livers from Eu-DTPA treated rats 
were not used because only negligible amounts of radioactivity were detected by a portable 
gamma radiation detector at the time of autopsy.
Iodinated albumin was distributed in the non-parenchymal cells of the livers at higher 
concentrations than in the hepatocytes (92 vs 58 cpm/mg protein). The proportion of the 
(^^^I)albumin dose found in the hepatocytes (0.08% of dose/g protein) was much less than 
the l^^Eu (1.4% of dose/g protein) recovered from the ^^^Eu-albumin dose, showing that 
albumin was not taken up by hepatocytes.
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Fig.5.5 The partition of between hepatocytes and other cells of the liver.
Means of 2, 3 and 4 animals for Groups A, B and C respectively (+ s.d. for 
groups B & C).
5.2.4 The Uptake of Europium and Albumin into the Kidney
In animals which had been administered Eu-albumin complex (Group C, ^^%u- 
albumin and Group E, Eu-(^^^I)albumin) and ^^^EuClg at pH 7.4 (Group A), one kidney 
was taken from each member of the group and the kidneys cortices were pooled, 
homogenized and separated into various subcellular fractions (Table 5.3). The method for 
preparing the classical subfraction of the kidney by differential pelleting is exactly as 
described by Andersen et al. (1987).
The supernatant fraction contained material originating from the cellular cytosol, 
blood and the tubular filtrate and thus it was not possible to distinguish which of these 
components contained the greater proportion of ^^^Eu or ^^^I. The greater proportion of 
12^1 in the supernatant may be a reflection of the high plasma concentration of this at the
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time of autopsy (Table 5.1). Eu is also present at relatively high concentrations with the 
fraction containing nuclei. A difference of note between Eu derived from EuClg and Eu- 
albumin is the higher lysosomal concentrations obtained from the latter. The total amount of 
Eu recovered in the subfractions as a percentage of the amount in the homogenate is less for 
EuClg (about 75 %) than for Eu-albumin (about 90 %) and this is perhaps due to more Eu 
adsorbing to materials during fractionation than is able to with Eu-albumin.
Table 5.3 Localization of ^^^Eu and (Group E) in the Subcellular Fractions of 
Kidney Cortex.
Amount of radioisotope in the fraction 
as a percentage of the homogenate (%)
Group A Group CTreatment Group Group E (125i)
Subcellular Fraction
Soluble (Cytosol) 25.9 34.2 80.0
Nuclear 26.2 24.2 8.9
Microsomal 14.4 11.3 4.7
Mitochondrial/Lysosomal 8.3 18.5 4.7
The presence of significant amounts of exogenous material in the particulate fraction 
suggested that there was intracellular uptake of ^^^Eu. ^^^Eu which is associated with 
lysosomes probably represents uptake via the endocydc pathway and for this reason it was 
decided to further fractionate the ML fraction in order to resolve various populations of 
lysosomes and establish possible association of ^^^Eu with them. Andersen et al. (1987) 
described the rate sedimentation of the ML fraction in a zonal rotor. The method employed 
here was adjusted to achieve the same fractionation in a swing out rotor (Personal
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Fig.5.6 Distribution of and in the mitochondrial and lysosomal 
subfractions of kidney cortex.
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See text for explanation of profiles.
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communication, M. Dobrota). The protein peak in early fractions (Nos. 1 - 7) is due to 
cytosol and small membrane fragments (microsomes), the largest peak (about Nos. 11 - 27) is 
due to mitochondria and small lysosomes and a further small peak (Nos. 27 - 33) to large 
lysosomes (protein droplets) (Fig.5.6). ^^^Eu from EuClg pH 7.4 is associated with 
un sedimentable (soluble and very small particulates) material and mitochondria or light 
lysosomes. ^^^Eu and (^^^I)albumin from Eu-albumin are also associated with small 
lysosomes and especially large lysosomes. Whilst with the label this is not surprising 
and this is the expected fate of a filtered protein, the presence of ^^^Eu in these lysosomal 
populations strongly suggests that Ln bound to albumin are also delivered intracellularly 
where they will probably be retained.
5.3 Discussion
When looking at these results for the purpose of extrapolating them to data for other 
Ln, it should be borne in mind that Eu occurs towards the middle of the lanthanide series. 
Administered in ionic form as its salt at acidic pH or as a weak complex. Eu distributes 
almost equally between bone and liver (Berke, 1968; Durbin et al., 1955). Lighter Ln mostly 
deposit in the liver and heavier Ln deposit on bone and are excreted in the urine (Chapter 1.5; 
Durbin et al., 1955). Gd, the lanthanide metal which is perhaps at present of most interest 
because, in the form of Gd-DTPA, it is used in MRI imaging as a contrast agent, is the 
heavier neighbour of Eu and thus may have a similar distribution.
The difference in tissue distribution between EuClg pH 3 and EuClg pH 7.4 appears 
to be more of degree than of kind. This is perhaps expected because after injection some of 
the "Free" Eu ion will precipitate with phosphate and bicarbonate and form large hydroxy 
aggregates and thus resemble EuClg pH 7.4. The hepatic association of EuClg, from "Free" 
and even colloidal Eu, with hepatocytes confirms the view of others (Aeberhardt et al., 1962; 
Berry et al., 1989; Evans, 1990) that the liver uptake of Ln is not solely attributable to
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Kupffer cells. Berry et al. (1989), by the use of electron microprobe microanalysis, have 
localised Ce with phosphate in the lysosomes of hepatocytes and Kupffer cells. These 
observations thus indicate that Ln are indeed internalised via the endocytic pathway into 
hepatocytes and phagocytosed into Kupffer cells. The metals are then dumped as the 
insoluble phosphate in lysosomes. The mechanism or the form of Ln endocytosis into 
hepatocytes is not clear. Ln-transferrin complex is probably not a candidate for endocytosis 
as this complex appears too weak to be formed in blood (Chapter 4; Schomacker et a l, 1988; 
Zak & Aisen, 1988). The observation that Ln selectively inhibit Kupffer cell phagocytosis 
and pinocytosis without affecting hepatocyte endocytosis (Bouma & Smit, 1989) probably 
reflects the phagocytic nature of Kupffer cells whose function is indeed to remove denatured 
protein, antigen-antibody complexes and many aggregates, precipitates, particulates (Wisse et 
al., 1991). The binding of Ln to the Kupffer cell membrane most probably affects membrane 
properties such as fluidity, preventing further phagocytosis (membranes are discussed as 
targets of Ln action in Chapter 7).
Bone sequestration and urinary excretion were the main fates of ^^^Eu from Eu- 
albumin complex. This is consistent with the in vitro experiments (Chapter 4.4) where 
albumin prevented Eu uptake by hepatocytes and Eu-precipitation in phosphate-containing 
media. There is no direct evidence that the Eu remains bound to albumin in vivo and does not 
redistribute to other plasma ligands but the relative abundance of albumin in plasma and the 
stability of the Eu-albumin complex (Chapter 1.5.3.1; Chapter 4; Schomacker et al., 1988) 
make this possibility remote. The shift of Eu burden from liver to bone suggests that 
exchangeable Ln^^ has a higher affinity for bone than liver. Both mineral and osteoid 
components of bone have been implicated in the uptake of Ln (Evans, 1990).
The water soluble Eu-DTPA complex is rapidly and almost completely excreted in the 
urine, as has been found with Gd-DTPA complex (Weinmann et al., 1984; Wedeking & 
Tweedle, 1988). Although there appears to be no data available in the literature on how 
much Ln remains chelated to DTPA in urine, its very high stability constant (Ig Kg for Eu- 
DTPA is 22.4) and well characterized stability in blood, as shown by lack of tissue binding
163
and in vitro studies (Tweedle et al., 1988), suggest that the complex remains intact. As the 
Gd-DTPA complex is now licensed (by Schering) for human MRI use it has to be assumed 
that the stability of the complex was acceptable to the regulatory authorities. The definitive 
data on stability, excretion, possible retention of Gd-DTPA is presumably confidential.
The high molecular weight Eu-albumin complex does not appear to be excreted intact 
because the urinary concentration of ^^^Eu (34 % of the dose) is greater than that of 
(^^^I)albumin. The recovered in the urine (19 % of the dose), was not precipitable with 
proteins by trichloroacetic acid and thus represents free rather than (^^^) albumin 
(Section 2.2.2 of this chapter). The difference between urinary excretion of Eu and albumin 
from the complex is probably related to different rates of reabsorption from the tubular 
filtrate. Albumin is normally filtered at the glomerulus in small amounts (Bowman’s 
space:plasma ratio of albumin is <0.01; Dworkin & Brenner, 1985). The filtration of 
albumin, however, can be increased by reduction in the net negative charge on the molecule 
(Dworkin & Brenner, 1985), as caused by Eu binding. In the filtrate, Eu-albumin may 
dissociate under the slightly acidic conditions (pH 6 - 7 ;  Koeppen gf al., 1985) and/or 
following partial degradation of albumin by ectoproteases on the luminal face of the brush 
-border membrane. Alternatively Eu may be reabsorbed in proximal tubular cells with 
albumin (Maunsbach , 1966). The Eu-albumin complex may then dissociate in the 
acidic environment of the endosome and diffuse back into the filtrate but it is more likely that 
the high concentration of phosphate in lysosomes precipitates Ln which is retained for long 
periods. Even after 24 hr, which is probably a relatively long time after peak excretion, 
l^^Eu was present in the lysosomal compartment of the kidney cells (section 2.4 of this 
chapter).
1 rn
The retention of some Eu from Eu-DTPA in the kidney suggests some dissociation 
of this complex in the tissue and/or that sites with very high affinity e.g. inorganic phosphate, 
for Eu exist in the kidney. The kidney retention of Ln-DTPA is of interest because of the 
clinical use of Gd-DTPA. Whilst the proportion of the dose (0.35 %) retained is low, it is not 
clear if this residual amount may represent a significant risk. In patients receiving Gd-DTPA
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at the routinely used dose of 0.1 mmol Gd-DTPA/kg (15.7 mg Gd/kg), it is estimated that 
0.055 mg/kg of Eu would be retained. This is about 1/300^^ of the LD^q value for i.v. 
administration of Ln, as the salt, in rats (Table 1.9). However, lanthanides clearly exhibit 
potent biological activity on some systems in vitro e.g. membrane Ca transport systems, at 
very low concentrations (Table 1.8). On the other hand, the form of Eu retained may be 
relatively inert. However, until more definitive data of the form, amount and long term 
effects of the retained Ln in the kidney are available, it is not advisable to dismiss Gd-DTPA 
as representing no risk. Furthermore, Ce administered in a high. dose to rats has been 
reported to deposit on the glomerular basement membrane and cause lesions to cells of the 
proximal convoluted tubule (Berry et aL, 1989).
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CHAPTER 6
THE EFFECT OF LANTHANTOES ON CELLULAR CALCHJM HOMEOSTASIS
6.1 Introduction
9 +Free intracellular cytosolic calcium levels [Ca inside cells are maintained at very 
low concentrations (10"^M - 10"^M) compared to approximately- lO '^M  Ca^^ in 
extracellular fluids. As previously discussed (Chapter 1.6), this calcium gradient is 
maintained by plasma membrane Ca "^'" pumps, Na'*‘/Ca^‘*‘ exchangers and also by uptake of 
Ca^"  ^into the lumen of the endoplasmic (or sarcoplasmic) reticulum and mitochondria. Tight 
regulation of [Ca^‘*']j is important because it controls the activity of a wide range of essential 
biochemical processes inside cells (see Chapter 1.6).
Lanthanides have been used as a research tool in the study of Ca^ "*" binding sites and 
Ca^ "*" transport because of their similar size and chemical properties (see Chapter 1.4 and
1.6); generally, they have an inhibitory effect on Ca^+ transport (Chapter 1.6). As 
demonstrated with BBMV (Chapters 3 and 4) and electron microscopy (e.g. Flatt et al., 1980; 
Chapter 1.5.4), lanthanides bind strongly to membranes and thus when searching for a 
potential site of biological activity, the calcium pump and calcium-dependent receptors and 
the perturbation of cell calcium homeostasis, must be prime candidates.
The first experiments in this chapter (Section 2) assess the effect of europium on Ca^ "*" 
uptake by intestinal BBMV. This membrane differs from other epithelial plasma membranes 
in that it originates from a membrane that is involved in the absorption of large amounts of 
calcium; most epithelial plasma membranes pump Ca^ "*" from the cytosol to maintain the 
transmembrane Ca^ *** gradient A calcium binding-protein, CaBP (Calbindin) that has a high 
affinity for Ca^"^ (K j^ approx 0.3 |iM), appears to be responsible for carrying Ca^*  ^across
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9+intestinal absorptive cells and hence maintaining a low [Ca in spite of the large amounts 
of Ca uptake at the BBM (Wasserman & Taylor, 1966; Bronner, 1987; Frausto da Silva & 
Williams, 1991). Intestinal brush-border membrane vesicles are isolated in a predominantly 
right-side out form and hence accumulate Ca^ "*" (Miller & Bronner, 1981 ; Shibita & Ghishan, 
1991). In contrast, other epithelial plasma membrane vesicles accumulate Ca^"  ^only if they 
are inside-out and Ca^ "*" pumping by the Ca^'^'-ATPase is stimulated (e.g. Vieyra et al., 
1989).
In studies of Ca^"  ^uptake by rat intestinal BBMV, it has previously been reported that 
LaClg inhibits uptake (Miller & Bronner, 1981; Miller et al., 1982). The effects of the 
europium on Ca transport into rabbit intestinal BBMV wàs assessed-as changes in the 
uptake of radioisotopic ^^Ca in the absence and presence of Eu. Eu, as its chloride salt 
(Chapter 3) or donated from ligands (Chapter 4) bound strongly to BBMV with little 
evidence of internalization. However it is not clear, especially with the chloride (Chapter 3), 
how much Eu^^ is available to bind to membrane Ca^"*'-binding sites because of the 
formation of Eu "Unfilterables".
Isolated hepatocytes were chosen as a second system in which to study the effect of 
Ln on cellular Ca homeostasis. Ln are toxic to hepatocytes in vivo, producing steatosis and 
cell necrosis (Chapter 1.7) but alterations in Ca homeostasis, and perhaps most importantly 
changes in [Ca^"^p have not been investigated as causes of the toxicity. Claret-Berthon et al. 
(1977) reported that La displaced a fraction of the rapidly exchangeable Ca pool, probably 
surface-bound Ca, in perfused rat liver. In contrast to this and indeed to other observations 
on the effect of Ln on Ca uptake (Chapter 1.6), La stimulated the uptake of Ca^*  ^as assayed 
by 45ca and total cell Ca in isolated hepatocytes (Parker & Barritt, 1981); no inhibition of 
Ca^"  ^outflow was noted. The reason for the different results of Claret-Berthon et al. (1977) 
and Parker & Barritt (1981) is not known.
The effect of Ln on hepatocyte cellular Ca will be initially measured (Section 3.1) as 
the total calcium content of the cells. However, cell calcium content is an insensitive index of
9 1  ^ ’
[Ca'^ because the amounts of calcium associated with the plasma membrane, nucleus.
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mitochondrion and endoplasmic reticulum are much greater than the contained in the cytosol.
can be sensitively measured using Ca^'^-specific fluorescent dyes e.g. quin2, fura-2, 
indo-1, that can be loaded into cell cytosol (Tsien et al., 1982; Grynkiewicz et al., 1985; 
measurement of [Ca^* ]^  ^using dyes is reviewed in Rink & Pozzan, 1985, Cobbold & Rink, 
1987, Rink, 1988, Tsien 1988, Tsien & Pozzan, 1989). These dyes form fluorescent 
complexes with calcium and have dissociation constants for dye-Ca complex of 100 - 250 
nM, making them sensitive to physiological concentrations of [Ca^'*lj. The dyes are loaded 
into intact cells as the membrane-permeant acetoxymethyl (AM) esters and become trapped 
inside cells when hydrolyzed by intracellular esterases to the carboxylic acids. The simplest 
technique of measurement of [Ca^"^]p as employed here, is from the fluorescence of a 
population of isolated cells suspended in a cuvette but can also be elegantly analyzed
in single cells in culture (e.g Nieminen et al., 1988) with a system comprising a 
fluorescence microscope and an image analyzer.
6.2 The Effect of Europium on Uptake by BBMV
6.2.1 Experimental Protocol
Exactly the same methodology and conditions used in the experiments with Eu 
(Chapter 4) were employed to investigate the effects of Eu on Ca^ "*" uptake by intestinal 
vesicles. Exact details of using ^^Ca, Eu^ "*" and incubation times are given in the text. 
BBMV were captured by filtering onto 0.22 pm filters and washed twice with 5 ml of 0.15 M 
NaCl, 2 mM PIPES pH 6.8. The ^^Ca activity retained on the filter was counted.
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6.2.2 The Kinetics of Calcium Uptake
The vesicles rapidly accumulated calcium (Fig.6.1). If the uptake curve is
extrapolated to zero time, the amount of Ca^"^ associated with the vesicles at this time is
9 +calculated to be about 5% or less of the total added Ca ; this component of the Ca uptake 
probably represents binding to the membrane surface and is much less than that seen with 
EuClg (over 80%; Chapter 4.2; Fig.4.1). Only a small proportion (less than 1 %) of calcium 
was retained by the filters in the absence of membranes indicating that calcium did not form 
precipitates in solution nor bind to the filters.
The affinity (K^) and maximum rate (V ^ ^ )  of Ca uptake by BBMV were calculated 
as 39.7 ± 12.2 pM and 1.51 ± 0.31 nmol Ca^‘*‘/mg prot/min respectively (mean ± s.d. of 
results from 3 intestinal preparations). To determine these parameters, the initial rate of Ca^"  ^
uptake was assayed after 45 sec incubations at 20, 50 and 100 pM Ca^ "*". and V^^^ 
were calculated from a double reciprocal plot (Fig.6.3); the line of best fit was computed by 
regression analysis. The Ca^"  ^contamination of the buffers in which BBMV were prepared 
(resuspension buffer. Chapter 2.2.1) was relatively constant at 12.2 pM ± 3.3 pM (mean ± 
s.d. from 5 buffers).
Reported values for and V^^^^ of Ca '^*' uptake by BBMV suggest that there are 
two distinct binding sites. In vesicles from rat duodenum. Miller et a/. (1981) determined 
two binding sites for Ca^ "*" at equilibrium with affinities of 37 pM and 16.6 mM but in a later 
study assessed these as 1.6 pM and 3571 pM respectively (Miller et ah, 1982). Also in the 
rat, Shibita & Ghishan (1991) measured a single site with an affinity of about 700 pM but 
they removed the rapid binding component, presumably because it represented non-specific 
binding to the membrane exterior, before calculating this value. In BBMV prepared from 
rabbit intestines, Merril et al. (1986) did not calculate kinetic parameters of Ca uptake but 6-8 
nmol Ca/mg protein were bound after 5 min incubation with 250 pM Ca^* ,^ which appears to 
be a similar rate of uptake to that determined in this study (2.4 nmol/mg at 50 pM). The low 
affinity (K ^ in mM range) component was not identified in these experiments because Ca^"^
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Fig.6.1 Calcium uptake by BBMV.
45,25 p.1 of BBMV were added to 25 jil of CaCl2, 150 mM choline chloride, 20 
mM PIPES. Final [Ca '^*’] 50 p.M, protein concentration 3.5 mg/ml and pH 
7.2.
The results are corrected for ^^Ca retained in the absence of BBMV (< 0,3% 
of total Ca). Values are the mean ± s.d. of triplicate determinations on a single 
intestine.
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Fig.6.2 The initial rate of calcium uptake at different concentrations.
Experimental conditions are as in Fig.6.1.
The results are corrected for ^^Ca retained in the absence of BBMV. 
Values are the mean ± s.d. of triplicate determinations on a single intestine.
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Fig.6.3 A double reciprocal plot of calcium uptake by BBMV.
Data taken from Fig.6.2. In this intestinal preparation = 51.68 }iM and 
Vmax = 0-216 nmol/mg/sec (1.3 nmol/mg/min).
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Fig.6.4 The effect of albumin on calcium uptake by BBMV.
X Results show a double reciprocal plot of the uptake of 20, 50 and 100 
|iM "^^CaCl2 following 45 sec incubation with BBMV.
A Calcium uptake in the presence of 400 p.M albumin.
Experimental conditions as in Fig.6.1.
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binding was measured only at low concentrations (upto 100 |iM usually and once upto 500 
|iM). Most of the measured Ca^ "*" uptake is likely to represent uptake by intact BBMV, but it 
cannot be excluded that part could be binding to other material in the preparation e.g. unfused 
brush-border membranes, microvillar core protein (Chapter 3.2).
6.2.3 The Effect of Europium on Calcium Transport
Ca^"  ^uptake into BBMV was not inhibited by preincubating the vesicles for 15 min 
with upto 100 |XM EuClg (Table 6.2). This result suggest that although-europium is fully 
bound to BBMV under these conditions (Chapters 3.3.2 and 4.2) it is not associated with 
membrane Ca^'^-binding sites and/or free europium ions are not available.
It has also been established (Chapter 4) that Eu can be donated to membranes in a
more soluble form if it is bound to a suitable ligand (e.g. albumin); this form of Eu might
have a different effect on Ca^ *** uptake. In testing for the effect of Eu-albumin complex on
Ca^ "*" transport, the action of the albumin alone was also studied in order to determine the
effect of its competition for Ca^ **" with the membranes. The albumin was dialyzed against
EDTA and choline buffer to remove contaminating Ca^ "*" (molar ratio of Ca:albumin was
1:10 before and 1:39 after dialysis). Albumin (400pM, equivalent to 2.7%) alone inhibited
BBMV Ca uptake (Table 6.3 and Fig.6.4); this albumin concentration was chosen as it is
fairly near to that found in extracellular fluids (3 - 5%). In the presence of albumin there is
9+an apparently decreased affinity of the BBMV for Ca with a slightly increased maximum 
rate of Ca^ "*" uptake suggesting that albumin competitively inhibits Ca^ "*" uptake by BBMV. 
The inhibition is likely to be due to competition for binding Ca^"  ^ions between the albumin 
and the BBMV rather than albumin acting on membrane Ca^"*"-binding sites. It was 
calculated that the contaminating Ca^"^ in the albumin could not have accounted for the 
albumin inhibition.
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Table 6.2 The Effect of EuClg on Ca^"  ^Uptake by BBMV.
[EuClg]
(liM)
[Ca2+]
(pM)
Calcium uptake **
(% of normal activity) 
Intestine 1 Intestine 2
5 20 100.4
5 50 100.8
5 100 88.1
50 20 90.5 95.2
50 50 88.1 100.0
50 100 84.6 107.0
100 20 95.9
100 50 100.8
100 100 101.6
** 45caicium uptake was assayed after 45 sec incubation with BBMV, incubation conditions 
as in Fig.6.1. Final pH 7.15 and BBMV concentration 3.5 mg/ml.
BBMV were preincubated with Eu for 15 min before addition of Ca^ "*". None of the results 
were significantly different from untreated uptake as determined by the unpaired students t- 
test The results are the means of triplicate determinations.
A fine precipitate, possibly of Eu, denatured protein or both, was observed when Eu 
was added to the albumin solution. It was found in subsequent studies (Chapter 4.2.3.2) that 
dialyzed albumin bound Eu rather weakly. The Eu-dialyzed albumin mixture produced a 
similar inhibition to albumin alone (Table 6.3) which was to be expected since the Eu was not 
effectively donated by the dialyzed albumin. As dialyzed albumin was a poor ligand for Eu, 
the effect of Eu, donated in a soluble form from ligands, on Ca^"^ uptake by BBMV are 
unclear. These studies of the effect of lanthanide/ligand combinations on Ca^"^ transport 
need to be extended further. If albumin is used as a donor of Eu, it must be remembered that
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the protein also contains bound calcium. As Ca and Eu apparently do not bind at the same 
albumin site (Chapter 4.2.3.2), the ^^Ca could perhaps be bound to albumin first and then 
donated to the BBMV. In order to study the effect of Ln-ligands on Ca^"  ^by BBMV, low 
molecular weight ligands that are available Ca^'^-free and that have a low affinity for Ca 
may be useful.
Table 6.3 The Effect of Eu-Albumin (Dialyzed) on Ca Uptake by BBMV.
Treatment Km Vmax
(pM) (nmol/mg prot/min)
None 26.6 1.74
400 pM Albumin 169.1 2.12
4(X) pM Albumin/50 pM Eu 160.7 2.22
Experimental conditions as given in Table 6.2.
Results are triplicate determinations from a single intestinal preparation.
6.3 The Effect of Lanthanides on Calcium Homeostasis in Isolated 
Hepatocytes
Isolated hepatocytes were chosen as a relatively simple system in which to investigate 
the effects of Ln on cellular calcium homeostasis. .
Holmium was chosen as a representative of the lanthanide series because 
concentrations of this lanthanide could be readily measured by atomic absorption 
spectroscopy.
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6.3.1 The Effect of Holmium on Total Cell Calcium
6.3.1.I Experimental Protocol
Hepatocytes were isolated and yield and viability assessed (Chapter 2.3).
I
The hepatocytes were resuspended at a concentration of 1 x 10^ cells/ml in calcium-free 
buffer (see below) pregassed with 95% 02/5% CO2. Calcium was omitted from the buffer to 
maximize the effect of Ho.
(Buffer: 0.1 M mannitol, 0.1 M NaCl, 0.1 mM MgSO^, 20 mM PIPES, pH 7.4,37°C).I
Buffered H0CI3 (see Chapter 2.1.1; final concentrations from 1 pM to 5000 pM) or an equal 
volume of buffer were added to the hepatocytes.
. The hepatocytes were incubated with
t gentle shaking for 15 min at 37°C.
CaCl2 was added to the medium to a final concentration of 2.5 mM.
I The hepatocytes were incubated as above for a further 15 min.
The hepatocytes were pelleted by centrifuging at 50 g.
%  #
The hepatocytes were resuspended The supernatant was decanted off and
in an equal volume of Ca^'^-free calcium, holmium and LDH (lactate
buffer, recentrifuged and then dehydrogenase)assayed as given in
resuspended in Ca '^*’-ffee buffer. Chapter 2.3.2 and 2.3.1.2.
Calcium, holmium, LDH and protein were assayed 
as given in Chapter 2.3.2,2.3.1.2 and 2.5.2 (b).
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6.3.1.2 Results
The hepatocytes contained 25% and 37% more calcium after being treated with 1000 
pM and 5000 pM Ho respectively, expressed on a per mg of protein basis (Fig.6.5, Table 
6.4). Ho did not interfere with Ca or protein analysis, as judged from Ca and protein stand­
ards that had Ho added at concentrations from 0.01 to 30 mM and 0.1 to 10 mM respectively. 
The cell Ca content, expressed as a percentage of the total amount of Ca recovered in the cells 
and supernatant, is increased by 13% and 14% by 1000 pM and 5000 pM Ho (Table 6.4); 
this demonstrates that the increase in cell Ca content cannot be explained by an increased 
amount of total Ca. Assuming a cytocrit of 5%, one gets a cell Ca concentration of 0.6 mM, 
which agrees quite closely with reported values of 1-2 mM total Ca in mammalian cells 
(Alberts et al., 1983).
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Fig.6.5 The calcium and holmium content of isolated hepatocytes treated with 
holmium.
The results are the mean + s.d. of triplicate determinations in 3 separate 
experiments. See text for experimental details.
* p<  0.05 compared to calcium content of untreated cells.
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Table 6.4 Calcium Content and Hepatocyte Viability after Holmium Treatment
[Holmium]
(pM)
Hepatocyte calcium content
(% of total Ca 
(nmol/mg prot) in Hep and Sup)
Total recovery 
of calcium 
(nmol)
Hepatocyte 
LDH leakage 
(% of total)
0 18.5 ±2.2 1.54 ±0.52 4635 ±175 42.2 ±8.5
1 18.8 ± 1.0 1.49 ±0.44 4662 ± 346 41.7 ±7.8
10 18.2 + 0.6 1.56 ±0.56 4475 ±583 39.4 ±8.2
100 18.8 ±1.5 1.52 ±0.37 4743 ±463 40.5 ±5.9
1000 23.2 ±4.7 1.74 ±0.43 4716 ±482 39.8 ±3.2
5000 25.4 ±3.2* 1.75 ±0.50 4862 ±119** 25.2 ±13.8
See text for experimental protocol. Mean ± s.d. of 3 separate experiments, 
p < 0.05 different from untreated cells (unpaired t-test).
0.05 < p < 0.1 different from untreated cells.
The increase in cell calcium is not related to greater cell permeability and cell death, 
as judged by leakage of the cytosolic enzyme lactate dehydrogenase (Table 6.4), with Ho 
appearing to be slightly cytoprotective. The reduction in extracellular LDH may be partially 
due to a direct effect of Ho on LDH assay; in suspensions of lysed hepatocytes. Ho, at 0.2 
mM and 10 mM, inhibited assay of LDH activity by 3% and 12%. However this does not 
fully account for the 60% reduction in LDH leakage observed at 5 mM Ho. Lanthanum has 
also been shown to reduce cell damage caused by the omission of Ca^"  ^from extracellular 
medium (Thomas & Reed, 1988). The rapid fall in viability during incubation was most 
likely due to the "Poor" medium (phosphate-free, initially Ca '^*‘-ffee) required for work with 
the rare earths. Following a single 30 min incubation, LDH leakage was 26.6 ± 0.3 % in 
Ca '^**-free basic medium, 18.0 ± 0.9% with 2.5 mM Ca^"  ^and only 11.4 ± 0.5% in a cell 
culture medium (Leibovitz L15).
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The increase in hepatocyte Ca was correlated with saturation of hepatocytes with Ho 
(Fig.6.5). The hepatocytes contained 22.7 ± 12.7 nmol Ho/mg protein and 16.8 ± 5.4 nmol 
Ho/mg protein after treatment with 1 mM and 5 mM H0CI3 respectively. Hepatocyte Ho 
content is probably a more accurate index of the dose of Ho received than the concentration 
of Ho added because of the ability of lanthanides to adhere to glassware etc. The results 
suggest that Ho and Ca are present at different sites in hepatocytes because the Ho binding, 
despite being of similar magnitude to Ca content of the cells (Fig.6.5), increases rather than 
decreases cell calcium content. Total cell calcium is the sum total of calcium present with the 
plasma membrane, cellular organelles and the cytosol and thus does not accurately reflect the 
concentration of free Ca^"  ^in the cytosol.
6.3.2 Measurement of Intracellular Calcium
The effect of Ln on [Ca^'*']j was also investigated by a very sensitive method, 
employing Ca^'^-specific fluorescent dyes e.g. quin2, that can be loaded into the cell cytosol. 
Details of the methodology employed for measuring [Ca^'^j using fluorescent dyes are given 
in Chapter 2.3.3.
6.3.2.1 Lanthanide Quenching of Calcium Probe Fluorescence
The fluorescence of quin2 is sensitive to quenching by certain metals e.g. Zn^ "*", 
Mn^ *** (Arslan et al., 1985; Rink & Pozzan, 1985). It has also been demonstrated that Ln 
quench quin2 fluorescence by forming relatively stable 1:1 complexes (Clarke et al., 1988). 
It was therefore important to measure the direct effect of Ln on dye-fluorescence so that 
appropriate correction could be applied when determining the effect of Ln on [Ca^*^]j.
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Holmium was found to quench quin2 fluorescence even in the presence of excess EGTA,
which would have chelated much of the Ho (Fig.6.6 (b); Lg K Ho-EGTA 17.9).
Fura-2, was tested for its sensitivity to Ln quenching. With fura-2, can be
measured as the ratio of the excitation signals at 340 nm and 380 nm, which are the excitation
signals for Ca-bound and Ca-free dye respectively. Ce, Hd and Eu quenched fura-2 (2 pM)
fluorescence by about 50 % at concentrations of about 0.5 pM (e.g. Fig.6.7). The level of
Ca^"  ^present was just below that which would saturate fura-2. When lanthanides were added
from 0.5 to 3 pM, the fluorescence signal took some minutes to reach an equilibrium value.
9 4 -Lanthanide inhibition of fura-2 could be overcome by adding EGTA and excess Ca (Fig
6.7). The inhibition of fura-2 fluorescence was not common to all divalent and trivalent ions 
because Ap***, at concentrations upto 50 pM, had no effect on fura-2 fluorescence.
Thus the use of Ca-fluorophores to measure changes in [Ca "^*]^  caused by Ln requires 
careful interpretation of results, to discriminate between Ln quenching of dye signal (some of 
which may be extracellular) and changes in [Ca^ "*"]^ .
6.3.22 Results
The results of an experiment measuring the concentration of intracellular calcium, 
without Ln, in isolated hepatocytes are shown in Fig.6.8. The peak emission of the 
quin2/AM loaded cells (upper right hand trace) is about 490 nm (quin2) compared to a peak 
emission of 460 nm, mainly from NADPH, in cells incubated with DMSO (the carrier for 
quin2/AM). Initially the quin2 signal (upper left hand trace), measured at an excitation 
wavelength of 339 nm and emission wavelength of 492 nm, was increasing. This probably 
represents leakage of cell quin2 to the extracellular medium where saturating Ca 
concentrations were present. The extracellular quiu2 signal was quenched by adding Mn 
(100 pM) and was restored when DTPA (200 pM) was added to chelate the Mn. Mn and 
DTPA had no effect on the fluorescence of DMSO loaded cells (Fig.5.5). ATP (100 pM),
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400360320280
Ex. Wavelength (nm)
Fig.6.6(a) Ca-quin2 excitation spectrum.
400360280 320
Ex. Wavelength (nm)
Fig.6.6(b) Holmium quenching of 
quin2 fluorescence.
Emission wavelength = 492 nm.
Incubation solution (intracellular-like); 21 }iM quin2, 125 mM KCl, 1 mM MgCl2, 20 mM 
PIPES pH 7.05.
A The for Ca-quin2 is so low U Conditions as for D.
(100 nM) that a maximal signal is V + buffer.
recorded from contaminating Ca "^ .^ W + 34.3 |iM H0CI3.
B + 420 |iM EGTA (min. fluorescence). X 205 ^M H0CI3.
C + 43.3 |iM CaCl2 (final concentration). Y 376 i^M H0CI3.
D 130 iiM CaCl2.
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which stimulates [Ca^'^j (Cobbold et al., 1988), increased the fluorescence signal; it caused a 
transient rise in the background fluorescence of unloaded cells. Calibration of the 
fluorescence signals in terms of [Ca^ "**]^  was made by lysing the cells using digitonin (4.2 
P-M) to give a maximum fluorescence signal; the Ca^"  ^was chelated by EGTA (5 mM) to 
give a minimum signal. [Ca^'*lj before and after addition of ATP was calculated as given in 
Chapter 2.3.3.(c).
In duplicates from this experiment, basal [Ca^'^jj was 228 and 192 nM and rose to 
1123 and 469 nM following stimulation with ATP. The value of basal [Ca^'^j recorded by
other workers is about 200 to 250 nM (e.g. Berthon et at., 1984; Long & Moore, 1987).
9+However, consistent values for [Ca in isolated hepatocytes could not be 
determined; investigation of this problem and its possible causes are discussed below 
(Chapter 6.3.2.3). Some single experiments on the effects of Ho on [Ca^"*]  ^(as followed by 
changes in the 339/492 signal) were carried out and appear to provide valid results. Ho (up to 
55 |iM) did not have any effect on the fluorescence signal when added to the cuvette 
containing hepatocytes incubated in Krebs-Henseleit medium (Fig.6.9). However, in a 
calcium-free, phosphate-free buffer Ho, (5 and 55 pM) reduced the fluoresence signal but this 
was inhibited if the cells had been pretreated with Mn (100 pM; Fig.6.9) or EGTA (7.1 mM; 
results not shown). This suggests that Ho may be quenching extracellular quin2 rather than 
affecting [Ca^*^j; in Krebs-Henseleit medium, phosphate and bicarbonate precipitation may 
prevent this Ho effect on quin2. At these concentrations Ho had no effect on the 
autofluorescence of unloaded cells. At a concentration of 0.5 mM Ho increased the signal in 
quin2 loaded cells but also in control cells loaded with DMSO. Unfortunately it was not 
possible to calibrate the signal in terms of [Ca^'^Jj because the detergent used in this 
experiment, Triton X-100, caused a large change in the background fluorescence (see below) 
and this prevented the maximum emission of the dye from being calibrated.
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6 3.2.3 Difficulties in Measuring in Isolated Hepatocytes
Overall, measurement of intracellular Ca with quin2 in hepatocytes proved 
inconsistent. [Ca '^*']  ^ranged from 69 - 273 nM and often no accurate measure of [Ca^‘*']j 
could be made at all as the fluorescence signal was the same as the maximum fluorescence 
signal, suggesting that [Ca^‘*']j was very high. A combination of factors may have 
contributed to problems in the measurement of [Ca^'^p
Quin2 leakage from the hepatocytes was relatively rapid, as revealed by Mn quench­
ing of extracellular quin2 and the signal being restored by the chelation of Mn by DTPA 
(Fig.6.8). Cells that have been treated with proteolytic enzymes during their isolation tend to 
be permeable to the dyes (Tsien & Pozzan, 1989). In future, leakage might be reduced by 
conducting experiments at 20°C - 30®C and if using fura-2 by inhibiting cell anion transport 
with probenecid to reduce loss of fura-2 from the cells (Malgaroli et al., 1987; McDonough & 
Button, 1989).
The relatively large amount of cell autofluorescence also made [Ca^"^^ measurement 
with quin2 difficult (Fig.6.8). Probably most of the cell autofluorescence is derived from 
NADH or NADPH which have an excitation peak at about 345 nm and emission peak at 450 
nm, close to the respective peaks of 330 and 490 nm for quin2. Cell autofluorescence can 
account for 15 to 30 % of total fluorescence (Rink & Pozzan, 1985). Fura-2 may be less 
susceptible to this problem because its emission peak is slightly further from the nucleotides 
than that of quin2 and it has a much greater intrinsic fluorescence.
The agents (detergents and Ca^*  ^chelating agents) added to calibrate the [Ca^*^]  ^
signal introduced difficulties because they altered the fluorescence signal, as judged in cells 
not loaded with quin2. Triton X-100 (0.1%), used to permeabilize cells, markedly reduced 
the fluorescence, possibly by reducing viscosity of the solution. Digitonin (2 pM) appears to 
be a better choice than Triton X-100 because it interfered much less with the signal whilst 
ionomycin may be an alternative agent reported to permeabilize cells (Tsien & Pozzan, 
1989). EGTA, which was added after permeabilisation to strip all Ca^"  ^from quin2 to obtain
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a minimum fluorescence value, also reduced the fluorescence. Changes in fluorescence 
caused by these agents were accounted for in calculation of [Ca^"*]p
Just after hepatocyte isolation into Krebs-Henseleit, at least 85 % (mean = 91%; s.d.= 
4%) of the total number of cells were viable as judged by Trypan Blue dye exclusion; the rate 
of loss of viability varied between experiments with between 20 and 80 % of cells healthy 3 
hours post isolation. As the intracellular calcium concentration is raised in dying cells, they 
should be as healthy as possible. Also, dying cells release esterases and thus hydrolyze the 
dye extracellularly preventing cell loading with dye. In order to try to improve the 
maintenance of cell health, the Krebs-Henseleit was replaced by cell culture medium. Eagle’s 
minimum essential medium (MEM), supplemented with amino acids; in this medium the cells 
were more stable with about 80 % of cells viable after 3 hours incubation. It should be noted 
that fluoresence measurements in the cuvette must be made in a salt solution to reduce 
background interference.
Yeast {Saccharomyces Cerevisiae, 754 strain) were investigated as an alternative 
system under which conditions for measurement of [Ca '^^'jj might be optimized without the 
need for animal tissues. These cells, unfortunately, did not take up quin2/AM.
6.4 Discussion
9 4 -The mechanism(s) of Ca absorption across the intestinal brush-border membrane 
has not been characterized (Bronner, 1987), but studies with BBMV demonstrating saturable 
uptake suggest a carrier mediated transport and/or uptake through membrane channels (e.g. 
Miller gf aL, 1982; Schedl & Wilson, 1985). Under the conditions employed here, Ca^"^ 
uptake was not perturbed by pretreating the BBMV with 100 pM EuClg to try to occupy 
Ca^"  ^transport sites. However, the same concentration of LaClg was reported to inhibit 
Ca^*^  uptake by approximately 50 % in rat duodenal BBMV (Miller & Bronner, 1981; Miller 
et al., 1982). The apparently conflicting results may represent a difference in potency
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between the lanthanides (atomic No. of La and Eu is 57 and 63 respectively) at this binding 
site, caused by different size or other physico-chemical property. Species difference in the 
mechanisms of Ca '^*' uptake by BBMV (Schedl & Wilson, 1985) may also explain the 
differing effect of Ln on Ca^ "** uptake by BBMV. The result of these studies with EuClg in 
rabbit BBMV demonstrate that Ln cannot be assumed to be inhibitors of Ca transport, even 
under conditions where Ln binding to membranes has been demonstrated (Chapter 4).
Holmium increased the calcium content of hepatocytes, which is in contrast with the 
general observation that Ln displace calcium from tissues and inhibit membrane calcium 
fluxes (e.g. Langer & Frank, 1972; Flatt et al., 1980; dos Remedios, 1981). Parker and Bar­
ritt (1981) have previously reported that LaClg (0.2 to 1 mM) also stimulates ^^Ca exchange 
in isolated hepatocytes, leading to an increase in cell calcium content. As judged here by 
enzyme leakage, the increase in cell calcium content is not due to reduced cell viability, also 
in agreement with Parker & Barritt (1981). In fact. Ho appears to be cytoprotective at high 
concentrations (Table 6.4). From this initial observation on the possible increase in total cell 
calcium, mechanisms of Ln action on hepatocyte calcium homeostasis can only be speculated 
upon.
Ln could inhibit the plasma membrane Ca^'^-ATPase, which removes Ca^ "*" from the 
cell cytosol with high affinity (K ^  of 1 \iM  or less; Birch-Machin & Dawson, 1988); Ln 
inhibit Ca^^-ATPase on other cell plasma membranes (e.g. Schatzmann et al., 1986). This 
has been found not to require intracellular penetration of Ln in red blood cells (Schatzmann et 
al., 1986; Szasz et al., 1978) but in any case the distribution of Ln in in vivo experiments 
suggest that hepatocytes may indeed internalize some Ln (Chapter 5). However, Parker & 
Barritt (1981) suggested from kinetic analysis of their ^^Ca fluxes that Ca efflux was not 
inhibited by La. Thus the increase calcium content of hepatocytes may involve enhanced 
Ca^*  ^influx. The mechanism by which this occurs is not known but might involve Ln 
interaction with specific Ca^*  ^inflow channels or be due to Ln saturation of external 
plasma membrane phospholipids, leading to changes in cell membrane permeability.
The quenching effect of the lanthanides combined with the technical problems in
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measuring [Ca^'^j did not allow accurate or reproducible determination of the effect of Ln on
[Ca '^*’]j. Measurement of [Ca^’^ jj in isolated hepatocytes will probably be more easily
obtained using fura-2 and indo-1 than quin2 because of their greater intrinsic fluorescence.
When trying to distinguish between the effect of Ln on [Ca^'^j^ and effect on the dye, it may
be helpful to compare results obtained with both fura-2 and indo-1 because whilst Ln inhibit
fura-2, La^"^ has been shown to stimulate the fluorescence of indo-1 (Peeters et al., 1989).
[Ca^'^j might also be measured as the activity of glycogen phosphorylase a\ the formation of
9 +phosphorylase a is catalyzed by Ca -sensitive glycogen phosphorylase kinase (Long & 
Moore, 1987).
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CHAPTER?
DISCUSSION
7.1 Conclusions
The cellular uptake of essential metals occurs via specific transport mechanisms
da Silva
which have evolved to satisfy body or tissue requirements (Chapter 1.2; Fraustoj& Williams,
1991). Generally, non-essential metals are excluded from transport mechanisms for essential
metals and thus non-essential metal ions, fortunately, tend to be poorly absorbed in the
gastrointestinal tract and not readily taken up by cells (Foulkes, 1984). In addition, low
availability of non-essential metal in water and the environment may also preclude substantial 
da .Silva
cellular uptake (Fraust^& Williams, 1991). However, the following reasons outline why the 
study of cellular uptake of non-essential metals, with special reference to the lanthanides, is 
of importance.
(a) Non-essential metals can interfere with i) uptake ii) biological activity at active sites, 
of chemically similar essential metals; lanthanides are analogues of calcium.
(b) Environmental and man-made contamination can lead to exposure to high 
concentrations of non-essential metals; commercial uses of lanthanides are rapidly 
increasing.
(c) Non-essential metals may have therapeutic/toxic/diagnostic potential; the lanthanides 
display a wide range of interesting biological properties and a Ln based compound is 
currently in use as a contrast agent
The results presented were mainly obtained with Eu, which was chosen for technical 
reasons and because Eu is positioned in the middle of the Ln series but are likely to extend to 
rest of the members of the series because of their similar physical and chemical properties 
(Choppin, 1989). The principle conclusions of this project are discussed below.
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(1) Eu, as the chloride salt, forms aggregates (microprecipitates) in solution at neutral pH 
(Chapter 3), even in phosphate- and bicarbonate-free conditions. Once formed, these 
aggregates are relatively stable, even in the presence of DTP A, a powerful ligand for Ln. 
When injected i.v. the Ln aggregates are distributed in a manner consistent with particulate 
matter (Chapter 5; Aeberhardt et al., 1962). Thus, EuClg is a poor form of Ln with which to 
investigate membrane transport and biological activity because concentrations of available Ln 
are likely to be low. The formation of aggregates, giving rise to low concentration of free 
ion, may explain conflicting reports of the ability of Ln to cross cell membranes in vitro e.g. 
cardiac muscle (Langer & Frank, 1972; Peeters et al., 1989; Chapter 1.5.4). Conversely, in 
tissues capable of phagocytosis, intracellular Ln may originate from phagocytosis of 
particulates. These formation of Ln microprecipitates question the quantitative value of 
results where Ln salts are added to perturb a particular system as it is clear that at 
physiological pH an unknown proportion of Ln is likely to be present as L n ^ \
(2) For a range of Eu complexes of high and low molecular weights, a consistent 
(reverse-sigmoidal type) relationship is obtained between the log Kg (Eu-ligand; abscissa 
values) and delivery of Ln, as judged by binding to BBMV, under phosphate- and 
bicarbonate-free conditions at physiological pH. A balance between keeping Eu in solution, 
chelation of metal to ligand (ligand:metal ratio of 2:1) and donation of metal to brush-border 
membranes is best achieved by complexes of about log Kg of 7 -12 e.g. citrate, NTA. From 
these studies it is not clear in what form (e.g. Ln '^*', Ln(OH)^'*', Ln-ligand), Ln donated by 
"suitable" ligands (log Kg of 7 - 12) binds to BBMV. In any case, complexes of log Kg of 7 - 
12 create much more controlled delivery of Ln than from the chloride and are likely to be 
useful in studies of biological actions of Ln, performed under similar conditions (see Further 
Studies in Section 2 of this Chapter). A limitation of using log Kg to represent the strength of 
complexes is exemplified by Eu-catechol, which has a log Kg of 11 but does not effectively 
bind Eu in these conditions. Aluminium-catechol complex also has a high stability constant, 
suggesting a strong complex, which in practice turn out to be weak (Martin, 1991). For both 
Eu and Al, log Kg may overstate catechol binding strength because it does not account for
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protons competing with metal for basic binding sites on the ligand (Martin, 1991; Catsch & 
Harmuth-Hoene, 1979). More complex parameters, such as conditional stability constants, 
may predict more closely the ability of ligands to bind/donate Ln (Catsch & Harmuth-Hoene, 
1979; Martin, 1991).
(3) The stability of Ln-complexes is dependent on competing reactions for the ligand and 
metal. This is demonstrated by the precipitation of Eu from ligands (Eurligand 1:2 and 1:5) 
of log Kg of 7 - 12 (Chapter 4.4) when phosphate was present and from cell culture medium 
that contained other metals, phosphate and bicarbonate. If the ratio of ligand:Eu is raised so 
that ligand is present in large excess (e.g. citrate:Eu of 20:1), then Eu is maintained in a 
soluble form and donated to BBMV. Thus pre-formed Ln-ligand complexes with an excess 
of ligand may be useful in studies of Ln action, removing the requirement that they be carried 
out in phosphate- and bicarbonate free solutions. Interestingly, Eu-albumin at low ligandzEu 
ratios (1:5), despite a relatively low log Kg (6.4), is less susceptible than other low molecular 
weight complexes of higher stability constants to competition from phosphate or other metal 
ions in solution and indeed keeps Eu in solution in physiological media. This is confirmed by 
a distribution in vivo which shows that Eu from Eu-albumin (1:4) is excreted in urine and 
bound to bone but not precipitated in blood; the Eu:albumin ratio is, however, much 
increased after injection. Whilst pre-formed Eu-albumin complexes are stable, transfer of 
Eu^^ to albumin under physiological conditions appears only to be possible if Eu is 
transferred from another ligand e.g. citrate (Schomacker et al., 1988). Perhaps surprisingly, 
injecting EuClg at acidic pH does not enable Eu binding to albumin. Despite the vast excess 
of albumin as the potential ligand. Eu was distributed in a manner similar to aggregated 
EuClg at pH 7.
(4) Ln strongly interact with brush-border membranes, as revealed by a fraction of Eu 
bound to BBMV which cannot be removed by DTPA. Very small amounts of Eu are 
recovered in the BBMV interior, so there is only weak evidence to support the hypothesis that 
Eu can be transported across the brush-border membrane. Strong membrane binding and 
poor internalization of Ln is consistent with the classical view of Ln as membrane
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imperaieant metals (e.g. Flatt et al., 1982; Chapter 1.5.4). Avid membrane binding but poor 
internalization by brush-border membranes is also observed with other non-essential heavy 
metals, e.g. inorganic mercury and cadmium (Foulkes, 1988; Bevan & Foulkes, 1989) and so 
the uptake of Ln by BBMV would tend to confirm the proposal (Foulkes, 1985; Foulkes, 
1988) that some common binding site(s) may account for.BBMV uptake of non-essential 
metals, despite their differing chemistries. Such binding sites may also be important in the 
initial binding of essential metals to membranes because heavy metals and organic cations 
non-specifically interfere with uptake of essential metals (Foulkes, 1985). However, as Eu 
apparently does not interfere with calcium uptake (Chapter 6), it is unlikely that all heavy and 
essential metals have common binding sites on brush-border membranes.
The interaction of lanthanides with BBMV is temperature sensitive, suggesting that 
membrane fluidity is important in Ln uptake. Membrane fluidity may regulate Ln uptake via 
the movement of carrier proteins in the membrane (Foulkes, 1988) or via the accessibility of 
proteins and glycolipids for binding (Shinitzky, 1984).
The change in vesicle morphology observed after treating BBMV with EuClg, 
suggests that Ln binding to brush-border membranes leads to derangements of membrane 
organization. As membrane organization is critical to cellular function, Ln in principle may 
alter cellullar function through actions on membranes, that are apparently not linked to the 
homeostasis of essential elements. Brush-border membranes may be particularly sensitive, 
perhaps because of their particular membrane composition, to alterations in membrane 
organization by metals because Kirschbaum (1984) reports that a number of metals, but 
particularly the Ln, alter the membrane organization of renal BBMV. Changes in cellular 
function following alteration in membrane organization were proposed as a cause of heavy 
metal nephrotoxicity (Kirschbaum, 1984). The observation of Berry et al. (1989) of lesions 
of the proximal convoluted tubule following i.p. administration of Ln salts to rats is further 
circumstantial evidence that brush-border membranes are a potential target for Ln action. 
This mechanism of Ln toxicity is of concern because Gd may be retained in the kidney after 
administration of Gd-DTPA, which is used as a contrast agent in humans (see below).
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Inhibition of Kupffer cell phagocytosis (equivalent to reticuoendothelial blockade) following 
Ln coating of the cellular membrane suggests that Ln effects on membranes may not be 
limited to brush-border membranes (Hustzik et al., 1980).
5) From the results of an in vivo distribution study it was demonstrated that whilst liver 
and bone are the targets for Ln particulates (e.g. LnClg), kidney and bone retain Ln from the 
soluble Ln complexes Eu-albumin and Eu-DTPA. In the liver, Ln particulates are distributed 
into non-parenchymal and parenchymal cells. The mechanism of Eu uptake in hepatocytes is 
not clear but may involve pinocytosis, inflow through non-specific ion channels (Crofts & 
Barritt, 1990), or transfer via endogenous ligands. No specific cytotoxicity test were carried 
out but the hepatic accumulation of Ln is consistent with the toxicity of Ln towards 
hepatocytes (Arvela, 1979) and the inhibition of Kupffer cell phagocytosis (Lazar, 1973; 
Hustzik et al., 1980). As (in the rat) substantial amounts of albumin are filtered the 
reabsorption of albumin most likely delivers the Eu to the endosome/lysosome compartment. 
Release of Eu from Eu-complexes to bone may involve Ln binding to osteoid and phosphate 
components of bone (Evans, 1990).
(6) Holmium, as the chloride salt, increased the total calcium content of hepatocytes, 
rather than a displacement of calcium that has been observed with most tissues (e.g. Langer & 
Frank, 1972). This suggests that the effect of lanthanides on calcium fluxes, generally taken 
to be inhibitory, may be more specific between tissues than previously thought (dos 
Remedios, 1981). However, it is not known whether Ln disturb the pool of cytosolic free 
calcium, which controls many cellular functions.
A practical application of this study with Ln compounds is towards the potential 
development of entities with selective therapeutic and diagnostic applications. In the 
development of therapeutic compounds, it is essential that the metal is delivered and released, 
at least partially, from its complex to have an effect at a target site. Conversely, Ln 
compounds for diagnosis may be required to be very stable to minimize toxicity from free Ln 
and reflect the biological properties of the complex rather than the ligand. The results of this
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project suggest that it may be possible to deliver Ln with the appropriate Ln-ligand 
combinations.
7.2 Further Studies
The binding sites of Ln, and non-essential heavy metals in general, remain poorly 
characterized in brush-border membranes. In view of frequent references to i) the 
competition between non-essential heavy metals and essential metals for absorption (Foulkes,
1984) but also ii) non-specific binding sites for non-essential metals on brush-border 
membranes (Section 1 of this chapter), it would be interesting to test if Ca, which is closely 
related to Ln, and metals such as Cd, Zn, which have very different chemical properties to Ln, 
interfered with the uptake of Eu from Eu-ligands. The experiments could be carried out at 
varying temperatures to differentiate between the effects of competition on the DTPA- 
resistant site and DTPA-sensitive binding sites for BBMV. Alteration of BBMV structure 
e.g. digestion of ectoproteins using papain, may help elucidate binding sites for metals on 
BBMV. Further studies with other members of the Ln series may reveal if the mechanisms of 
cellular uptake and distribution are dependent upon a chemical or physical parameter e.g. 
ionic radius, ionization potential, of this closely related series.
Brush-border membrane vesicles are a convenient system in which to study initial 
phases of binding and transport across the luminal membrane but may not be indicative of the 
complex process of in vivo intestinal absorption (Foulkes, 1984; Johnson, 1989). For 
example, BBMV possess no mechanisms for the removal of metal from intracellular sites 
which may become saturated. Also, some intestinal absorption, especially of uncharged 
compounds as reported for aluminium citrate and chromium-EDTA (Bjamasson et a l, 1985, 
Froment et al., 1989), may occur via intercellular junctions. It would be of interest to 
determine if BBMV binding and transport, or lack of it, of Ln-ligands is related to absorption
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in vivo. This may be of relevance to the uptake of other non-essential metals whose uptake 
may be influenced by ligands e.g. Al. A possible experimental approach is to orally 
administer a series of Eu-ligand complexes and assess absorption from body content and 
urinary excretion. There are cases though, especially with Ln, when measuring absorption 
after adm inistration, the balance sheet indicates some absorption which is ju st 
binding/retention on the luminal membranes in the intestines. An alternative approach is in 
situ perfusion of a section of intestinal lumen and vasculature, permitting control of the 
luminal environment and direct measurement of metal transfer into blood (Steel & Cousins,
1985).
The binding and transport of Ln-ligands has been investigated in the intestinal brush- 
border membrane, which is functionally different from other membranes in absorbing large 
amounts of many metals, and also differs in composition because it is rich in cholesterol, 
protein and glycolipids and has low membrane fluidity (Madara & Trier, 1987; Hauser et al., 
1980). A survey of log Kg of Eu-ligand and membrane binding with several different 
membranes e.g. red blood cell, hepatocyte plasma membrane, mitochondrial membrane, 
would identify if similar mechanisms of Ln binding exist between cells. Assessment of Ln 
membrane binding versus cell/organelle function may indicate whether Ln membrane binding 
is reponsible for biological effects. Further, membrane compostion e.g. protein content, 
glycosaminoglycan content, may be important with respect to Ln binding and membrane 
actions. On the other hand, binding of Ln to plasma membranes may be simply a function of 
phosphatase activity. Determination of Ln binding to liposomes containing known mixture of 
pure phospholipid and protein or glycolipid may also be useful in determining the membrane 
binding sites of Ln.
The kidney is a potential target for Ln released from stable Ln complexes. The 
biological effects of Gd-DTPA complex are of interest because it is administered in large 
doses as a contrast agent in MRI. The toxicity of Ln-DTPA to kidney needs to be examined 
in detail. Electron microsopic analysis of tissue may prove useful in assessing any pathology 
but also in detecting the localization of Gd, either by probe analysis or using the electron
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density of the metal. Further study of the subcellular distribution using dual-labelled Ln and 
DTPA may be able to determine if for example, Ln-DTPA complex is internalized into 
tubular epithelium intact or if Ln released in the acidic conditions of urine, is binding to 
tubular membranes.
Lanthanides possess interesting biological properties e.g. anticoagulant action, 
inhibition of Kupffer cell endocytosis, stimulation of collagen polymerisation, inhibition of 
calcium transport, which have therapeutic potential (Evans, 1990). As a beginning in the 
search for Ln drugs, it would be of interest to compare the efficacy of Ln salts and Ln-ligands 
in models of disease that involve these properties.
If the Ln are indeed such potent analogues of Ca, their effect on intracellular free 
calcium pools is likely to be profound. Definitive studies to check these effects on isolated 
hepatocytes or other relevant cells are critical in evaluating Ln physiological activity.
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Appendix 2
The Lanthanide Series
Name Symbol Atomic No. Atomic Weight
Light lanthanides Lanthanum La 57 138.9
Cerium Ce 58 140.1
Praseodymium Pr 59 140.9
Neodymium Nd 60 144.2
Promethium Pm 61 147.0
Samarium Sm 62 150.5
Middle /  transition Europium Eu 63 152.0
lanthanides Gadolinium Gd 64 157.3
Terbium Tb 65 158.9
Heavy lanthanides Dysprosium Dy 66 162.5
Holmium Ho 67 164.9
Erbium Er 68 167.3
Thulium Tm 69 168.9
Ytterbium Yb 70 173.0
Lutetium Lu 71 175.0
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Appendix 3
Structures of Ligands
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